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SUMMARY
The polymerase chain reaction (PCR) has been widely described as a possible 
test format for mycobacterial diseases. This thesis investigates the suitability 
o f PCR for the detection o f mycobacterial disease in several formats. Firstly 
how it may be simplified for use in developing countries, through the use of 
non-radioactive detection based on fluorescein or biotin labelling during PCR. 
Secondly the possible use of PCR in tuberculosis diagnostic laboratories as 
investigated in the collaborative study designed by Noordhoek et al. 1994, 
where Southern blotting and probing with digoxygenin labelled probe were 
investigated. Thirdly its possible use as an in-situ method for the detection of 
mycobacteria in tissue sections, this work demonstrated direct incorporation 
o f digoxygenin into PCR products.
The final part of this thesis describes the investigation o f the use o f PCR based 
on the gene coding for the M.hovis protein antigen MPB70 for the detection 
of M.bovis infection in cattle. The investigation o f cross-reactivity o f the PCR 
test with other mycobacteria indicated the presence of an hitherto undiscovered 
Mycobacterium kansasii MPB70 gene analog. This analog was partly 
sequenced and characterised. Single stranded conformation polymorphism 
(SSCP) analysis and sequence determination of the MPB70 analog in a range 
o f M.kansasii strains showed significant variation in the DNA sequence and 
predicted amino acid sequence among different M.kansasii isolates.
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INTRODUCTION
1.1. IM ycobacteria
The genus Mycobacterium contains organisms that are pathogenic to man and 
others that are non-pathogenic environmental organisms. The total number of 
species in the genus is over 30, which can be divided into 2 major groups the 
slow and the rapid growers. The genus is an heterogeneous one, although all 
species are variably acid-fast. Gram -f ve, non-motile, non-spore forming 
curved or straight rods.
This thesis concentrates on the mycobacterial pathogens o f man and 
economically important animals, principally with Mycobacterium tuberculosis 
the causative organism of tuberculosis (including the tuberculosis complex 
organisms BCG, Mycobacterium bovis and Mycobacterium africanum) and with 
Mycobacterium leprae.
The best known property of the genus is the ability of the bacterial cells to 
resist decolouration by weak acids after strong staining with arylmethane dyes 
such as basic fuchsin.
This property termed acid-fastness is not unique to the mycobacteria. Members 
o f other genera such as Corynebacterium and Nocardia may exhibit some acid- 
fastness especially when grown in lipid rich media. Usually these organisms 
decolorise when a combination of acid and alcohol is used, because they may 
be acid fast but not alcohol fast (Levy-Frebault and Portaels, 1992). The acid 
fast stain or Ziehl-Neelsen stain is widely used for the detection of 
mycobacteria in clinical or environmental samples (Collins et a l ,  1985). The 
exact chemical basis for the phenomenon is still poorly understood, but dye 
retention is reported to be associated with the mycolic acids covalently bound 
to the arabinogalactan in the cell wall rather than those lying freely in the cell 
wall.
1.1.2The Mycobacterium tuberculosis complex
The tuberculosis complex consists o f M. tuberculosis, M. bovis (including 
strain BCG) M. africanum and Mycobacterium microti. M. tuberculosis can 
be grown on simple media composed of only inorganic salts asparagine and 
glycerol. Cell division takes 12-20 hrs and it may take 2-6 weeks for colonies 
to appear on primary culture. M. bovis is very closely related and its status as 
a separate species is questionable. Some tubercle bacilli isolated in Africa have 
been considered sufficiently distinct to warrant the species status of 
Mycobacterium africanum, the properties of this species are very close to those 
o f M. bovis.
l.l.B Tuberculosis in m an
Tuberculosis is still one of the major life threatening bacterial diseases, 
afflicting all races, ages and socioeconomic groups throughout the world 
(Collins, 1991). Tuberculosis was probably endemic in animals in the 
palaeolithic period long before it afflicted man (Bates and Stead, 1993). The 
organism may have been a variant of M. bovis. The first human cases were 
probably isolated cases caused by eating infected meat or drinking 
contaminated milk. When man began to settle in larger villages in the Middle 
ages the incidence increased. The disease only reached epidemic proportions 
during the industrial revolution due to extensive urbanization, overcrowding, 
poor working conditions, alcoholism and inadequate nutrition. Annual 
incidence may have reached as high as 800 per 100,000 by the mid 18th 
century. Then for largely unknown reasons, the disease went into a slow 
decline. By the turn of the 20th century it was down to 200 per 100,000 per 
annum (Collins, 1982). Much of the decline was due to non-specific factors 
such as changes in living standards, housing, and social change. The turning 
point in the history o f tuberculosis occurred on March 24th 1882, when Robert 
Koch announced his culture o f the tubercle bacillus. Koch also described a 
staining technique for this bacillus which was subsequently modified by 
Erhlich. The modern staining technique, although it bears the names Ziehl-
Neelsen, is essentially Erlichs original method. After Koch's discovery a 
number of preventative measures were introduced, the most successful of 
which were the pasteurization of milk and the development of the BCG vaccine 
as discussed in a later section.
1.1.4Pathogenesis of Tuberculosis
During the 20th century tuberculosis has changed from a disease predominantly 
found in the Northern and temperate zones of Europe to one found in the 
tropical and subtropical regions o f Africa, Asia and Central America, this is 
largely blamed on poverty in underdeveloped countries. Tuberculosis has also 
changed from a disease primarily seen in infants and young adults to one 
associated with old men, the homeless, alcoholics and drug addicts (Collins, 
1991). Most adults posses considerable innate resistance to tuberculosis. In the 
U .S.A . only a few percent of tuberculin converters actually develop active 
disease (Collins, 1991). Most infected individuals develop sufficient local 
immunity to limit the spread of tubercle bacilli beyond the draining hilar and 
tracheobronchial lymph nodes, thus preventing the development of clinically 
significant disease. However most resistant hosts seldom eliminate the bacilli 
entirely, developing instead a permanent carrier state. Failure of the cellular 
defenses to limit the spread of the tuberculous infection beyond the draining 
lymph node depends on a number of factors such as severe malnutrition, 
intercurrent infection or lack of immunocompetence caused by 
immunosuppressive therapy or autoimmune disease or more recently to human 
immunodeficiency virus (HIV). 
l .l .S S p re a d  of Tuberculosis
The main portal o f mycobacterial entry is through the mucous membranes. 
Commonly mycobacteria enter the host via the mucous membranes o f either 
the respiratory or gastrointestinal tracts. Infection with tuberculosis occurs 
most commonly via the lung. Infection with tubercle bacillus occurs by 
inhalation o f droplets 1-10/xm in size and through the ingestion o f contaminated 
milk. The bacteria reach the alveoli where they are ingested by alveolar 
macrophages. Dissemination o f the organism occurs first via the lymphatic
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system to the regional lymph nodes and then via the blood stream to other 
organs. This dissemination occurs very rapidly, within several hours. The 
primary infection has three elements; the lesion at site o f entry, the lesion at 
the regional lymph node and possibly a more distant lesion. Subsequently the 
course and nature o f the disease varies considerably from patient to patient 
from a benign self limiting infection of short duration to a progressive and 
fatal condition if  untreated. A patient with active lung disease constitutes a 
large reservoir of infection. Large numbers of bacilli may be released into the 
bronchioles and bronchi, from where they are disseminated via respiratory 
secretions to other portions o f the patient's lung and by coughing to other 
individuals. In a closed environments such as a prison, nursing home, or 
shelter for the homeless, very high tuberculin positivity rates can occur (Stead, 
1989). Cross-infection studies in tuberculosis wards indicate that the inhalation 
o f droplets bearing one, or two, tubercle bacilli can result in active infection 
(Collins,F , 1993). Factors affecting transmission of pulmonary tuberculosis can 
be defined as follows:
Source factors
Smear positive patient-size of infecting dose 
Severe cough (good aerosol producer)
Singing, shouting, sneezing
Mobility and sociability (degree o f self isolation)
Environmental factors 
Climate 
Housing 
W ork
Density of population 
Host factors
Constitutional, personal, genetic and racial 
State of health, illness and immune status, nutrition 
Interphase
Degree of contact (closeness, frequency)
(taken from Patel and Abrahams, 1989)
Individuals at high risk such as contacts of smear positive patients may be 
given preventative chemotherapy as discussed under treatment.
1.1.6Laboratory Diagnostic Methods for Tuberculous Disease 
1.1.6.1Culture-Based Techniques
Table 1.1 represents a summary o f data taken primarily from Jacobs and 
Eisenach, 1993 and selective data from Hunt and Persing, 1993. This table 
indicates the available methods for the laboratory diagnosis o f tuberculosis and 
their relative sensitivities and time required for result.
Diagnostic tests for tuberculosis are based on either detection o f M. 
tuberculosis in a clinical sample, or recognition o f the host response to the 
organism (Jacobs and Eisenach, 1993). The most widely available specimen 
is sputum so many new tests are based on this material, other specimen 
material may be faeces, blood or cerebrospinal fluid. Acid-fast microscopy of 
sputum or other clinical specimens followed by culture confirmation is the gold 
standard for the diagnosis of tuberculosis. These traditional methods are slow 
and expensive, however, with variable sensitivity. M ore rapid techniques have 
now been developed such as the BACTEC radiometric system (Becton 
Dickenson Diagnostic Instrument Systems, Sparks, Maryland). This technique 
was developed for the detection, identification and drug susceptibility testing 
of mycobacteria. An aliquot o f concentrated specimen is inoculated into 
Middlebrook 7H12 media. Growth is detected by measuring the release of 
^^C04  from '^‘C-palmitic acid and is expressed as a growth index. Detection 
rates o f mycobacteria in specimens can be significantly higher with the 
BACTEC system than with conventional culture techniques, and can also be 
used to assess drug susceptibilities in strains and minimal inhibitory 
concentrations of new drugs (Heifets and Good, 1994).
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1.1.6.2Molecular Techniques 
The use of gene probes
Gene probes are most effectively used for spéciation since the time needed for 
growth o f sufficient material to use is too long for them to be o f diagnostic 
use. Probe methods utilize nucleic acid hybridization with specific labelled 
sequences in the test sample. Two DNA probe systems for the identification 
o f mycobacteria are commercially available. The Gen-Probe system (Gen- 
Probe, San Diego, California) uses a labelled DNA probe complementary to 
the ribosomal RNA (rRNA) of the target organism. RNA is present in the cell 
in several thousand copies compared to one or a few copies o f most genomic 
sequences. The SNAP system (Syngene, San Diego, California) utilizes an 
alkaline phosphatase-labelled oligonucleotide probe that is directed towards a 
portion of the rRNA gene (Lim et a l , 1991). In the SNAP system, the target 
is immobilized on a membrane and hybridization is detected by a colorimetric 
assay. The GenProbe system is the most widely evaluated o f these systems 
several groups have found the Af. tuberculosis complex probe to be 99-100% 
specific (Sherman et a l ,  1989). Since large numbers o f organisms (10^ M. 
tuberculosis cells) were used in the test, sensitivity has not been a 
consideration, this shows that these tests are suitable for spéciation but not 
rapid diagnosis.
Recently, GenProbe introduced probes that are labelled with acridinium ester. 
Detection of these probes is based on the hydrolysis o f the ester by hydrogen 
peroxide, which results in chemiluminescence. The chemiluminescent probes 
(Accuprobes) hybridize with the target, and the resulting hybrid is protected 
as a result of intercalation of the ester within the hybridized molecule (hence 
termed hybridization protection assay). Single-stranded (non-hybridized) probe 
is rapidly hydrolysed and the chemiluminescence remaining after hydrolysis is 
a direct measurement of the amount o f hybrid formed (Arnold et a l , 1989). 
This type of assay is popular since it is rapid and simple. Sensitivity o f such 
systems is questionable since a high growth index is needed before testing. 
However the combination of radiometric and gene probe techniques can 
markedly reduce time for laboratory diagnosis to within 2 weeks, although this
12
still represents a long time lapse before treatment can begin.
1.1.6.3Gas Chromatography-Mass Spectrometry for Tuberculostearic Acid
Gas chromatography-mass spectrometry (GC-MS) with selective ion 
monitoring has been successfully used to detect tuberculostearic acid in 
sputum, cerebrospinal fluid, and other clinical material. Larson et a l , (1987) 
have shown detection o f tuberculostearic acid by GC-MS using selected-ion 
monitoring of the pentafluorobenxyl ester derivative. The analytical results 
agreed with those from culture of the organisms, combining this data with that 
o f negative-ion mass spectrometry provided high sensitivity and specificity in 
trials. It is limited, however, in use due to the presence o f tuberculostearic 
acid in other members of the mycobacterial genus and actinomyces. Brooks et 
a l , (1990) described a technique called frequency pulsed electron-capture gas 
chromatography (FPEC-GLC) to detect carboxylic acids in cerebrospinal fluid. 
This method allows the identification of femtomole quantities of 
tuberculostearic acid and provided 95 % sensitivity with a 91 % specificity rate 
compared to culture results and clinical findings. Such techniques can be 
extremely rapid FPEC-GLC might be used to diagnose tuberculous meningitis 
in three hours. These chromatographic techniques are extremely complex, 
however, and require expensive high maintenance equipment which is unlikely 
to be suitable for use in developing countries.
1.1.6.4ImmunologicaI detection of Mycobacteria
Serological diagnosis is widely used in medicine and is most useful when no 
other diagnostic sample is available. Bacteriological diagnosis o f tuberculosis 
can be slow, or difficult in the case of tuberculous meningitis. A variety of 
serological tests have been developed to detect antibodies against tuberculosis; 
however most o f these tests lack the specificity and sensitivity required to 
make them clinically useful. The technique most frequently employed is the 
enzyme linked immunosorbent assay (ELISA). ELISA measures the binding 
o f antibody to antigen, which is fixed onto a solid phase support. The antigen 
used is of major importance in determining the specificity of the ELISA, both 
crude and purified antigens have been employed, highly purified antigens are
13
more specific with sensitivities of between 65-85% for culture positive 
specimens of extrapulmonary tuberculosis (Daniel and DeBanne, 1987). 
Some groups such as Chan et a l  (1990) have combined multiple sérodiagnostic 
methods such as ELISA and haemagglutination assays for three glycolipid 
antigens. Here a positive result in any of the four tests was found in 22% of 
cases, including 58% of smear positive patients, 32% of smear negative, 
culture positive patients, and 0.7% of normal subjects. These tests exhibit 
specificity at the cost o f sensitivities, possibly due to the variation amongst 
individuals in the proportion of antibodies to different antigens o f the tubercle 
bacillus.
Serological techniques are believed to be more useful in detecting 
extrapulmonary tuberculosis. A serum antibody test would be ideal but assays 
with crude antigens have poor specificity because of the presence o f cross­
reacting epitopes between M. tuberculosis and other mycobacteria. 
Alternatively detection of antigens in clinical specimens has been studied by 
several groups, much of this work has been directed at the diagnosis of 
tuberculous meningitis since there is much need for rapid diagnosis. By means 
of chemical and immunological methods several purified antigens have been 
prepared which have improved the ELISA assay test characteristics. When 
used for smear positive pulmonary tuberculosis, the sensitivity reached 83-95 % 
with a specificity o f over 95%, (Daniel, 1989) this specificity level was much 
reduced however in extrapulmonary tuberculosis 34-40%. Wilkins and Ivanyi, 
1990 developed a sandwich ELISA adaptation o f the solid-phase antibody 
competition test (SACT-SE) with special reference to smear-negative 
pulmonary and extrapulmonary cases. Antibodies to the 38 kDa M. 
tuberculosis antigen were detected in 73% of extrapulmonary cases and 70 % 
of smear negative cases o f pulmonary tuberculosis. The 43kDa 
immunodoninant antigen of M. tuberculosis has been used in a double antibody 
sandwich ELISA this assay demonstrated nearly 100% sensitivity for 
cerebrospinal fluid (Wadde et a l , 1990). This kind of diagnostic test can only 
be applied cautiously since antibody titres may vary with disease severity and 
site o f disease, for example patients with abdominal, renal or skin tuberculosis
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show no antibody response to certain epitopes. Thus the use o f sérodiagnostic 
assays will be limited until the sensitivity and specificity o f such tests can be 
assured (Jacobs and Eisenach, 1993).
l.l.TDiHerentiating infection from disease
In order to evaluate mycobacterial diagnostics effectively, one must consider 
the difference between infection and disease. The presence o f certain 
mycobacterial species in human specimens does not always correlate to their 
involvement with disease. Colonization of certain mycobacterial species can 
occur as a secondary infection unrelated to the primary cause o f disease. 
Colonization may be transient, intermittent or prolonged. Wolinsky (1981) 
states that infection is said to occur when the host reacts in some recognisable 
fashion to the presence of the parasite, usually by the formation o f antibodies 
or by the development o f hypersensitivity of the skin but without overt 
manifestations such as tissue necrosis, abscess, or radiologic change. An 
example is a person with a positive skin test but no other evidence of disease. 
However if  the person with a positive skin test shows appropriate symptoms 
such as fever and cavitation of the posterior upper lobe this would imply 
tuberculous disease. The ill-defined area between infection and disease must 
be considered when extremely sensitive techniques such as PCR are used since 
very low levels of organisms may be detected. The significance o f any test 
result also depends on factors such as presence of predisposing conditions, and 
whether the number of organisms and their effect constitute presence, 
colonization, infection or disease.
1.1.8CONTROL AND TREATMENT OF TUBERCULOSIS 
l.l.S.lTuberculin skin testing
Control of tuberculosis depends on effective case finding and appropriate 
treatment. One method of case finding is through skin testing. Purified protein 
derivative (PPD) is a crude mixture prepared from filtrates o f heat sterilized 
cultures of Af. tuberculosis. It was developed by Florence Siebert in 1939. 
Most o f the constituents o f PPD are small proteins but there are also
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polysaccharides and some lipids. The Mantoux test is still commonly used it 
involves the intradermal injection of 0.1ml of prepared solution o f tuberculin 
(or 5 tuberculin units of PPD). The exact mechanism of the PPD skin test is 
not completely known. Induration at the site of PPD injection is thought to be 
caused by both the influx of sensitized T cells into the area as well as the 
release of lymphokines from these T cells. The release o f lymphokines results 
in the local vasodilation, edema, and recruitment o f other inflammatory cells 
to the area. Reactivity o f the PPD skin test in a given individual can suggest 
but not confirm, the diagnosis of tuberculosis. Reactivity o f the PPD can also 
provide a measure of the patients delayed type hypersensitivity (DTH) immune 
responses. Factors known to reduce PPD response include young age (less than 
3 months), malnutrition, immunosuppression and viral infections.
1.1.8.2 Anergy
Not all individuals with active TB respond to PPD skin testing. Skin test 
unresponsiveness or 'anergy' may develop after initial tuberculosis skin test 
reactivity as the TB infection progresses. Overwhelming tuberculosis may lead 
to selective anergy to PPD, the mechanism by which anergy occurs is poorly 
understood but poses an interesting immunodiagnostic problem.
1.1.8.3 Vaccination
During the early part of this century many workers including Koch and 
Trudeau were working to develop a vaccine against tuberculosis. Trudeau 
established that a live attenuated vaccine was more effective than a killed 
vaccine. The vaccine known as bacille Calmette Guerin (BCG) was eventually 
used with success in man was produced by Albert Calmette and Camille 
Guerin between 1908 and 1921 at the Institut Pasteur in Lille by multiple sub­
culture. Virulent strains of M. tuberculosis tend to attenuate when maintained 
on laboratory media for prolonged periods of time, especially when grown in 
the presence of detergents, which are added to disperse the bacterial growth 
throughout liquid culture. The detergent reduces the lipid content o f the cell 
wall, and the organisms become progressively attenuated. This effect led to the 
development of the BCG vaccine when Calmette and Guerin passed a virulent 
strain of M. bovis through 231 consecutive transfers in potato-glycerol bile
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medium. This vaccine was first used to protect infants born o f tuberculous 
mothers. Since that time, more than a billion doses of vaccine have been 
administered. This vaccine BCG was first used in 1921 but was not universally 
accepted and was not subjected to clinical trials until 1939. Over several 
decades the efficacy of BCG vaccination has been challenged. Relative 
protection levels vary from 80% in North American Indians to 0% in Madras. 
Southern India. Various explanations for these widely different results include; 
variations in the potency and immunogenicity of the BCG strain used, 
difference in host response due to genetic and nutritional factors; regional 
differences in the tubercle bacilli causing infection; prior immunization by 
strains of M. tuberculosis o f low virulence; prior immunization by contact with 
environmental mycobacteria and lastly induction o f antagonistic immune 
response due to prior contact with environmental mycobacteria (Grange, 
1989). It is most likely that the failure o f certain trails is attributable to various 
factors and not one factor alone.
Some countries have never advocated its widespread use such as the U .S.A . 
and Holland, and have until the current upsurge due to HIV enjoyed the same 
level of decrease in incidence as observed in the U.K. where it has been 
widely used. The U .S.A . does not encourage the use of BCG vaccination since 
it precludes the diagnostic use o f the Mantoux test. Despite its obvious 
shortcomings live BCG vaccination is still the only widely accepted anti- 
tuberculous vaccine available for human use (Fine, 1989). Although 
Mycobacterium microti was seen to be just as protective in U.K. studies 
carried out by the Medical Research Council. To date some 3 billion doses of 
BCG have been administered worldwide.
It is unclear why BCG has failed in certain vaccine trials and the complex 
immunological effect o f this vaccine is poorly understood. The surprising 
results of some trials including Chingleput (Anon, 1978) are that BCG is more 
effective against leprosy than TB, for reasons which are unclear.
Many workers hope that the immunoprophylactic effect o f BCG could be 
enhanced by specifically increasing the expression o f genes whose products are 
important for immune protection. This requires the identification and
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manipulation o f such antigens (the identity of which is as yet unknown) and the 
development of models other than expensive and ineffectual animal models to 
test the efficacy of new vaccines.
1.1.8.4Chemotherapy
The treatment o f tuberculosis has undergone many changes in the last few 
decades. In the early twentieth century, lung collapse therapy or pneumothorax 
and surgical resection supplemented bed rest and supportive care in advanced 
cases. Many patients were kept in sanatoria for long periods o f time. Probably 
the most important breakthrough was the use of streptomycin in clinical trials 
in 1942. Resistance to streptomycin soon emerged, it was then used in 
combination with para-amino salicyclic acid (PAS). Isoniazid was first used in 
1950 and in combination with streptomycin and PAS, this combination 
produced very low relapse levels and little spontaneous resistance in the 
bacteria. The advent of effective oral therapy lead to the conclusion that home 
therapy was as good as sanatorium treatment and after 1966 most sanatoria 
were closed.
There are 3 abilities antituberculosis drugs may posses:-
(1) bactericidal action, an ability to kill large numbers o f actively metabolizing 
bacilli.
(2) sterilizing action, a capacity to kill slowly or intermittently metabolizing 
semi-dormant bacilli - the persisters.
(3) the ability to prevent the emergence of resistance.
Drugs now commonly used for previously untreated patients are isoniazid, 
rifampicin, pyrazinamide, streptomycin, ethambutol, thiacetazone and para- 
amino salicylic acid (PAS). The reserve, or second line drugs, are 
ethionamide, prothionamide, cycloserine, kanamycin and capreomycin. 
Antituberculous drugs vary in their ability to prevent emergence o f resistance. 
Their efficiency in doing this depends on the extent to which they inhibit all 
o f the bacilli in the lesion continuously. Rifampicin is the most successful in 
preventing bacteriological failure when given with isoniazid. Streptomycin and 
ethambutol are marginally less effective. Pyrazinamide is less effective, and 
PAS and thiacetazone are the least effective. Explanations for the inefficacy
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of streptomycin and pyrazinamide are that they only inhibit part o f the 
bacterial population. Streptomycin is inactive against organisms in an acid 
environment and pyrazinamide is inactive against those in a neutral, or 
alkaline, environment. Ethambutol must be given in sub-optimal doses due to 
its toxicity and PAS and thiacetazone are only bacteriostatic. Drug regimes for 
tuberculosis have traditionally been very long, it is now possible to treat 
tuberculosis with 64 doses, whereas 3000 were used in early regimes. Regimes 
can be for 6 ; months or longer, intermittent one, two or three times a week 
or a once weekly regime. However short course therapy calls for patient 
compliance or potential infectious smear-positive patients may rapidly spread 
disease.
Two biological characteristics of M. tuberculosis are o f particular relevance 
in the chemotherapy of tuberculosis. Firstly there are likely to be major 
differences in the metabolic rates of bacilli in the lesions o f untreated patients. 
Bacilli in well oxygenated lesions such as pulmonary lesions are likely to be 
metabolizing rapidly whilst other organisms can remain dormant or semi- 
dormant for some years, under metabolic pressure such as low oxygen tension 
or low pH. Secondly drug resistance emerges by mutation (such as described 
below), so that even wild strains may contain resistant mutants after prolonged 
exposure to antituberculosis drugs. Patients on monotherapy may develop 
lesions entirely composed of the drug resistant mutant. This type o f resistance 
is secondary resistance since it is a consequence of therapy. Primary resistance 
exists in the invasive organism before therapy begins. This type o f resistance 
can be detected quickly by sensitivity testing before chemotherapy begins. 
Recently much has been discovered about the molecular basis o f drug 
susceptibility and resistance. Heym et a l  (1993) have characterised the gene 
katG which encodes a catalase peroxidase required for isoniazid (INH) 
susceptibility o f M. tuberculosis. The inhA gene has also been described by 
Banerjee et al. (1994) which encodes a target for isoniazid and ethionamide in 
M. tuberculosis. A missense mutation in the mycobacterial inhA gene was 
shown to confer resistance to both INH and ethionamide (ETH) in M. 
smegmatis and M. tuberculosis. Preliminary evidence suggests that the inhA
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protein may be involved in mycolic acid synthesis, making inhA a primary 
target o f action for INH and ETH.
1.1.8.5Drug susceptibility testing of Mycobacterium tuberculosis
After identification the best course o f chemotherapy is decided upon by the 
use of drug susceptibility or sensitivity testing. Drug susceptibility testing has 
previously been extremely important in the treatment of tuberculosis. With the 
increased incidence o f multidrug resistant strains it is o f primary importance. 
Sensitivity testing requires a high degree of accuracy. This is required since 
the following factors can often affect the test results:-
(1) Variations in the activity of different batches o f the same drug and storage 
o f culture media containing drugs,
(2) The range of concentrations of the drugs used and the size o f inoculum,
(3) The relation between the in vitro and in vivo activity of the drug,
(4) Slow growth of the organism and possible reduction in effective 
concentration of the antibiotic during prolonged incubation,
(5) The proper controls in the testing experiments.
Sensitivity testing is difficult, slow and often expensive. Different methods are 
employed depending on location and funding of laboratories. There are at least 
five "traditional" methods o f drug sensitivity testing routinely used throughout 
the world.
A) The absolute concentration method
This method introduced by Meissner (1964) was popular in parts o f Europe. 
The method effectively determines the minimum inhibitory concentration 
(MIC) of each drug for the test organism. The most common solid medium 
used is Middlebrook's 7H11. Usually solid media are used which give cleaner 
end-points. The medium is melted, the appropriate amount of antibiotic added 
and petri dishes or tubes are poured. Plates or tubes are inoculated with the 
test organism and incubated at 37°C for 18-21 days. Each strain is tested at 
least in duplicate.
B) The proportion method
This method is popular in the USA and also in Europe (Vestral, 1975). It 
compares the number of colonies growing on drug containing media with the
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number on drug-free media. The criterion for resistance is that the number of 
colonies on the drug-containing medium is 1%, or more, of the number on the 
drug free medium.
C) The resistance ratio method
This method is used in the U.K. (Collins and Lyne, 1984). The MIC of the 
test strain is compared with the modal average results o f several control strains 
using the same batch of medium. Therefore, the exact amount o f drug in the 
medium is not so important as that o f the absolute concentration method. The 
resistance ratio of each test strain to each drug is calculated by dividing the 
MIC o f the test strain by the modal MIC, which is the average MIC of the 
control strains. Strains giving a resistance ratio of 1 or 2 are reported as 
sensitive and ratios higher than this are considered resistant.
D) The Disc method
This method was introduced by Collins (1955), modified by Wayne and 
Kransnow (1966) and was found to be useful for field work by Griffith et ah 
(1971). One paper disc containing the test drug is placed in each quadrant of 
a Felsen plate and 7H11 agar medium is poured and allowed to set. The 
quadrants are inoculated with the test and control organism and incubated till 
all the zones of inhibition are visible. The zones of inhibition are then 
compared with that of the control strains.
E) The Radiometric method:
This method is described in detail as a diagnostic method since it can be used 
for detection identification and drug susceptibility testing. This method is gives 
rapid and reliable results, but the materials and equipment used are considered 
by some to be too expensive for routine use. Disposable o f radioactive waste 
was also a drawback. The introduction o f a non-radioactive system has altered 
this.
F) A very sophisticated method of drug susceptibility testing has been 
developed by Jacobs et al. (1993) by means o f luciferase reporter phages. 
Drug susceptibility can be assessed by means o f a method based on the 
efficient production o f photons by viable mycobacteria infected with reporter 
phages expressing the firefly luciferase gene. Light production depends on
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phage infection, expression of the luciferase gene, and the level o f adenosine 
triphosphate (hence bacteria must be viable). A signal can be detected within 
minutes of infection of virulent M. tuberculosis with the reporter phages. 
Culture of conventional strains with antituberculous drugs like rifampicin 
results in extinction of light production. But light signals after luciferase 
reporter phage infection of drug resistant strains continued to be produced. 
There is optimism that this system will accelerate sensitivity testing.
1.1.8.6Multi Drug Resistant (MDR) Strains of Tuberculosis
The problem of drug resistance in Af. tuberculosis strains is not a recent one, 
but the emergence of multi drug resistant (MDR) strains has only been 
highlighted since the AIDS epidemic has been observed. The highest incidence 
o f MDR tuberculosis strains is in the United States. Reasons for the high levels 
o f MDR strains include the wide availability o f antibiotics to the general 
public, and patient non-compliance with drug regimes leading to partially 
treated infections re-establishing in patients. Many of the cases of MDR strain 
infections in both AIDS and non-AIDS populations pose a significant health 
threat not only to contacts but to healthcare personnel and laboratory staff 
(Weiss, 1992). Their high degree o f resistance to most of the first-line drugs 
renders the patient virtually untreatable. Tuberculosis and HIV infections are 
a virulent combination since HIV infected individuals are particularly 
susceptible to infection with MDR stains of M. tuberculosis which give rise to 
a rapidly fatal disseminated disease for which there is currently no therapeutic 
answer.
1.1.8.7Tuberculosis and Human Immunodeficiency Virus (HIV)
Tuberculosis in HIV infected individuals takes an extremely rapid course. The 
normal host defences, cell mediated and delayed type sensitivity responses that 
are present in immunocompetent individuals are depleted or absent in the HIV 
infected individual. C D 4+ cells (T4 cells) and macrophages play a central role 
in immune defences against M. tuberculosis. HIV specifically infects C D 4+ 
cells and macrophages, so that these cells are progressively reduced in number 
and efficiency. Macrophage function is also effected by the lack of
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macrophage-activating factors normally produced by the CD44- cells. These 
factors allow the development of progressive primary pulmonary tuberculosis, 
haematogenous dissemination of tubercle bacilli to extrapulmonary sites, and 
increased likelihood of reactivation of previous tuberculosis infection. The 
problem of tuberculosis in HIV infected patients has been most extensively 
studied in the U .S.A . where both reactivation o f previous infection and new 
infection have been demonstrated. Many HIV-infected persons have been 
placed in specific housing facilities so the their care can be facilitated, however 
the effect o f placing so many immunocompromised persons in one building is 
to allow the rapid spread of diseases such as tuberculosis. Daley et a l  (1992) 
used molecular genetics techniques such as RFLP analysis to show that the 
presence o f one infected person in a housing facility quickly led to the 
infection of other HIV-infected occupants with the same tuberculosis strain. 
These workers noted the extremely rapid progression o f disease amongst the 
persons in the care facility. Clearly persons entering a care facility such as this 
should be screened for tuberculosis since they constitute such a potent source 
o f infection. The combination of HIV infected individuals and multi-drug 
resistant tuberculosis strains is an even more dangerous one since these strains 
seem to be particularly virulent in HIV infected individuals giving rise to even 
more rapidly disseminated disease.
The use of BCG vaccination in HIV infected individuals is not considered safe 
since some HIV infected individuals have shown disseminated BCG infection 
in much the same way M. tuberculosis infection manifest themselves. BCG 
vaccination of infants born of HIV infected mothers is often carried out 
although there are reports of disseminated disease in Zaire. This is thought to 
be due to the patients inability to mount any of the usual responses to the 
bacteria allowing them to multiply too rapidly and thus reach the level o f an 
infection. This means that unless another tuberculosis vaccine is created the 
only means o f protecting HIV infected patients from tuberculosis is by use of 
preventative chemotherapy, which can have toxic side effects and increase the 
prevalence of drug resistant strains.
Tuberculosis is the most common opportunist infection in patients with HIV
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infection worldwide. In some areas however, it is secondary to infection with 
Mycobacterium avium strains. (See atypical mycobacterial infections later.)
1.2.1LEPROSY 
General Introduction
The origins of leprosy are obscure the causative organism Mycobacterium 
leprae has a very narrow host range being virtually restricted to man. The 
historical time of origin o f the leprosy bacillus is probably only a few hundred 
years BC when it was described in the "Shushruta Samhita" written in India 
in 600 BC. The disease was probably brought to the mediterranean region by 
the soldiers of Alexander the Great returning from their Indian campaign in 
327-326 BC. At the beginning of the 13th century, leprosy was rampant in 
Europe, from Iceland to Italy and started decreasing in Europe from the 15th 
century. Today the disease is still endemic at low levels in Portugal, Spain, 
Italy, Greece, Turkey, Cyprus and Southern Russia (Thangaraj and Yawalker, 
1986).
Historically those afflicted with the disease have been described as 'unclean' 
leading to their ostracism from society. Many thousands o f people across the 
ages were isolated in leper colonies which existed entirely separately from 
society in general. Thus leprosy is not just a physical disease but one causing 
considerable psychological distress to those who are afflicted. The word leper 
became so stigmatised that the World Health Organisation (WHO) no longer 
use it except in an historical sense and many workers feel the word "leprosy" 
should be replaced with "Hansens" disease.
Hansen discovered the leprosy bacillus in 1873. Despite being one o f the first 
identified pathogens o f man it has yet to be cultured in vitro. M. leprae is an 
obligate intracellular acid fast bacillus multiplying mainly inside the 
macrophages of the skin (histiocytes) and the nerves (Schwann cells). The M. 
leprae bacillus closely resemble M. tuberculosis bacilli but are less acid fast 
and sometimes beaded in appearance. Leprosy bacilli are pleomorphic, straight 
or curved, rod-like gram positive bacteria. Leprosy bacilli have never been 
grown on artificial media. This means that Koch's postulates cannot be
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satisfied for this organism. There is, however, an overwhelming body of 
evidence to prove that it is the causative organism of leprosy.
Shepherd in 1960 first reported the growth of leprosy bacilli in the mouse 
footpad where the generation time was believed to be 12-14 days in the 
logarithmic phase, with a overall mean generation time o f 18-42 days. 
Kirchheimer and Storrs (1971) reported a disseminated M. leprae infection in 
nine banded armadillo. The infected armadillos liver may contain up to 10  ^
bacilli per gram of tissue allowing for the generation o f M. leprae tissue for 
research purposes. The difficulty and expense of growing M. leprae in mouse 
footpads makes study of this organism very difficult. Neither mouse footpads 
nor armadillos are genuine animal models o f the disease, some monkeys are 
susceptible and provide a better model but are not convenient to use, thus 
vaccine testing must be carried out directly on humans.
Infection with M. leprae is thought to be through skin contact or where 
applicable through nasal droplets. As with tuberculosis the majority o f infected 
individuals never develop symptoms, about 5% of those infected develop 
disease after 3-6 years.
1.2.2Pathogenesis of leprosy
The leprosy bacillus can replicate within many cell types such as macrophages, 
Schwann cells, smooth muscle cells, hair follicles and sweat glands. The 
spectrum of leprosy disease depends on the immunological response o f the 
host. At one end o f the leprosy spectrum is tuberculoid leprosy. This is 
characterised by a strong cellular immune response, low levels o f circulating 
antibody, and few bacilli present in the lesions. The clinical symptoms are 
thought to be caused by the strong immunological response in the nerve cells 
and surrounding tissue. Lepromatous leprosy represents the other end of the 
spectrum and is characterised by cellular anergy to M. leprae leading to 
massive replication o f the organisms in the tissue but little immunological and 
inflammatory tissue reaction with high level o f circulating antibody. Pathology 
is due to very high numbers o f bacilli in the tissue directly causing nerve 
damage and characteristic lesions. What causes the individual to develop one
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form of disease and not the other is unknown. The proportion o f patients at 
each pole o f the spectrum varies in different parts of the world.
Leprosy is classified according to the spectrum of the disease as indicated by 
the clinical, histopathological and other indices o f immune responsiveness of 
the patient. For the purpose of speciflc classification five positions have been 
described within the spectrum with an additional classiflcation o f indeterminate 
(Ridley and Jopling, 1964). In descending order of immune response these 
are:-
TT Tuberculoid 
BT Borderline tuberculoid 
BB Borderline 
BL Borderline lepromatous 
LL Lepromatous 
I Indeterminate
The spectrum is continuous with some patients in a position between two 
groups, most cases are readily assigned to one group or another. Movement 
occurs readily within the spectrum, the closer to the middle of the spectrum 
the more unstable the patient is within the spectrum. The most unstable group 
is BB from which point downgrading in absence of treatment or upgrading 
with treatment is most likely. The groups described refer to the types of 
disease that develop once the disease is fully established. Before this happens 
there is an early period when the lesions are uncharacteristic, either clinically, 
histopathologically, or both, and cannot be classified in the spectrum. This 
phase is described as indeterminate leprosy and can last for up to ten years,
it does not mean the diagnosis is in doubt, simply that the lesions cannot be
classified.
The individuals resistance or immunity determines whether lesions will 
disseminate throughout the body. If  resistance is low dissemination is apparent, 
if  high far less dissemination occurs. Resistance also determines the relative 
distribution between sites that are most favoured for growth. Nerve for 
example is a better protected site than skin so more nerve lesions are likely in 
resistant patients. In tuberculoid leprosy there are no significant lesions apart
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from those in the skin nerve and regional lymph, in lepromatous leprosy 
lesions are scattered into many sites such as lymph node, spleen, liver, eyes 
and testes.
Reactions in leprosy are acute inflammatory phases that are separate from the 
normal activity of infection. They may be caused by allergy or 
hypersensitivity. Reactions often occur after chemotherapy. The reactions are 
broadly of two types. Jopling type I due to DTH in tuberculoid or borderline 
lesions, which cause much nerve damage. Jopling type II also called erythema 
nodosum leprosum (ENL) which are believed to be associated with immune 
complex deposition principally at the sites of lepromatous lesions. 
Complications with leprosy infection can occur, before the introduction o f 
chemotherapy the commonest cause of death in leprosy patients was 
tuberculosis, but there is no evidence to indicate that leprosy predisposes 
people to other mycobacterial infection. Important complications in leprosy 
today which frequently cause death is secondary amyloidosis, where tissue 
degenerates and causes amyloid deposits especially in the liver, spleen, heart 
and kidneys.
The term paucibacillary and multibacillary leprosy are also used to describe 
tuberculoid and lepromatous leprosy respectively.
1.2.3Spread of Leprosy
An infected human is currently considered the only source o f Af. leprae 
infection. The infective capacity of lepromatous (multibacillary) case is 4 -1 1  
times greater than those with tuberculoid or paucibacillary cases, making 
lepromatous cases the most likely cause of infection. Generally it takes 
prolonged and close contact for transmission to occur. Intra-familial contact 
with a multibacillary patient is more risky than extra-familial contact. Skin to 
skin contact is probably not necessary, since the main portal o f exit is the nose 
in multibacillary patients. Untreated lepromatous patients may discharge as 
many as 10* leprosy bacilli from their nasal secretions each day. Thus inhaled 
leprosy bacilli may enter through the respiratory tract and be carried to sites 
suitable for multiplication. Leprosy bacilli have been found in the nasal mucosa 
of household contacts of patients with multibacillary disease. It is possible that
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bacilli may also enter the skin via abrasions or insect bites when nasal droplets 
are deposited on the skin surface. Indirect transmission has occasionally been 
thought to occur through the wearing of clothes o f a multibacillary patient or 
the use of bedding, since Af. leprae remain viable for several days in bedding. 
Localised infection has also been reported due to infected injection needles and 
tattooing needles.
Children run the greatest risk of leprosy infection, peak onset age is between 
10 and 20 years. Susceptibility to leprosy is considerably varied, susceptibility 
may be genetically determined. The type o f leprosy to develop seems to be 
determined at least partly by HLA-linked genes. Family studies with HLA 
typing have indicated and HLA-linked recessive gene leading to the 
tuberculoid form. Geographically Americans, Europeans, Anglo-Indians, 
Chinese and Japanese are more susceptible to the disease and are more prone 
than Africans and Indians to multibacillary leprosy. Environmental factors are 
probably those most directly affecting spread of disease. Overcrowded housing 
leads to more close contact with the source of infection and favours leprosy. 
Transmission of leprosy depends primarily on the infectiousness o f the 
affected person and the susceptibility of the contact and the closeness, 
frequency and duration of the exposure.
1.2.4The Lepromin Test
Skin-testing is of no diagnostic value in leprosy; but it can be useful 
epidemiologically as a guide to the extent of exposure o f a community to the 
leprosy bacillus and it can place the patient more accurately within the 
spectrum.
Lepromin tests are carried out with purified heat killed suspensions of 
autoclaved Af. leprae derived from armadillos, in which the bacterial contents 
have been standardized. There are two reactions, neither o f which is 
necessarily diagnostic for leprosy. The early (Fernandez) reaction is a DTH 
type observed after about 24-48hrs, which is generally positive in tuberculoid 
leprosy and negative in other forms of infection. This reaction is comparable 
to the tuberculin reaction. The late (Mitsuda) reaction develops after three to 
five weeks, probably due to the slow degradation o f intact bacilli. This
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reaction is considered to represent the subject's potential capacity for the 
development of DTH to leprosy bacilli in response to an immunizing dose. It 
is most closely related to granuloma formation, and histologically a positive 
reaction resembles a lesion in tuberculoid leprosy. Lepromin testing is virtually 
useless diagnostically due to anergy often found in the contacts of lepromatous 
patients (Thangaraj and Yalwalker,1986).
1.2.5Diagnostic Techniques fo r Leprosy
Diagnosis of early stage leprosy can be very difficult and given the social 
stigma attached to this disease final diagnosis is not given unless evidence is 
definite. Three cardinal signs of leprosy are firstly sensory impairment in 
infected area, secondly enlargement and tenderness o f peripheral nerves 
associated with signs of peripheral nerve damage such as paralysis, and thirdly 
finding non-cultivable acid-fast bacilli in the lesions. Primary diagnosis of 
leprosy is always made on the clinical features, which are beyond the scope 
of this discussion. Laboratory investigations are then carried out to confirm 
diagnosis.
1.2.5.1Bacteriological Exam ination
Skin smears are taken from all patients suspected of having leprosy, they are 
generally made by the slit and scrape method from the most active looking 
edge of the lesion. Nasal smears or nose blow smears can also be examined. 
It is not however possible to prove that acid fast bacilli found in smears are M. 
leprae since they could be any acid fast organism. M ore confirmatory evidence 
is needed and leprosy should not be diagnosed on the basis of acid fast bacilli 
found in the nasal membrane. A negative skin smear in no way rules out 
leprosy in early or doubtful cases.
1.2.5.2Bacteriological Index (HI)
The bacteriological index (BI) indicates the density o f bacilli in smears and 
includes both living and dead bacilli. According to Ridley's logarithmic scale, 
it ranges from zero to 6 based on the number o f bacilli seen in an average 
microscope field of the smear using the oil immersion objective:-
0 No bacilli in any of 100 oil-immersion fields
1 1-10 bacilli, on average, in 100 oil-immersion fields
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2 1-10 bacilli, on average, in 10 oil-immersion fields
3 1-10 bacilli, on average, in each oil-immersion field
4 10-100 bacilli, on average, in each oil-immersion field
5 100-1000 bacilli, on average, in each oil-immersion field
6 more than 1000 bacilli, on average, in each oil-immersion field 
1.2.5.3M orphological Index (MI)
The morphological index is the percentage o f presumably living bacilli in 
relation to the total number of bacilli in the smear. It is calculated after 
examining 200 pink-stained free standing (not clumping) bacilli. This is first 
recorded separately for each smear. The percentages are then added up and 
divided by the number of smears to give the MI of the patient. This technique 
is based on the observation that irregularly staining bacilli are dead. It is a 
valuable indicator o f the patient's response to chemotherapy. It is however 
very difficult to apply due to subjectivity and lack of standardisation.
1.2.5.4Histological Exam ination
Skin or nerve biopsies can important in the evaluation o f leprosy lesions. Skin 
biopsies are advisable if  multibacillary leprosy is likely but no acid-fast bacilli 
are seen in skin smears, and in the case of paucibacillary leprosy if  sensory 
impairment is not marked. Skin biopsies are taken from the most active edge 
of the lesion and include the full depth o f the dermis. In tuberculoid leprosy 
typical tubercles comprising epitheloid cells, Langhans giant cells and a 
surrounding zone of lymphocytes are found in the dermis.
In lepromatous leprosy, the epidermis shows thinning and flattening o f the rete 
ridges. The characteristic histological finding is a diffuse highly bacilliferous 
granuloma in the dermis. The granuloma mainly consists o f macrophages 
which fail to differentiate into epitheloid cells. Instead they become mere sacs 
containing multiplying leprosy bacilli: lepra cells. Lymphocytes are scanty or 
absent. In the late stages, the cytoplasm of macrophages undergoes fatty 
changes resulting in the formation of Virchows foamy cells.
Borderline lesions show features of both tuberculoid and lepromatous leprosy 
in different areas and depths below the epidermis. Langhans giant cells and
30
bacilli laden macrophages may co-exist in the same section. As in lepromatous 
leprosy, in all types of borderline leprosy, especially in BL or BB cases, there 
is a granuloma-free clear subepidermal zone in which leprosy bacilli are rarely 
seen.
Nerve biopsies are only taken when there is no skin lesion. Biopsy o f a main 
nerve is not justified. However biopsy o f a thickened cutaneous sensory nerve 
is of diagnostic help in primary polyneuritic leprosy. In such cases, it usually 
shows typical or borderline histology, together with bacilli, in most borderline 
cases.
1.2.6Iiiimunodlagnosis of Leprosy
A primary problem with leprosy diagnosis is the spectrum of the disease. 
Lepromatous patients may have very high numbers o f organisms and high 
serum antibody levels, but tuberculous patients have low numbers o f organisms 
and low serum antibody levels.
Enzyme linked immunosorbant assays have been used to assay antibodies 
against the antigen PGL-1. The phenolic glycolipids o f the cell membrane 
contain a phenol glycol core attached to variable oligosaccharides including the 
M. leprae-spQcifio antigen PGL-1. The most promising results have been 
achieved by measurement o f IgM antibody against the surface phenolic- 
glycolipid I, ELISA with this antigen appears to be sensitive and specific both 
when tested against healthy controls and patients with other mycobacterial 
disease. Other serological assays such as complement fixation, gel diffusion, 
immunofluorescence and radioimmunoassays have been used but these show 
blurred discrimination between patients and controls due to cross-reactivity 
interference. Even when satisfactory immunodetection is achieved, the problem 
of detecting colonization and infectivity o f carriers before the immune response 
is initiated will remain. Monoclonal antibodies offer quick and precise 
identification o f M. leprae (Kolk et a l ,  1985), work continues to establish 
serologically useful antigens (Filley et a l ,  1994), but such assays are often 
complex and are unlikely to be available in areas where leprosy is endemic.
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1.2.7Gene Probes for Leprosy Diagnosis
Gene probes are unsuitable for diagnosis of leprosy since the organism cannot 
be cultured. Many typing techniques such as RFLP analysis require at least a 
microgram of bacterial DNA, however the polymerase chain reaction (PCR) 
as discussed later can be used. Examination of available organisms grown in 
mouse footpads or armadillo derived leprosy like bacilli show that there are 
genetic differences between human and armadillo derived strains. Amongst 
human strains there is little genetic heterogeneity (Williams et a l ,  1990). 
1.2.8Chem otherapy of Leprosy
Until 1941 there was no really effective anti-leprosy drug, in 1941 Guy Faget 
used a derivative of dapsone (Promin) for the intravenous treatment o f leprosy. 
At present multidrug therapy is recommended by the World Health 
Organisation (WHO) using dapsone, rifampicin. With careful use
of multiple drug therapy and good patient compliance leprosy can definitely be 
arrested in an individual and controlled within a community (Maurice, 1989). 
Dapsone is the most important drug in leprosy chemotherapy and the cheapest. 
Dapsone is almost completely absorbed by oral administration. Its mechanism 
of action is thought to be by interference with folic acid synthesis. Clinical 
improvement is usually seen within 6 months it is well tolerated and side 
effects are rare. Rifampicin is a semi-synthetic derivative of a fermentation 
product of Streptomyces mediterranei which acts by inhibiting bacterial 
ribonucleic acid (RNA) synthesis. It is the most potent bactericidal anti-leprosy 
drug available. The molecular basis of rifampicin resistance has been described 
by Honore and Cole (1993). This suggests that a mutation in the putative drug 
target RNA polymerase. These workers found a missense mutation in the rpoB 
gene which encodes the beta subunit o f RNA polymerase in rifampicin 
resistant strains of Af. leprae.
Both dapsone and rifampicin can induce erythema nodosum leprosum (ENL) 
reactions in lepromatous patients. Such reactions have to be treated as 
emergencies to prevent irreversible nerve damage. Mild reaction may respond 
to aspirin or chloroquin, but steroids are required for more serious episodes. 
Clorfazimine is anti-inflammatory as well as anti-leprotic and thalidomide
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despite its teratogenic properties can help control reactions in some patients. 
In 1981 a WHO study group recommended the implementation o f multidrug 
therapy, this was rifampicin and dapsone for 6 months for paucibacillary 
leprosy and rifampicin, dapsone and clofazimine for 2 years or until smear 
negative in multibacillary cases. After completion of therapy patients have to 
be followed up regularly to check that persistent organisms have not survived 
and re-established infection. Multibacillary patients are the hardest to 
completely eliminate bacilli in since they have such high numbers o f bacilli 
present and a greater chance of persistent or resistant organisms existing after 
treatment.
As previously mentioned during the usually chronic course o f leprosy acute 
episodes or reactions may occur. Any type of leprosy except the indeterminate 
form may undergo a sudden inflammatory phase, or exacerbation. Sometimes 
this reaction is due to immunological changes during chemotherapy. Reaction 
may be spontaneous or brought on by intercurrent infections or physical stress. 
It is generally accepted that there are two types of reaction exhibited. The 
Type I reaction is a Type IV hypersensitivity reaction, for which the terms 
reversal or "upgrading" reaction is used following an increase in cell mediated 
immunity (CMI) and a shift towards the tuberculoid pole, and the term 
"downgrading" is applied to a reaction resulting in a reduction in CMI and a 
shift toward the lepromatous pole. Reversal reaction commonly follows 
treatment, downgrading reactions occur in patients not receiving adequate 
treatment. Despite their differences these reactions are hard to distinguish 
clinically. The Type II reaction is ENL which is a Type II hypersensitivity 
reaction. It is not associated with a CMI change and it tends to occur after 1 
or 2 years of treatment. Severe cases o f ENL may require immediate 
hospitalisation due to the extensive damage caused.
1.3.1B0VINE TUBERCULOSIS
The topic of bovine tuberculosis is of course closely related to that o f human 
tuberculosis and sone would say that the differential classification 
Mycobacterium tuberculosis and Mycobacterium bovis is an artificial one.
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However for the purpose of this thesis they will be discussed separately as they 
can constitute two infections in terms o f spread and control.
Some would say that the earliest form of tuberculosis was bovine derived 
tuberculosis which occurred when man domesticated cattle for milk and meat. 
Humans may contract Af. bovis from domesticated animals infected with 
tuberculosis, such as cattle, sheep, goats, camels, pigs, dogs and cats, 
generally through the alimentary canal after the consumption o f their meat, or 
unprocessed milk. The consumption o f unprocessed milk is particularly 
dangerous for children since it produces a high infection rate. 
1.3.2Diagnosis of Tuberculosis in cattle
Current diagnosis of bovine tuberculosis is by the caudal fold test for delayed 
type hypersensitivity (DTH) a test analogous to the human Mantoux test as 
described earlier. In cattle a DTH reaction due to a subcutaneous injection of 
M. bovis PPD is considered indicative of infection with M. bovis. However as 
long ago as 1892 the shortcomings of tuberculin testing where acknowledged
Bang (1892) stated: " it is found that the tuberculin test is no more perfect
than are other things in this world. Sometimes it fails." Tuberculin reactions 
are not always found in infected cattle presumably due to anergic like 
conditions. Negative tuberculin results can often be recorded due to misreading 
o f the test by the veterinarian, since it can be a subjective analysis. A positive 
reaction may be given in cattle which have no visible lesions (nvl) this can be 
for a number o f interesting reasons. Firstly cattle may have another 
Mycobacterial infection such as Johne's disease which is caused by 
Mycobacterium paratuberculosis. Secondly a non progressive infection with 
organisms such as M. avium and Af. kansasii v/hich gives sensitization or 
thirdly transient sensitizing infection with non-pathogenic Mycobacteria from 
water or soil causing non-specific sensitization.
1.3.3Control Strategies
Control of the spread of bovine tuberculosis is based on the regular tuberculin 
testing of herds and slaughter of all infected cattle, whilst placing the rest of 
the herd under a restricted movement order. Import controls are also placed
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on cattle coming into the country, often they must be quarantined for long 
periods and tuberculin tested. Chemotherapeutic control of bovine tuberculosis 
is not tenable, this is largely due to the fact farmers may be given a false sense 
o f the non-infectivity o f cattle. Also the widespread and long term use of 
antibiotics in cattle can not only lead to the introduction o f large amounts of 
antibiotics into the food chain, but also can lead to antibiotic resistant M. bovis 
organisms being passed on the humans. Some small scale antibiotic use is 
indicated for non-beef or breeding stock that may have come into contact with 
infected livestock. Isoniazid has been effectively used in cattle where important 
breeding stock are infected or when small outbreaks occur and where culling 
o f cattle could mean severe hardship for farmers.
Ongoing control programs are carried out by many nations including the U .K ., 
U .S .A ., Australia and New Zealand. Of these countries only in Australia is the 
disease almost eradicated. In many parts o f the world there is little effort to 
control the disease. Any attempts to control it are hampered by the lack o f an 
unequivocal diagnostic test. Other problems with effective control include other 
reservoirs of disease such as farmed, or park, deer herds and natural reservoirs 
of tubercle bacilli in wild animals.
1.3.4Transmissioii of Mycobacterium bovis
Open bovine tuberculosis disease in cattle is spread from cattle with open 
infection to other cattle. Primary pulmonary infection in cattle rarely heals 
spontaneously and results in highly infectious cases. Humans can acquire 
infection from cattle by consumption of contaminated raw milk or by inhalation 
of a contaminated droplet from live infected cattle or infected carcases. 
Infection can also be acquired from consumption of infected lymph nodes. 
Transmission o f M. tuberculosis from man to cattle has rarely been 
documented. It may be that M. tuberculosis had limited pathogenicity in cattle 
since it does not normally produce progressive disease. By contrast 
transmission of M. bovis from farm workers to cattle has been well 
documented. Infection is reported to have been transmitted via respiratory and 
genito-urinary tracts. Today M. bovis infection as a cause o f infection in man 
accounts for only about 1 % of tuberculosis in man, and of this 1 % pulmonary
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disease occurs in only 40-50% and some of these will be smear negative 
making the likelihood of human to human infection quite low.
Transmission of Af. bovis from wild animals to cattle and man occurs mainly 
from badgers (in the British Isles) as discussed further. Wild deer also act as 
potential reservoir o f M. bovis infection but they are thought to have a much 
lower level of infection. An outbreak of M. bovis in domesticated deer in 
Canada in 1990 resulted in one case o f active Af. bovis infection in a 
veterinary surgeon (Hardie and Watson, 1992). This suggests that farm 
workers and veterinary surgeons are those most at risk from Af. bovis 
infection.
1.3.5Reservoirs of Bovine Tuberculosis
In Australia the eradication program for bovine tuberculosis has been 
extremely successful due to the continuous if  not necessarily co-ordinated 
efforts of farmers and veterinarians, in rigorous tuberculin testing and import 
control. Australia does not have the natural reservoir o f possum found in New 
Zealand. In the U .S.A . there is growing concern as to the role o f bison as a 
wildlife source of tuberculosis in cattle near Yellowstone park.
Natural reservoirs of infection are badgers in the U.K. and the possum in New 
Zealand. These wild animals constitute a reservoir o f infection that is 
extremely hard to monitor and if necessary eradicate.
In the U.K. the Ministry of Agriculture Fisheries and Food (MAFF) have 
adopted an eradication policy for affected areas (such as South West England) 
since a tuberculous badger was found in Gloucestershire in 1971. This 
suggested that badgers were a significant reservoir o f disease. Gassing of 
badgers was carried out since it gave a lower recolonization rate. Another 
hindrance to the eradication of badgers in affected areas is the badgers ability 
to live for long periods after infection and pass infection on to its offspring. 
Exactly how the bacilli are passed from badger to cattle is unknown. M AFF 
have shown that up to 20% of badgers in areas where tuberculosis occurs in 
cattle were infected with Af. bovis. Up to the end of 1991, M AFF had 
undertaken 734 badger control operations where tuberculosis in cattle was 
thought to have originated from badgers. This control program has had
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questionable effect since there was no significant decline in the numbers of 
herds with tuberculin positive animals in regions in South West England 
(Brown et al, 1994).
Despite the circumstantial evidence for the link between badgers and infected 
cattle the main mode of transmission of the disease is unknown. It is assumed 
that most cases in cattle arise through inspiration or ingestion of bacilli during 
contact with grass contaminated with infected badger urine, faeces or sputum. 
How cattle come into contact with contaminated pasture is unknown. Brown 
et al. (1994) suggest that heterogeneous landscapes with many boundaries 
produce suitable areas for badger territory marking with urine. Urine is known 
to be a potent source o f bacilli and these workers postulate that since cattle 
graze preferentially around field margins they are likely to come into contact 
with badger urine.
The bush tailed possum was introduced to New Zealand from Australia in 
1858. The lack of predators and the amenable new bush environment meant 
that the species flourished. A decline in the fur trade has lead to a large 
population increase for the possum. The density of population has lead to 
destruction of native tree species and they are implicated in the spread of 
bovine tuberculosis. There is hope that the possum population may be 
controlled by sterilization, culling or vaccination against bovine tuberculosis. 
Vaccination may lead to larger populations o f possums which would be 
dangerous from an environmental point of view (Roberts, 1992).
1.3.6Tuberculosis in Farmed and Wild Deer
Tuberculosis in deer represent a problem in its own right and also a possible 
source of infection for farm workers and cattle. In New Zealand and Denmark 
deer farming is a major industry driven by the high price of antler velvet. In 
the U.K. deer farming had brief popularity when it was hoped veal would 
become popular. It was not the success it was hoped to be and the ban on 
antler velvet in the U.K. means that the industry has not boomed. There are 
however deer farms and numerous parks that have large herds.
Wild deer are a known source of tuberculosis infection in cattle, but the risks
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to cattle from farmed deer are unknown. The incidence of tuberculosis in wild 
deer is generally considered higher than those in farmed deer. However 
disease in farmed deer shows rapid progression due to the stress created by 
farming conditions. In Switzerland it has been suggested that badgers and foxes 
may have been infected by eating diseased roe deer carcases.
In New Zealand the possum probably provides a reservoir for deer infection 
in much the same way as it is a source of cattle infection. There is evidence 
that some isolates of Af. bovis from deer, possums and cattle in the same 
locality are identical. In New Zealand there is also evidence that farmed red 
deer have infected cattle and possums in areas not previously considered 
endemic zones. The body of evidence suggests that there is relatively free 
transfer of Af. bovis between susceptible farmed and wild animals.
Denmark, New Zealand and the U.K. have eradication schemes for 
tuberculosis in deer similar to those for cattle, relying on tuberculin testing and 
slaughter o f reactive animals. In the U.K. tuberculosis in deer was only made 
a notifiable disease in 1989. Tuberculin skin testing is not even as specific in 
deer as it is in cattle and like cattle unless animals are tested at the right stage 
of infection they may be anergic. Sensitization also occurs due to Af. avium 
infection which are more prevalent in deer than cattle. In the U .K . deer 
farming did not show that growth it has in New Zealand where it is 
economically significant.
1.4.1Non-tuberculous Mycobacterial infections
Af. kansasii and M. avium represent two members of the group o f atypical 
mycobacteria that cause non-tuberculous Mycobacterial infection. Af. kansasii 
causes disease primarily in immunocompromised individuals and persons with 
predisposing respiratory defects, and occasionally in cattle. Af. avium causes 
infection in immunocompromised hosts including HIV infected individuals. The 
differentiation o f these two Mycobacteria from Af. tuberculosis complex 
bacteria has become more sophisticated in recent years and may account for 
some o f their increased rates of diagnosis. Clinical features o f pulmonary 
disease caused by either Af. kansasii or Af. avium can be deceptively similar
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to those caused by M. tuberculosis. Diagnosis is generally made on the 
cultivation and identification of the causative organism. But isolation o f the 
organism alone is insufficient to establish a diagnosis as the strain could be a 
secondary saprophyte of the diseased tissue or just a contaminant. Diagnostic 
problems occur when there are repeated scanty isolates which may represent 
saprophytic colonization.
1,4,2Mycobacterium kansasii infections
Pulmonary M. kansasii infection often occurs in previously diseased or 
damaged lungs. One such predisposing disease is silicosis, this disease is 
acquired by persons such as sandblasters, it has been demonstrated (Baily et 
ah, 1974) that M. kansasii infections commonly complicate and accelerate 
silicosis. Extrapulmonary and disseminated cases of M. kansasii have also 
been reported including cervical lymphadenitis, dermatitis and osteomyelitis. 
In immunocompromised patients disseminated and pulmonary cases have been 
described (Levine and Chaisson, 1991). In the U.S. M. kansasii is the second 
most common non-tuberculous mycobacterial infection in patients with AIDS 
after M. avium complex. It has also been found that M. kansasii infections 
require modified chemotherapy when compared to tuberculous disease. This 
highlights the need for rapid differential diagnosis of the two infections.
M. kansasii infections are also found in cattle. These represent a problem for 
farmers because they can cause sensitization to tuberculin leading to slaughter 
of cattle. At present farmers in the U.K. are not compensated for cattle lost 
due to M. kansasii infection. M. kansasii infection can also reduce the price 
o f meat and again differential diagnosis between M. bovis and M. kansasii 
infection is important.
l,4,3Mycobacterium avium Complex (MAC) Infection
The Mycobacterium avium complex includes M. avium and Mycobacterium 
intracellulare as well as many strains not assigned to either species. MAC is 
the most common species complex isolated in most clinical mycobacteriology 
laboratories. It has long been associated with pulmonary disease resembling
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tuberculosis and with cervical lymphadenitis in children and has now assumed 
great importance as a cause o f disseminated disease in patients with HIV. 
M.avium complex occurs in 30-50% of HIV infected patients, when 
disseminated MAC can cause fever, sweats, weight loss and anaemia. 
Development of disseminated disease in HIV- infected patients may correlate 
to factors such as anaemia, prior opportunistic infection and interruption in 
Zidoudine therapy.
MAC is an ubiquitous organism and can be recovered from water soil and a 
variety of animals including birds and cattle. Epidemiological studies suggest 
that MAC strains associated with pulmonary disease may differ from those 
associated with disseminated disease in AIDS patients. It may be that 
pulmonary disease is generally a reactivation o f a latent infection occurring 
generally in older people and that AIDS associated disseminated disease is a 
recent acquisition of the bacterium. Traditionally serotyping has been used to 
differentiate different MAC strains, unfortunately many strains are untypable. 
Genomic methods using gene probes or RFLP analysis have also been used but 
do not correlate well with serotyping data. Molecular phylogeny based on data 
from selected regions of 16S-23S rRNA internal transcribed spacer 
(Frothingham and Wilson, 1989) shows some clinically significant divisions 
between different MAC strains. 
l.SC haracteristics of Diagnostic Tests
Before considering the usefulness of any diagnostic test we must consider the 
characteristics o f the test that may influence its application. When tests give 
a yes or no answer the results are straightforward. In many tests such as 
ELISA there are range o f values such that there may be an overlap between 
the results of those with and without disease. So for ELISA tests, a cutoff 
point is established. For a Polymerase Chain Reaction (PCR) based test the 
result is generally positive or negative but its usefulness is measured in terms 
of sensitivity and specificity.
Sensitivity is the fraction of subjects with disease who have a positive test, and 
specificity is the fraction of subjects without the disease who have a negative 
test. When establishing a cutoff point for an ELISA test there is generally a
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trade-off between sensitivity and specificity such that one can only be increased 
at the expense of the other. The same is broadly true for PCR based tests in 
that when tests are extremely sensitive i.e. when nested PCR is used, the 
specificity o f the test is compromised due to the increased likelihood of 
contamination and spurious cross-reactions.
When a test is used in a clinical setting the user does not know what the likely 
diagnosis may be, this means that accuracies o f positive and negative 
prediction, the predictive values of the test, become important (Daniel and 
Debanne, 1987). Predictive values vary with the prevalence of the conditions 
being tested among the population under test. For a fixed sensitivity and 
specificity lower prevalence rates lead to fewer false negative results and hence 
better negative predictive accuracy. Similarly higher prevalence rates lead to 
more true positive results and better positive predictive accuracy. In a 
population where a disease is present in the minority o f people then the 
accuracy of positive prediction is greatly influenced by the specificity of the 
test. In an area of low disease prevalence the accuracy o f negative prediction 
is not influenced, relatively, by test specificity, because false negative results 
can only be a very small fraction of all o f the negative results obtained.
The efficacy of a test can also depend on what is required of it. W ill it be used 
for screening a population for probable positive results? Is it designed to be the 
definitive test upon which final diagnosis and treatment regime is decided? 
Diagnostic tests currently available represent imperfect systems which can be 
assessed on their sensitivity, specificity, ease of use (equipment used, training 
needed) and relative cost. A suitable test for a diagnostic laboratory may have 
no place in field conditions, where a compromise may have to be struck 
between ease of use and sensitivity and specificity values. This may also mean 
that tests suitable for field conditions are not considered sensitive and specific 
enough for laboratory use.
1.6Diseases of Possible Mycobacterial Aetiology
There are several diseases of unknown aetiology that have been from time to 
time speculatively associated with Mycobacterial species, among these the most
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studied are sarcoidosis and Crohn's disease.
Sarcoidosis is a multisystem granulomatous disease o f unknown cause that 
usually affects young people and accounts for substantial morbidity and chronic 
ill-health. The disorder is characterised by the formation of multiple-caseating 
granulomas in more than one organ. The histological similarity between 
sarcoidosis and tuberculosis points to a possible mycobacterial aetiology, but 
attempts to grow mycobacteria from sarcoid tissue have not succeed. However 
sarcoid tissues have yielded unidentifiable slow growing, variably acid fast 
organisms. It has also been suggested that cell-wall deficient mycobacteria that 
are hard to culture are involved. There is some evidence based on PCR 
analysis o f lung lavages that the lungs of sarcoid patients show the presence 
of M. tuberculosis TUNk (Saboor e / û/., 1992).
An aetiologic role for mycobacteria on Crohn's disease has long been the 
subject of study and speculation. Unfortunately more speculation than evidence 
remains available. Crohn's disease is a granulomatous disease o f the human 
intestine, often resulting in the need for excision o f part o f the large intestine. 
Many organisms have been isolated from the intestines o f Crohn's disease 
patients one of which is Af. paratuberculosis the causative agent o f Johne's 
disease in cattle (as described chapter 4).
Transmissible agents have been shown to be present in both sarcoid and 
Crohn's disease tissues, these agents passed through a 0 .2^ filter implying they 
are not normal forms of bacteria. Suggestions are that these are L-forms or 
cell wall deficient forms of mycobacteria. This would also explain the lack of 
efficiency of standard anti-mycobacterial drugs because cell-wall deficient 
forms would probably be metabolically deficient.
Another fascinating suggestion is that sarcoidosis may be caused by lysogenic 
bacteria. Mankiewicz and Beland (1964) isolated faintly acid-fast and 
morphologically distorted bacteria from 7 out o f 10 granuloma biopsies from 
patients with sarcoidosis. These bacteria liberated phages which lysed various 
mycobacteria. Unfortunately the bacteria were not identified. Other workers 
have implied that phages can induce loss of acidfastness, protoplast formation 
and changes in antigenicity in infected bacteria.
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The debate continues as to the aetiological agents o f both Crohn's disease and 
sarcoidosis with many anecdotal isolations of both bacteria and viruses from 
disease sites. Which of these is the cause of the disease and which merely 
secondary colonists remains unclear. 
l.T T he Polym erase C hain Reaction
The polymerase chain reaction (PCR) is the pioneering technique for in vitro 
amplification of nucleic acids (Saiki et at. , 1985) and as such represents the 
most popular and widely developed amplification technique.
1.7.1PC R  M echanism
PCR produces greater than 10^-fold amplification o f target DNA sequence in 
l-2hrs through repetitive cycles of replication. Firstly double stranded target 
DNA is heat denatured at about 94°C. Two oligonucleotide primers (present 
in huge excess of the target) anneal to opposite strands o f the target at variable 
temperature, 45-72°C, and are extended at 72°C by a thermophilic DNA 
polymerase (often Taq polymerase derived from Thermus aquaticus) producing 
a complementary copy of each target strand. This cycle is repeated around 30 
times generally using thermal heating blocks that can be programmed to 
change temperature. Primer extension products from each cycle serve as a 
target during the next cycle. Consequently, each cycle can theoretically 
produce a 2-fold increase in target copies. This means a theoretical value of 
2 X 10"-fold amplification can be achieved in 30 cycles (Walker and Little, 
1993), although about 10^-fold is more typical due to inefficiencies and 
competing background reactions.
The success of the PCR requires attention to certain key factors which depend 
on the sequence to be amplified. Some points to note are prim er and target 
sequences, time and temperature of dénaturation, annealing and extension steps 
and reagent concentrations.
1 .7 .2 0 th e r Am plification Systems
Due to patent restrictions on the use of PCR other amplification techniques 
have been developed to avoid the payment of license. Among the most 
developed o f these systems are strand displacement amplification (SDA) 
(Becton Dickinson) and transcription mediated amplification (TMA) (Gene-
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Probe Incorporated).
1.7.2.1Strand Displacement Amplification
Strand displacement amplification is an isothermal amplification process that 
takes advantage o f the ability of Klenow fragment of E.coli DNA polymerase 
to start at the site o f a single stranded nick (created by the enzyme HincII) in 
double stranded DNA, extend one strand from the 3 ' end, and displace the 
downstream strand of DNA (Walker et a l ,  1992). The replicated DNA and 
the displaced strands are then substrates for additional rounds o f 
oligonucleotide annealing, nicking and strand displacement such that the 
amplification proceeds in a geometric manner and can produce 10^-10* fold 
amplification in about 2hrs. The specificity of the SDA reaction is based on 
the choice o f primers to direct the DNA synthesis. This technique has been 
used in the chemiluminescent detection of Af. tuberculosis bacteria by Spargo 
et a l  (1993). These workers demonstrated that 10  ^fold amplification o f target 
could be achieved in 2hrs, which is similar to figures claimed for PCR, but a 
thermal cycler is not need since the technique is iso-thermal. The technique is 
prone to contamination in much the same way as PCR.
1.7.2.2Transeription Mediated Amplification (TMA)
Transcription mediated amplification is an isothermal target based reaction. It 
has been combined with a homogeneous detection method to detect Af. 
tuberculosis in clinical specimens (Jonas et a l ,  1993). This test uses lysed 
mycobacteria from which rRNA is amplified by TMA. The rRNA target 
sequences are copied into a transcription complex by using reverse 
transcriptase and then RNA polymerase is used to make numerous RNA 
transcripts o f the target sequence from the transcription complex. The process 
then repeats autocatalytically. The entire assay takes 3-4hrs and since it takes 
place in only one tube it is said to be less prone to contamination. Under 
laboratory condition Jonas et a l  (1993) claimed to be able to detect as few as
1,000 copies of rRNA. This is about half the number of copies o f rRNA in a 
single M. tuberculosis bacillus, and is capable o f lO’-fold amplification. 
1.7.2.3QB-Replicase System
The QB replicase system is a method for amplifying probe nucleic acid. It is
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effective because the RNA-dependent RNA polymerase from bacteriophage QB 
has the ability to synthesize large amounts of product strand from small 
amounts of template. The reaction mechanism is exponential because each 
product strand can serve as a template strand for the following synthesis. RNA 
synthesis continues at an exponential rate until the number of RNA molecules 
equals the number of polymerase molecules. In order to take advantage of this 
property RNA probes have been produced which can be replicated and thus 
amplified by QB RNA polymerase (Lizardi et a l , 1988). The drawback to this 
technique is the fact that non-specifically as well as specifically hybridized 
probe is amplified, resulting in a high background. M ore recently this assay 
has been used for the detection of M. tuberculosis (An, et al, 1995).
1.7 .3Applicability of PC R  to M ycobacterial Diagnostics 
Slow growing or non-cultivable mycobacteria are obvious targets for the use 
of PCR based tests. In principle the drawbacks of other mycobacterial 
diagnostic techniques, as discussed previously could be solved by the 
application of PCR which allows the in-vitro amplification of target DNA to 
a detectable level within a matter of hours. Theoretically PCR is a simple test 
which allows the detection of DNA from a single microorganism in a clinical 
sample. However in practice many problems have been encountered with the 
method. The most important being the generation of false positive reactions 
because of the amplification of contaminating DNA, which may include the 
products of previous PCRs. The second major problem has been false negative 
reactions caused by PCR inhibiting factors found in clinical specimens such as 
sputum and blood. Thus all PCR based test have to be assessed on the same 
criteria. Are they specific and how sensitive would they be using clinical 
specimens?
1.7.4Speclficity
The specificity of a PCR test has usually been analyzed by using the test on 
a panel of other mycobacterial species and an allied species such as Nocardia. 
Many workers have tested their PCR primers against an extensive range of 
mycobacteria, but generally only one strain from each species. This has not 
allowed for the presence of gene analogues in certain strains within species and
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may lead to false positive results significantly reducing the specificity of the 
test.
In general specificity is obtained by prudent choice of target, for example 
species specific insertion elements are a popular choice as are species specific 
regions of 16S rRNA genes.
1.7.5Sensitivity
Many workers claim exquisite sensitivity from PCR based tests under 
laboratory conditions, ranging from several genomes to fractions of genomes. 
Realistically on clinical samples about 10 genome equivalents can be detected 
(Clarridge et ah, 1994). The large disparity between sensitivities shown on 
extracted or purified DNA samples and clinical specimens is largely caused by 
inhibitory substances found in clinical specimens. Factors such as chelating 
agents can dramatically change the MgClg concentration in the reaction, 
causing loss of sensitivity.
Generally sensitivity is not a problem with PCR based tests, in fact it is the 
extreme sensitivity of the reaction that can be its greatest drawback since it 
gives rise to contamination.
1.7.6Avoiding contamination with PCR
Initial experiments with PCR in many laboratories throughout the world were 
successful and there was great optimism between 1987-1990 about the 
diagnostic potential of PCR tests. However it was found that when a primer 
pair was used for PCR for several months PCR amplicon contamination of 
reaction began to occur. A highly optimised PCR system capable o f detecting 
1-10 molecules o f target DNA is so exquisitely sensitive that it may be 
contamination from previously amplified products (amplicons) that reside in the 
laboratory environment. This was a great blow to the diagnostic potential of 
PCR. Many workers published on the subject of avoiding false positive results 
in PCR (Kwok and Higuchi, 1989). Most laboratories now routinely carry out 
different stages of PCR processing in different rooms being mindful of 
equipment or labcoat transfer from room to room. Such practice will reduce 
contamination but not prevent it. Thus many decontamination techniques have 
been developed, the most popular of which is the use of the enzyme uracil
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glycosylase (UDG) which removes uracil from DNA (Longo et ah, 1990; 
Wang et al., 1992). The method requires that the PCR is performed using 
dUTP instead of T I P. All amplicons made will therefore contain uracil instead 
of thymine. UDG treatment of the sample about to undergo PCR will then 
result in the degradation o f previous amplicons, without affecting the target 
DNA because virtually all organisms lack deoxyuracil. Subsequent heating of 
the sample to 95°C cleaves the abasic amplicons rendering them resistant to 
subsequent amplification. Although this technique is very effective, the test 
must never have been carried out without the use o f uracil incorporation or 
amplicons will still exist, and all other methods o f contamination control must 
be adhered to including use o f negative controls. Unfortunately the use of 
dUTP will require changes in the PCR conditions previously used for TTP 
based PCR. Optimal MgClz, dATP, dGTP, dCTP and dUTP concentrations 
may differ from those used in the corresponding TTP system. Another 
problem is running dUTP based systems overnight since prolonged storage of 
amplicons at 4-25 °C will degrade uracil containing products due to residual 
activity of UDG in tube.
l.T.TDevelopment of PCR Based Tests for Tuberculosis
Almost as soon as the PCR test using Taq polymerase had been described in 
detail (Mullis and Faloona, 1987), it was applied to the development of 
diagnostics for tuberculosis. Brisson-Noel et a l  (1989) described the 
amplification of mycobacterial DNA in clinical samples. Boddinghaus et a l  
(1990) described the use of the 16s ribosomal gene as a target. This is a 
reverse transcriptase step followed by amplification o f the cDNA produced, 
this is generally described as RT-PCR. Many formats have been used but one 
popular method is to amplify a target region common to all mycobacteria, then 
using a species specific probe the spéciation can be carried out, such as that 
o fH an ceera /. (1989). F issc/û /. (1992) described the used o f the 65kDa heat 
shock protein that is highly conserved among mycobacteria. To date probably 
the most popular target sequence for the detection of M. tuberculosis has been 
the insertion sequence IS6110, the popularity of this target is based on the fact 
it is present in 10-20 copies in M. tuberculosis. Eisenach et a l  (1990)
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described a trial using this sequence where using sputum samples 93% of the 
patients with active tuberculosis were PCR positive. Out o f 136 specimens four 
false positive results were found giving a specificity o f 97%. This study 
implied that PCR is useful for the detection of Af. tuberculosis in sputum 
samples. Clarridge et al. (1993) also used IS 6110 on clinical specimens and 
achieved sensitivity values of 83.5% and specificity of 99%. They suggested 
that if  results for multiple specimens submitted from the same patient had been 
considered, no patient who had three of more sputum specimens tested would 
have been misdiagnosed. However in disagreement with these findings 
Noordhoek et al. (1994) carried out a seven centre blind comparison of PCR 
for the detection of M. bovis BCG in sputa samples where huge disparities 
between laboratories existed with false positive rates ranging from 3-77% and 
sensitivities from 2-90% in samples containing 10  ^ mycobacteria. This study 
was flawed in that M. bovis BCG was used which has 1-2 copies o f IS6110 
compared to M. tuberculosis which has 10-20 copies which significantly 
reduced sensitivities. Other workers such as Kox et al. (1994) have had greater 
success where more careful studies using IS6110 as target and using the 
contamination control system based on uracil-N-glycosylase. 
l.T.SDevelopment of PC R  Based Tests fo r Leprosy 
Numerous PCR based tests have also been developed for the diagnosis of 
leprosy Hartskeerl et al. (1989) developed a primer pair based in the 36 kDa 
antigen of M. leprae. This test had a sensitivity limit of 20 bacteria equivalent 
o f DNA and in armadillo derived tissue only 1000 bacteria. Many workers 
have since worked on the optimisation of PCR test using fixed tissue since this 
is the generally available tissue from leprosy patients.
Archival tissue such as formalin fixed tissue poses a great problem to the 
development of PCR tests as such tissue is often inhibitory to PCR. In order 
to limit the problem of inhibition several groups have looked at different fixing 
procedures for biopsies, de W it et al. (1991) suggested that samples incubated 
for only 2hrs in neutral buffered formalin, or frozen only, were suitable for 
PCR amplification techniques. These workers however could not achieve PCR 
positive results in patients with low BI. Faillo et al. (1992) also found that
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neutral buffered formalin was a suitable fixative when used for periods under 
24hrs however some degree of inhibition was still observed. These workers 
observed that storing unfixed material in 70% ethanol was the best storage 
procedure for PCR samples.
One of the important issues regarding the use o f PCR for leprosy diagnosis is 
the applicability o f tests to the areas where the disease is endemic. Tests need 
to be carried out under field conditions where electricity supply may be 
unreliable and staff may have little prior training. It is believed by many that 
PCR technology may be applied in endemic areas and that its sensitivity would 
outweigh any difficulties such as contamination. The achievement of this 
objective requires not only simple robust methods for carrying out the PCR 
itself, but also simplified techniques for detection of amplified product. It may 
be that a reverse dot blot technique format could be used in this setting since 
it may be easier to carry out than Southern blotting, such techniques using 
non-radioactive labelling described in Woolford and Dale, 1992 and Fiss et 
al, 1992 might be applied.
Jamil et al. (1993) have used PCR to assess the efficacy o f leprosy 
chemotherapy. These workers found however that a proportion o f samples 
contained inhibitors to PCR and were excluded from this study. They also 
found that samples with low BI values, less than 1.5, could not be detected. 
This demonstrates the limited use of PCR for leprosy diagnosis since it often 
fails to detect the tuberculoid leprosy cases. These are the cases most needing 
a sensitive test to diagnose early disease.
l.SG ene Probes fo r the Epidemiological Exam ination of M ycobacteria 
To control the dissemination o f tuberculosis in a community or country it is 
necessary to examine the source of infection and see how each strain is spread. 
Phenotypic markers such as antibiotic resistance and phage susceptibility have 
been used for some time to examine outbreaks o f M. tuberculosis. Antibiotic 
resistance tends to be uniform for most strains and phage typing is o f limited 
epidemiological use (Ross et al. , 1992). M ore recently workers have tried to 
identify genetic markers to provide insight into the epidemiology of 
tuberculosis. Many early studies failed to show significant heterogeneity
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between strains (Shoemaker er û/., 1986).
The most widely studied and successfully used element for the examination of 
tuberculosis is the insertion element IS6110. This was simultaneously 
discovered by several workers including Zainuddin and Dale (1989) and 
Thierry et al. (1990). IS6110 is 1,355 bp insertion element (IS) found to be 
distributed throughout the M. tuberculosis complex. In general there are 5-20 
copies o f the element present in the genome of Af. tuberculosis present in 
various positions, however some isolates have been shown to have no IS6110 
but these tend to be in geographically distinct areas. Most investigators use the 
technique of Southern blotting to exploit the presence o f IS6110 and other 
genetic elements. The technique of restriction fragment polymorphism (RFLP) 
analysis has been most widely employed. A standardised protocol was agreed 
upon in 1991 (van Embden et al., 1993) this permits the comparison o f results 
obtained from different laboratories around the world.
Polymorphic banding patterns have been obtained using PCR amplification of 
fragments of IS6110 (Ross and Dwyer, 1993). PCR with arbitrary 
oligonucleotides has also produced polymorphic banding patterns that confirm 
the relationships between isolates in a known cluster o f tuberculosis cases 
(Palittapongarnpim er ûZ., 1993).
Other elements or sequences with some epidemiological potential include 
IS 1081 (Collins and Stephens, 1991), which is distributed rather 
homogeneously within strains of M. tuberculosis. This is more useful in 
differentiating BCG from stains of M. tuberculosis (van Sooligen et al., 1992).
Direct repeat (DR) sequence is a directly repeating sequence o f 36 bp 
interspersed by nonrepetitive DNA (Hermans et a l , 1991). The number of 
copies o f the DR sequence is 10-50 in Af. tuberculosis complex strains. The 
vast majority of Af. tuberculosis strains contain 1 or more IS6110 element in 
the DR-containing region of the genome. This locus is believed to be a hot 
spot for integration o f IS6110. The diversity created by the differences in copy 
number of DRs plus spacer sequences may provide sufficient polymorphism 
to make PCR based fingerprinting in these regions possible.
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Major polymorphic tandem repeats (MPTRs) which are 10 bp repeating 
sequences have also been described by Hermans et a l (1992), and these may 
play a role in genetic rearrangements and gene regulation although MPTRs are 
not commonly used for strain differentiation.
Similar in structure and host range to MPTRs polymorphic GC-rich repetitive 
sequences have been described by Doran et a l  (1992). These short sequences 
are present in multiple chromosomal clusters composed o f non-perfect repeats. 
The mechanism by which PGRS-associated polymorphisms are generated is 
unknown.
Since 1990 IS6110 based RFLP analysis has been widely used to understand 
tuberculosis transmission, making this method the standard tool for many 
investigators. This technique has been used to show clonal transmission 
between neighbours (Godfrey-fausett et a l ,  1992) and in a congregational 
living facility (Daley et a l ,  1992) as well as in other locations. The use of 
molecular typing techniques has led to better control measures where obvious 
spillover infections from groups such as drug users, alcoholics and the 
homeless have transferred to the general population.
The degree of polymorphism in a population of M. tuberculosis may also serve 
as a method of assessing the relative contribution of newly acquired and 
reactivated infection. There is likely to be more polymorphism were strains 
have been acquired from diverse places, for example in reactivation cases, 
than from patients who have had recent infection.
It is also hoped that molecular epidemiological typing will help in the 
understanding of any global spread of tuberculosis so that effective control of 
transmission can be carried out. In Europe there is a concerted effort to collect 
fingerprint data from many different strains and create a computer database o f 
fingerprints, clinical and bacteriological data. This database may help in the 
understanding of the impact of HTV, population movements and other 
sociological risk factors.
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CHAPTER 2
SIMPLIFIED PROCEDURES FOR THE DETECTION OF AMPT JFTFT)
DNA
2.1 INTRODUCTION 
2.1.1Applicability of rap id  non-radioactive detection m ethods 
Tuberculosis and leprosy by the very nature o f the slow progression of disease 
are often extremely difficult to diagnose in their early onset. These are both 
socially stigmatised diseases generally associated with poverty and more 
recently in the case of tuberculosis with AIDS (acquired immunodeficiency 
syndrome). It can therefore be extremely difficult to encourage patient 
compliance with drug therapy. It is essential to make rapid early diagnosis of 
these diseases preferably at a medical centre near to the patient's town or 
village. Slow diagnosis, conventional culture taking 4-6 weeks, leads to 
infected patients returning to the community untreated to spread these diseases 
more widely.
New technology such as that used for PCR and ELISA based tests offers the 
promise of rapid alternative techniques for the diagnosis o f tuberculosis and 
other mycobacterial diseases.
2.1.2U tilisation of non-radioactive labelling techniques 
Recent developments in the field of gene probe technology, in particular the 
introduction of the polymerase chain reaction (PCR) have allowed the design 
of tests capable of theoretically detecting a single organism in a clinical 
specimen, and in practice sensitivities approaching that level (De Wit et ah, 
1991).
The aim of this work was the development o f a rapid diagnostic test for 
leprosy that would be sufficiently simple and robust for use in field conditions 
in developing countries. In order to be useful in these conditions the test must 
involve the minimum of equipment and heat sensitive reagents or reagents with 
short shelf life and complex handling procedures ie. ^^P. The test should not 
require constant electrical current, as for gel electrophoresis, and should be 
capable o f being carried out by personnel with a small degree o f training. 
Radioactively labelled DNA probes generally have high specific activity. They
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are considered unsuitable in field conditions due to considerations o f user 
safety and cost of disposal o f radioactive waste, use, storage and disposal of 
radioactive isotopes and radiolabelled compounds being regulated by local and 
government agencies. More suitable labelling strategies for field conditions 
include stable enzyme based systems such as biotin labelling and fluorescence 
based systems such as fluorescein isothiocyanate.
A reverse probing format has been widely suggested as a suitable format for 
use in clinical laboratories (Fiss et a l ,  1992) since it is fast taking 1-2 days 
and this technique allows the detection o f PCR product without the need for 
gel electrophoresis or gel filtration o f products. The technique is out lined in 
figure 2.1. This involves the use of single stranded nucleic acid fragments, 
complementary to one strand of the target sequence (but not including the 
primer sequence) as a 'capture probe'. These DNA fragments are bound to 
individual pieces of nylon membrane or other support such as a microtitre 
plate, to detect the presence of suitably labelled PCR-amplified product. Thus 
after PCR-amplification the contents of each tube are hybridised to a separate 
piece of membrane carrying the complementary sequence; after washing to 
remove any non-specifically bound material, the labelled specific amplified 
product is detected. This technique was therefore used in a reverse dot-blot 
format using non-radioactive label incorporation during PCR. This might be 
more easily applied to a clinical setting than the research method of Southern 
blotting since it can be used on many samples at once and does not require gel- 
electrophoresis.
The reverse dot-blot method used is shown in figure 2.1.
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Figure 2.1Diagrammatic representation of the reverse probing technique
PCR
'  biotin-labelled 
Q  primer
biotin-labelled 
PCR products
6"
probe
nylon membrane
capture probe fixed 
to nylon membrane
PCR products hybridize to fixed probe; 
biotin label is detected by enzyme-substituted 
streptavidin
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2.2 GENERAL M ETHODS IN  THESIS 
2 .2.1G eneral PC R  methodology
All amplifications were carried out using the Hybaid Omnigene thermal cycler. 
All PCR reagents were used only for PCR and stored in a building separate 
to that where amplifications were carried out. The primers were used at 30 
pM. Taq polymerase (Boehringer Mannheim) was used at 2.5 units per 50/il 
reaction, buffer lOXs was supplied with Taq polymerase. Nucleotides (dNTPs) 
(Pharmacia) were used at lOOfiM. Reaction volumes were made up using 
sterile water (USB). All reactions were overlaid with 50/xl mineral oil (USB). 
Standard cycling conditions were:
95 °C Imin initial dénaturation x 1
37-65°C Imin annealing (variable)
72 °C 2min extension
95°C Imin dénaturation
25-30 cycles followed by:
37-65°C 2min
72°C 7min x 1
2.2.2Southern blotting
Southern blotting was carried out as Maniatis et a l  (1982), using 20 X SSC. 
After blotting overnight membranes were washed for 2 min in 5 X SSC and 
air dried. They were then baked for 30 min at 80°C.
2 .2.3Extraction of low m olecular weight DNA from  agarose gels 
Extraction o f small DNA fragments for use as probes was carried out using a 
DEAE paper method, agarose gels were stained after electrophoresis and a 
piece o f Schneider and Schull DEAE membrane was place in front o f the band 
in the gel. The gel was run until the fragment was eluted onto the paper. The 
paper was then placed at 70°C in a solution o f IM  NaCl 0.05M  L-arginine 
for 2hrs. After cooling, the aqueous layer was extracted once with an equal 
volume of iso-amyl alcohol, and precipitated in 3 vol ethanol. The resuspended
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product was quantified and used in the labelling reaction.
2.2.4Probe labellmg
Probes were generated by random primed labelling o f ds-DNA with 
digoxygenin dUTP, this method employs random hexanucleotides annealed to 
the denatured DNA template and Klenow enzyme to incorporate nucleotides 
including the DIG-dUTP into the newly synthesised probe molecules. This 
method should incorporate DIG-dUTP every 20-25 molecules in the newly 
synthesised DNA according to Boehringer Mannheim. The method was carried 
out as manufacturer's (Boehringer Mannheim) instructions. Generally between 
200ng and Img of probe was labelled in an overnight reaction at 37®C, this 
yields 4(X)-780ng labelled probe.
2.2.5Hybridizations
Hybridizations were carried out using a Hybaid micro-oven, usually the 
hybridization temperature was 65®C. All hybridizations were carried out 
overnight using hybaid hybridization bottles. Probe was then poured from the 
bottle and stored at -20°C for re-use. Post hybridisation washes were 2 X 15 
mins in 2 X SSC, 0.1%SDS at room temperature and 2 X 30 min in 0.1 X 
SSC, 0.1% SDS at 65°C, and were carried out in the hybridization bottle.
2.2.6Detection of probe
Digoxygenin labelled probes were detected using the chemiluminescent 
detection system according to the manufacturer's (Boehringer Mannheim) 
instructions. All detection steps were carried out in clean plastic boxes, anti- 
DIG alkaline phosphatase fragment treatment was always carried out in a 
dedicated plastic box. Chemiluminescent substrate was Lumigen PPD. To 
achieve steady state chemiluminescent reaction membrane was incubated at 
37°C for 15 min. Once steady state was reached the membrane was exposed 
to X-ray film (Fuji) for a suitable period from 5 min to 12hr.
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2.2.7Stripping of membranes
Membranes were kept at 4°C in 2 X SSC after first use and prior to 
reprobing. The membrane was then rinsed thoroughly in water and incubated 
in 0.2M  NaOH /0.1 % SDS for 40mins at 37°C, the membrane was then rinsed 
with 2 X SSC, the filter was then dried or used directly in hybridisation.
METHODS CHAPTER 2
2.2.8Cbromosomal DNA extraction from slow growing mycobacteria
Cultures were grown in 10ml Middlebrook medium (Oxoid) with OADC 
supplement(Oxoid) for 4-6 weeks. At 48hr before harvesting each 10ml culture 
had 1ml of 10% glycine added or lOO/d of lOOmg/ml cycloserine added. 
Cultures were harvested by centrifugation at 4,000rpm for lOmins. The pellet 
was resuspended in 200^1 of 2mg/ml lysozyme,0.3M sucrose 50/ig/ml RNase 
solution made up in TE buffer pH 8.0, and incubated at 37°C for 3hr. After 
which 100^1 of 5 % SDS in TE (pH 8.0) and 5^g proteinase K was added. The 
preparation was incubated at 37°C for a further 30mins. The resulting solution 
was extracted twice with an equal volume of phenol, then once with 
phenol/chloroform and once with chloroform. It was precipitated overnight 
with 3 volumes of 100% ethanol and 0.1 volume of 5M sodium acetate. The 
preparation was spun at 12,000rpm for 30mins in an MSE microcentaur 
microfuge, the supernatant was discarded and the pellet dried in a warm oven 
and the pellet was resuspended in 30-KX)/a1 of water or TE.
2.2.9Syntbesis of primers
All primers used in this study were synthesised on an Applied Biosystems 
(ABi) 381A DNA synthesizer. The chemistry involved was B-cyanoethyl 
chemistry as described in the manufacturer's instructions carrying out a 0,2fiM 
synthesis. B-cyanoethyl phosphoramidite oligonucleotides only require 
treatment with 35% ammonium hydroxide(ABi) to simultaneously cleave the 
product from the support and deprotect the phosphate groups. Modifying
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agents such as Aminolink 2 or Aminomodifîer II were used as bases except 
they were placed on port 5 of the oiligonucleotide syntheiszer. The addition of 
these reagents to the primer was achieved by placing an X in the sequence 
input to the synthesizer.
2.2.10Remoyal of primer from column and deprotection
Columns were removed from the synthesizer and 1.5ml o f concentrated 
ammonia (ABi) was passed in 0.2ml aliquots from a 2ml plastic syringe at one 
end into another. After 2hrs the ammonia was squirted from one syringe to 
another rapidly and the ammonia was placed in a screw cap eppendorf tube. 
The tube was then placed in a 55 ®C waterbath for at least 6hr or overnight. 
The ammonia solution was cooled to room temperature and 300^1 aliquots of 
the primer were precipitated in 3 volumes of ethanol and 0.1 volumes of 5M 
sodium acetate. Primers were centrifuged at 14,000rpm for at least 30mins and 
the supernatant discarded the pellet was centrifuged to dryness in a 
Uniscience vacuum centrifuge and resuspended in 50-100/^1 o f sterile water. 
2.2.11Estim ation of p rim er concentration
2/tl of the primer solution was diluted in 500/d of sterile water and examined 
spectrophotometrically at 260nm concentration was calculated as follows: 
33(oligo conversion factor) X O.D. 260nm X dilution factor =  ng/ul or 
mg/ml.
2.2.12Labelling of modified oligonucleotides
An aliquot of Aminolink 2 (ABi) or Aminomodifîer II (Clontech) modified 
oligonucleotide (200/tl) was placed in a 1.5ml microfuge tube and evaporated 
by vacuum centrifugation until a dry pellet was visible. The pellet was then 
dissolved in lOOfû of IM  NaCl and precipitated with 4(X)/il o f ethanol (this 
process desalts the oligo). The mixture was cooled to -20®C for 5mins , 
centrifuged for 2mins and the supernatant was discarded. The precipitate was 
dissolved in 42/d of 0.25M NagCog/NaHCOa buffer pH 9.0 (adjusted with 
0.25M sodium bicarbonate to pH. 9.0 with 0.25M  sodium carbonate). The
58
appropriate label, such as Rox (Abi) or FITC (Clontech) was added and the 
reaction was allowed to proceed overnight in the absence of light.
Initial experiments demonstrated the use of Aminolink 2 labelled PCR primers 
B CG l/2 (shown 2.3.2.1), this reagent adds a primary amine to the 5 ' end of 
the prim er during synthesis. The commercially available rhodamine dye - 
ROX,(ABi) was chemically attach as manufacturers instructions. The primer 
was then purified by passing it through a PD-10 sephadex column (Pharmacia) 
and through and olignucleotide purification cartridge (OPC, ABI), these primers 
were designated BCGX1/BCGX2. Secondly BCG primers B CG l/2 were 
multiply labelled with Aminomodofierll (Clontech), each prim er was 
synthesized with three primary amine groups within the sequence. ROX 
rhodamine based dye was reacted in overnight at room temperature and the 
primers designated BCG 1X3 and BCG2X3.
2.2.13Purification of prim ers 
PD-10 column
To remove unreacted dye moieties a Pharmacia PD-10 column was used, the 
column was washed twice with O.IM triethylamine acetate (TEAA)(ABi) pH 
7.0 approximately 5ml per wash was eluted, the sample was made up to l(X)/il 
with 0. IM  TEAA and loaded onto the PD-10 column and allowed to enter the 
column bed. Then 2ml o f O.IM TEAA was added and this was allowed to 
elute. A further 1.5ml 0.1m TEAA was added this was collected in 0.5ml 
fractions for further purification.
Oligonuleotide purification columns (OPG>
To separate primers with dye attached from those that had not reacted an 
oligonucleotide purification column was used. The OPC was flushed with 5ml 
o f acetonitrile (ABi) followed by 5ml o f 2M TEAA pH7.0, the entire solution 
eluted from the PD-10 cartridge was loaded onto the OPC with a 5ml syringe. 
The OPC was then flushed 6 times with 5ml aliquots o f 8% acetonitrile in 
0. IM  TEAA pH7.0. The primer was eluted by flushing the cartridge with 1ml 
20% acetonitrile in distilled water. The purified primer was dried in a vacuum
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centrifuge for 2hr until the pellet was dry.
2.2.14High Pressure Liquid Chromatography
All HPLC analysis was carried out using a Spectra Physics 8800 ternary pump 
based system with helium sparging o f all solvents.
2.2.14.1Anion Exchange Chromatography
Separation by anion exchange chromatography is largely based on charge. 
Each oligonucleotide in a mixture has a different net charge based in the 
number o f phosphate groups in the molecule (base length) and on the 
respective charges o f the bases (base composition). Separation o f the crude 
mixture is accomplished by slowly increasing their ionic strength o f the mobile 
phase. By doing so the longer more charged oligonucleotides will elute later 
than the shorter ones.
Anion exchange chromatography was carried out on a nuleogen 60-7 DEAE 
column (Macherey-Nagel,Duren)
Size 4mm x 125mm
Buffer A: 40% Acetonitrile, 0.02M Na-acetate, pH 5.5 
Buffer B: 40% Acetonitrile, 0.02M Na-acetate, 0.7M  LiCl pH5.5 
Gradient: 0-50% B in 120mins, 50-100% B in 250mins 
Flow rate: 3ml/min, 40 BAR 
Temperature: ambient
HPLC for Aminomodifîer H labelled primers
The evidence of HPLC analysis o f oligonucleotides has shown that 
contaminating short chains of nucleotides produced during synthesis and 
unlabelled primers can contribute to the lack of sensitivity o f this test. Further 
purification o f primers by HPLC was considered to be necessary.
Two new primers based on BCG l/2 were synthesized as follows:
AX5- 5 ’ XGAXAGXGXTCXGTCATCGACGGTAAGGAC 3'
BX5- 5 ' XACGXCCXGTXTGXACGTTACCGAGCCCAA 3 '
W here X is the position of an Aminomodofierll molecule, this molecule does 
not replace a base but is extraneous to the nucleotide sequence
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After synthesis it was important to remove two types o f synthesis failure 
product, firstly chains that are not full length these being removed by anion 
exchange chromatography and secondly those chain not having all 5 
Aminomodifîer II molecules incorporated this is achieved by reverse phase 
chromatography. DetectioniUV at 260nm 
Anion Exchange C hrom atography
Figure 2.2 shows a preparative run chromatogram for AX5, where detection 
o f prim er is by UV absorbtion at 260nm. This chromatogram is shown in 
figure 2.2. The top of the first large area peak (as indicated) was collected. 
2.2.14.2Reverse phase chrom atography
Samples from anion exchange chromatography were then purified by reverse 
phase chromatography. Separation o f oligonucleotides by this method relies in 
the difference in hydrophobicity among the various oligonucleotides produced 
in a synthesis. The sample is then eluted in ready to use form. Reverse phase 
chromatography was carried out on an Aquapore RP-3CX) column(ABi) as 
follows:
Size: 4.6 x 220mm
Buffer A: 0. IM  TEAA pH7.0
Buffer B: 100% Acetonitrile
Gradient: Linear gradient from 7-17% B over SOmins
Flow rate: 0.5ml/min
Temperature: ambient
Detection: UV at 260 nm.
In this process the increasing acetonitrile concentration means that less 
ionically charged molecules are eluted first and the oligonuleotide chains 
bearing the most aminomodified groups will elute last, a preparative run 
chromatogram of AX5 purification is shown in figure 2.3. The largest area 
peak (as indicated) was collected in fractions those with high O.D. reading at 
260nm were pooled and precipitated. The precipitate was labelled with FITC 
(fluorescein-iso-thiocyanate) in accordance with instructions from Clontech.
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Figure 2.2 Chromatogram showing anion exhange chromatograpy
profile of prim er AX5
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Figure 2.3 Chromatogram showing reverse phase chromatography
profile of prim er AX5
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2.2.15Reverse probing technique using biotinylated primers
PCR was carried out as above using biotinylated primers at 200ng per primer 
per reaction, where reaction volume was 100^1. 30 cycles were used with an 
annealing temperature of 37°C. lOfil o f each reaction was electrophoresed 
through a 2% agarose gel and photographed.
Hybridization was carried out. The capture probe DNA was heat denatured by 
heating to 95°C for 5 min it was then placed in ice . The capture-probe DNA 
was then fixed on the membrane by placing it on several sheets o f Whatman 
3MM paper soaked in 0.4M  NaOH for 20mins. Prehybridisation was carried 
out with 500/xl prehybridisation solution consisting of a skimmed milk base 
(0.05g), 6ml o f 20X s SSC, 1ml of 10% SDS and 13ml water for Ihr. The 
PCR reaction products were denatured by heating to 95°C for 10 min and 
placing on ice for 10 min. Hybridisation with 90^il o f biotin labelled PCR 
product was carried out at 65°C overnight in a total volume o f 590/il. 
Washing steps were 2X SSC ,0.1 % SDS, 2x15 min and 0.1% SSC, 0.1% SDS 
2xl5mins. Detection using streptavidin horseradish peroxidase was then carried 
out.
2.2.16Fluorescem incorporation during PCR
Known amounts of M. leprae DNA were amplified using standard PCR 
conditions with 200/iM of each dNTP except dTTP which was 33/xM; each 
reaction also contained 22 o f fluorescein-11-dUTP (Boehringer- 
Mannheim). Reaction volumes were 90ph Annealing temperature was 55°C. 
Detection o f fluorescent PCR product was firstly carried out by electrophoresis 
o f 20/xl o f product through a 2% agarose gel, this was photographed before 
and after ethidium bromide staining. 70/xl of the remaining reaction volume 
was applied to a 1ml Sephadex G-50 (Sigma) column and spun at 2,500rpm 
for 3min. A 40/d aliquot of each eluent was spotted onto clingfilm and exposed 
to UV transillumination and finally photographed.
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2.3 RESULTS
2.3 .1 .1PC R  with singly and  m ultiply fluorescently labelled prim ers 
To examine the efficiency o f these primers PCR reaction were carried out 
using standard conditions except for primer concentrations which were 
variable, annealing temperature was 45°C. Preliminary results not shown 
indicated that the use of multiply labelled primers increased the amount of 
fluorescence seen in the product, however this did not improve detection levels 
o f PCR sensitivity significantly. Experiments were carried out to determine 
wether these multiply labelled primers could be used in a reverse blot format, 
no detectable fluorescence was shown on the nylon membrane, this was due 
to quenching or possibly steric hindrance to hybridization caused by these large 
dye molecules.
2.3.1.5Reverse probing using m ultiply fluoresecently labelled prim ers
After both primers had been purified as above and coupled to fluorescent dye 
FITC they were first purified by size-exclusion chromatography using PD-10 
columns as described and secondly passed through an oligonucleotide 
purification column (OPC). These primers were then used in PCR.
Primers that had been purified and labelled as above were used in PCR 
reaction in varying concentrations, using standard conditions and an annealing 
temperature of 45°C. These experiments were initially unsuccessful due to low 
levels of primers produced. These purification processes are known to reduce 
percentage yield o f primer dramatically. Using large amounts o f labelled 
primer yielded some labelled PCR product with an changed mobility compared 
to the product of unlabelled primers. The amplified product o f PCR using 
these primers on Ing quantities o f BCG DNA was used in a reverse probing 
experiment. No hybridisation results were obtained due to failure o f product 
to hybridise to the membrane. This was probably due to fluorescein causing 
steric hindrance or contaminating unlabelled primers in the reaction which
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would more efficiently produce product and therefore use up the reagents such 
as nucleotides and Taq polymerase in the PCR.
2.3 .2 .1PC R  and Reverse probing using biotin labelled prim ers 
Due to lack of hybridisation with multiply labelled primers 5 ' end biotinylated 
primers were used, mode of biotin attachment is shown figure 2.4 using an N- 
hydroxysuccinimide ester o f biotin, primers BCGl and 2 (from sequence data 
Collins et a l ,  1990):
BCGl GAA GGT CGT CAT CGA CGG TAA GGA 
BCG2 CGC CGT TGA CGT TAC CGA GCC CAA 
These primers were used to amplify a 173 bp target from the 19kDa antigen 
encoding gene o f the Mycobacterium tuberculosis complex (Af. tuberculosis, 
BCG and M. bovis). Aliquots of Af. bovis DNA containing a wide range of 
amounts o f DNA(4fg to 4ng) were subjected to PCR amplification using the 
5 ' biotin labelled 19kDa antigen specific primers BCG 1/2. PCR conditions 
were as standard method v/ith an annealing temperature of 37®C, this low 
annealing temperature was necessary when biotin labelled primers are used for 
the PCR product. PCR mixes consisted of standard concentrations for a 100/d 
reaction with 200ng o f each biotinylated primer per reaction.
The success of the PCR procedure and the sensitivity o f the amplification was 
initially confirmed by subjecting a 10/cl aliquot of the reaction to agarose gel 
electrophoresis through a 2% gel (Fig 2.5). This results shows a sensitivity of 
4fg o f purified DNA; this represents approximately 1 organism. The extra 
band shown in this figure tends to occur when large amounts o f product are 
produced in the PCR, representing a concatermerization o f product.
The remaining 90/cl of each PCR mix was hybridised to a nylon filter bearing 
the 100 bp amplification product of primers BCG 3/4:
BCG3 TCC GTG GTC TGC ACA A 
BCG4 GGT TGC CGT CGG TGA A
Following overnight hybridisation and washes the presence o f Af. bovis DNA 
in the initial sample was demonstrated using enzyme (phosphatase) linked 
streptavidin according to the method of Young (1989). Using this procedure 
as little as 4fg o f Af. bovis DNA was routinely detected this corresponds to
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Figure 2.4
3’ 5'
•NH.
Oligonucleotide probe with 
5'-amino group
3" 5*
H H H
N—0 “C“(CH2)5”N"C"(CH2)4*
V NHS-linker arm-biotin
0
«
HN NH
H n H II
'N-C“(CH2)5"N~C”(fH2 ^ 4 /
/
5’-Biotin-modified oligonucleotide probe
Preparation  of biotin-labelled oligonucleotide probe. A 5'-amino 
derivatized oligonucleotide probe and N-hydroxysuccinimide long chain biotin 
are reacted at alkaline pH to form the biotinyl-Iinker-arm-oligonucleotide 
product.
Figure 2.5
1 2 3 4 5 6 7 8 9  10 11
Sensitivity of biotinylated prim ers fo r PCR. The amounts of M. bovis DNA 
used as template were; l:4fg; 2:20fg; 3:40fg4:400fg; 6:40pg; 7:400pg; 8:4ng; 
9:4ng; 10:negative (no DNA) control; ll:phiX 174 Hae II markers.
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Figure 2.6
î
© m
8 10
Reverse probe technique to  detect bio tin  labelled PC R -products. 1: non- 
specoffc control (M.smegmatis DNA as capture probe with amplified product 
as in track 9 in fig 2.4 .; 2:4fg; 3:20fg; 4:40fg; 5:400fg; 6:4pg; 7:40pg; 
8:400pg; 9:4ng; 10:negative control (no DNA in PCR;track 10 in fig 2.4).
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approximately one bacterium as shown in figure 2.6. This result corresponds 
to that obtained by gel electrophoresis and has the added specificity of the 
internal probe fixed to the membrane giving a similar result to that obtained 
with Southern blotting without the use of gel electrophoresis or lengthy blotting 
procedures.
2.3.3.1Fluorescein incorporation during PCR
The method described above requires the synthesis of specialised primers for 
each new PCR test, a simpler and universally applicable labelling technique is 
the incorporation o f detectable moieties during the PCR amplification cycles. 
Primers L epl/2  (sequence from Booth et û/,1988):
LE Pl AGA AAA CTT GTC TAT CAC A 
LEP2 CGA TTA GGC ATC TAT GAT T
These primers produce a 597 bp fragment of the 18kDa antigen encoding gene 
specific the Mycobacterium leprae. These primers were tested against a panel 
of other common mycobacterial species, and were demonstrated to be M. 
leprae specific.
One of the simplest methods for the detection of PCR product is dye 
incorporation.
Initial experiments using the incorporation of fluorescein-12-dUTP to produce 
labelled PCR product demonstrated that the critical parameter for labelling 
incorporation was the relative concentrations o f dTTP and fluorescein dUTP 
in the PCR mix. The optimum concentrations for the Af. leprae test (primers 
lepl/2) was 33/iM dTTP with 22 pM  fluorescein-12-dUTP per 90/xl reaction. 
These concentrations constitute a greatly reduced concentration o f TTP 
equivalents in the PCR mix compared to the 200pM  concentration o f the other 
nucleotides. Figure 2.7 shows that the fluorescently labelled PCR products 
from M.leprae DNA (tracks 5,) could be detected without ethidium bromide 
staining. (Fig 2.7a) and that the sensiivity was comparable with that seen in the 
ehidium bromide stained gel (Fig 2.7b). The same conditions were also 
necessary with M.bovis DNA using the BCG l/2 primer pair (tracks 1,2) and 
again the sesivity was comparable with and without ehidium bromide (compare
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Figure 2.7a and b
PRE ETHIDIUM STAIN 
1 2 3 4 5 6 7
B
POST ETHIDIUM STAIN 
1 2 3 4 5 6 7
Efficiency of fluorescein incorporationiLane 1: PCR product of 19kDa 
antigen gene of M.bovis, template is 2 ng M.bovis DNA.2:as 1 template Ing 
M.bovis DNA; 3: negative control for 1 and 2. Lane 4 negative control lanes 
5 and 6. 4: PCR product of 18kDa antigen gene of M.leprae using 2ng 
M.leprae DNA. 5:as 4 but template is Ing M.leprae DNA. 7:phiX174 Hae III 
mwt. markers.
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Figure 2.8 A and B
B
1 2 3 4 5 6 7 8  1 2 3 4 5 6 7 8
Detection of PC R  products by agarose gel electophoresis. l:no  DNA; 
2;20fg M.leprae DNA; 3:200fg; 4:2pg; 5:20pg; 6:200pg; 7:2ng; 8: PhiX174 
Hae III digest markers. A:direct visualisation; B: after ehtidium bromide 
staining.
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a and b).
The purpose o f the fluorescent dye incorporation was to obviate the need for 
gel electrophoresis, the following experiment was designed to show the 
sensivity o f PCR with fluorescent incorporation compared to ethidium bromide 
staining o f agarose gels, PCR products were only stained to show the 
comparison.
To examine the sensivity o f fluorescein incorporation a wider range of 
M. leprae template DNA was amplified. PCR reactions were carried out using 
the concentrations of dTTP and fluorescein-12-dUTP described above. PCR 
parameters were standard with 30 cycles and an annealing temperature of 
55°C. Figure 2.8 shows that the minimum amount detected was 2pg which 
was the same with or without EtBr staining. This result demonstrates the 
validity o f incorporation o f fluorescent dye for detection of PCR products. 
However the aim was to obviate the need for gel electrophoresis. To 
demonstrate this, the fluorescently labelled PCR product was separated from 
unincorporated fluorescein-dUTP by a sephadex G-50 column, then 40 p\ o f 
the eluant was applied to a sheet o f clingflim and placed on a transilluminator. 
The results shown in figure 2.9 show that fluorescence was observed in all 
samples with as little as 20fg of M. leprae DNA. This represents 
approximately 4-5 leprosy bacilli. No fluorescence was observed in the no 
DNA control.
These results would imply that the incorporation of relatively large molecules 
during PCR amplification does not significantly reduce the sensitivity o f the 
PCR test. This was also demonstrated by Chehab and Kan (1991).
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Figure 2.9
1 2 3 4 5 6 7
Direct detection of fluorescent PC R  products. 1: no DNA; 2: 20fg M. leprae 
DNA; 3:200fg; 4:2pg; 5:20pg 6:200pg; 7:2ng.
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2.4 Discussion
Since the purpose o f this work was the development o f a simple rapid test for 
mycobacteria it would seem that the use of singly or multiply 5 ' fluorescein 
end labelled primers was not practicable. The necessity for highly purified 
primers and specialist synthesis conditions makes such procedures too complex 
for use in most diagnostic laboratories. At the time this work commenced the 
only available (relatively chemically simple) techniques for labelling PCR 
products were the 5 ' end labelling techniques that had evolved from the advent 
o f DNA sequencers.The benefit o f hindsight and empirical observation o f the 
lack o f sensitivity shown by primers labelled in this way leads to the 
conclusion that such techniques are only useful if  sensitive equipment such as 
a gene scanner (gene scanner is modified software for the Applied Biosystems 
DNA sequencer which allows detection of fluorescently labelled DNA 
fragments) is available. Other workers have demonstrated the use of 
fluorescent labelled PCR primers in colour complementation assays (Folsom, 
1989 and Chehab and Kan, 1991). However both these techniques use the ABi 
genescanner making them prohibitively expensive.
Reverse probing is a simple technique that can be easily applied to the rapid 
detection of slow growing organisms such as the pathogenic mycobacteria. 
Reverse probing is suggested by Hunt and Persing (1993) to be better suited 
to the clinical laboratory setting than the research method o f Southern blotting. 
Southern blotting requires the running of agarose gels and lengthy blotting 
before the hybridization step. As shown, if the 5 ' end of the primers used for 
PCR are biotinylated the resulting labelled PCR product is detected 
colorimetrically. This technique showed sensitivities using purified DNA of 
approximately 10 mycobacterial organisms, although it is likely to be less 
sensitive using clinical samples due to the presence o f Taq polymerase 
inhibitors. The benefit o f the reverse probing technique is that it can likewise 
be applied to other labelling formats that do not require custom prim er 
synthesis. Reverse probing can be used when PCR is carried out with 
incorporation of biotin dUTP or digoxygenin dUTP which can both be detected 
colorimetrically. The disadvantage of these techniques being that they are
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enzyme based and require complex detection procedures. Attempts to use 
fluorescently labelled dyes in reverse probing formats were unsuccessful 
probably due to quenching by the membranes used. If  alternative supports for 
the capture probe are developed this may be a more successful technique.
The incorporation o f fluorescein-12-dUTP during PCR amplification is a very 
simple method of labelling. Detection o f labelled product is a one step process 
since it only requires that unincorporated label be separated from PCR 
product. Using a sephadex column to remove unincorporated label gave PCR 
sensitivities in that region of 5 M. leprae organisms, no fluorescence being 
observed in the negative control. Thus a high degree o f sensitivity was 
obtained using standard equipment. However since this method requires a 
centrifugation step it may not be suitable for a field based test. A simpler 
technique might be to apply the reaction to a solid support such as polystyrene 
or magnetic beads so that it can be washed to remove unincorporated label. It 
may be suitable to remove the unincorporated label by TCA precipitation. Still 
this proceedure would not give the degree o f specificity that comes with 
reverse probing.
These results indicate that the incorporation of fluorescein or end labelling with 
biotin molecules during PCR does not significantly reduce the sensitivity o f the 
test. It may be possible by the combination o f fluorescein-12-dUTP 
incorporation and reverse probing, coupled with a novel support mechanism 
to produce a simple robust test that could be used under some field conditions 
if  such a test could be produced at low cost.
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CHAPTER 3
Polymerase Chain Reaction (PCR) for the DiagnosLs of Mycobacterium
tuberculosis Infection
3.1INTRODUCTION
The principle features of tuberculosis and it's  diagnosis have been discussed 
in Chapter 1. In principle PCR is a simple test for the detection o f DNA from 
a single microorganism in a clinical sample. The sensitivity and speed o f a 
PCR based test make it potentially very useful for diagnosis o f tuberculosis; 
here rapid case detection can prevent further spread o f the disease. Many 
workers have completed studies using PCR for rapid diagnosis o f tuberculosis 
(Brisson-Noel et a l ,  1989, Eisenach et a l ,  1990, Kolk et a l ,  1992 and Kox 
et a l ,  1992 among many other publications. These individual studies did not 
supply evidence on the reliability and reproducibility o f PCR because they 
were only carried out in one laboratory with samples for which the results 
were known. Questions about the reliability of PCR compared to conventional 
techniques such as culture have been examined and ways o f making PCR more 
reliable have been described for example by purification o f sputum as 
described in Victor et a l ,  1992.
Gerda Noordhoek and Jan van Embden at the public health laboratories 
Leewarden, the Netherlands and RIVM Bilthoven respectively designed this 
multicentre blind study to answer some of the questions about the reliability 
and reproducibility of PCR as a diagnostic tool since in practice there are 
problems which have been encountered with the PCR. The most prevalent 
problem being the generation of false positive reactions due to contamination 
by target DNA which includes the products o f previous PCR amplifications 
(Kwok and Higuchi, 1989). In addition to this many clinical specimens have 
been demonstrated to be inhibitory to PCR amplification and methods 
described to prevent inhibition (Victor et a l ,  1992; Kox et a l ,  1994). The 
purpose of the study reported in this chapter was to assess the validity and 
reproducibility o f the detection by PCR o f M, tuberculosis in clinical material. 
Seven laboratories were invited to participate in a collaborative study to 
compare their abilities to detect the presence or absence of mycobacteria in a
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large number of randomised blinded samples containing known numbers of 
mycobacteria. All seven laboratories had previously shown experience with 
PCR for M. tuberculosis for both scientific and clinical purposes. The 
participants were asked to use the insertion element IS6110 (as described in 
Chapter 1) as the target for DNA amplification.
The results o f this multicentre study have been published (Noordhoek et at., 
1994)
To carry out this study I collaborated with Birmingham University where the 
DNA was extracted from the samples by Claire Spreadbury, I was then sent 
the samples for DNA analysis by PCR, Southern blotting and digoxygenin 
probing. The combined work of Claire Spreadbury and myself forms the 
results of participant number 4 in this study.
3.2M ETHODS
3.2 .1Preparation  of bacteria
This was carried out by Gerda Noordhoek.
M. bovis BCG strain 44 (Hermans et al. , 1990) was cultured in tween-albumin 
medium as previously described Kolk et a l ,  (1992), the number o f cells per 
microlitre was determined by a measurement o f optical density at 420nm in 
0.1 % Tween 80 with 0 .5 % BSA, 20mM Tris-HCl (pH7.6) in TBT. An optical 
density o f 0.15 was taken to correspond to 10* mycobacteria per ml. After 
staining for acid fast bacilli by Ziehl-Neelsen technique the bacteria were 
diluted in TBT to the desired concentration and were kept at 4°C until use. 
P repara tion  of sputa samples (also prepared by Gerda Noordhoek)
Sputum samples were collected from nontuberculous patients and saliva was 
collected from healthy office workers, all sputa and saliva samples were 
checked by cultivation and PCR for the absence of M. tuberculosis complex 
bacteria. HPLC grade water was obtained from Baker (Phillipsburg, NT).
In order to minimize contamination, samples were prepared in a laboratory not 
previously used for mycobacterial work. All disposable pieces o f equipment 
were unpacked in this laboratory and new positive displacement pipettes
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(Microman, Gilson) were used. All samples not containing mycobacteria were 
prepared on one day and samples that were spiked were prepared the next day, 
beginning with samples spiked with 1(F BCG cells and subsequently with 
10^,10^ and 10  ^cells.
3.2.2£xperimental design (By Gerda Noordhoek)
Seven copies of two sets (A and B) of samples were prepared; each set 
contained 100 coded tubes. The final volume o f each sample was 200/xl. 
Participants did not know which samples had been spiked nor at what levels 
the samples had been spiked.
Set A comprised 100 samples. When the results where decoded, set A was 
revealed to have contained: 25 samples without bacteria, 10 water samples 
spiked with 10  ^ Af. bovis BCG, 25 sputum samples without bacteria, 10 
sputum samples spiked with 1(F M. bovis BCG, 20 sputum samples spiked 
with 10  ^ Af. bovis BCG and 10 sputum samples spiked with 10* M. bovis 
BCG.
All 100 samples in set B contained saliva. Sixty samples contained no bacteria, 
20 samples were spiked with 1(F cells, and 20 samples were spiked with 10  ^
BCG cells, as with set A this information was not disclosed until the results 
were decoded. Immediately after preparation the cells were frozen. In another 
laboratory, not previously used for mycobacteria, the frozen samples were 
randomized so that each participant received a differently randomized set of 
samples.
Samples were shipped on dry ice, instructions were enclosed with the samples. 
Participants were requested to use the complete contents o f the tube for 
extraction treatment but no instructions were given regarding how much should 
be used for the PCR test, and were asked to process all the samples o f set A 
before starting to process those o f set B.
3.2.3Extract:on and Purification
This was carried out by Claire Spreadbury at Birmingham University 
according to Brisson-Noel et a l , (1989). To the whole 200fil sample, an equal 
volume of lysis mixture 0. IM  NaOH, 2M NaCl, 0.5 % SDS was added. The 
sample was then heated to 95°C for 15mins. It was then extracted twice with
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an equal volume o f phenol/chloroform, then precipitated with 2 volumes of 
ethanol. After precipitation the sample was centrifuged at 14,000 rpm for 20 
min dried and resuspended in 25-50/xl o f water depending on the size o f the 
pellet. Samples were then frozen and posted to University o f Surrey in boxes 
containing dry ice ready for PCR analysis to be carried out.
3.2.4PCR analysis of sputum samples
After DNA extraction all 200 samples were frozen and shipped to University
o f Surrey in boxes containing dry ice. 1-2/d o f extracted DNA was amplified
using the primers IN Sl and INS2 (Hermans et al 1990):-
INS 1 5 ' CGT GAG GGC ATC GAG GTG GC
INS 2 5 ’ GCG TAG GCG TCG GTG ACA AA
These primers amplify a 245 bp product comprising part o f IS6110 from M.
tuberculosis complex organisms.
After PCR amplification the products were electrophoresed through a 1.5% 
agarose gel.
The primers IN Sl and 2 often produce additional non-specific bands when
PCR is carried out on clinical samples this is probably due to non-specific
priming of DNA. To give clarity to results the agarose gels were then
Southern blotted and probed with a 188 bp digoxygenin labelled probe made
from the PCR product o f primers PT3 and 6 (Kolk et a l ,  1992):-
PT3 5 ' GAA CGG CTG ATG ACC AAA CT
PT6 5 ' ACG TAG GCG ACC CCT GCC CA
The probe generated by these primers is internal to the PCR product o f IN Sl
and INS2. Autoradiographs were then developed and the results recorded by
Dr.J.W .Dale and myself. The results were decoded by Noordhoek.
3.3RESULTS
3.3.1Efriciency of PCR for the detection of Af, bovis BCG in sputa and 
saliva samples
The results as published for all the groups are shown in table 3.1 For our 
laboratory number 4 this is referred to as the uncorrected results.
When examining the other groups results as shown table 3.1, and shown 
graphically in figures 3.3, 3.4 and 3.5, where results for part A are divided
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into water(a) and sputum(b) and results for part B are shown in figureS. Ic with 
the summary of the methods used by the various laboratories (table 3.2) in 
detail we see that "lab 1" had 77% of negative samples designated positive, 
this implies a lack of any internal controls in their analysis.
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This group (lab 1) demonstrated the problems of using diagnostic procedures 
in a laboratory where high levels o f amplification or cloning o f PCR products 
have been earned out. This group obviously have gross amplicon 
contamination in the laboratory. This is further evidenced by the fact this 
group used the anticontamination system described in Chapter 1 using uracil 
glycosylase to remove amplicon previously produced that have UTP substituted 
for TTP. The contamination shown must be derived from amplicons or cloned 
DNA produced in the laboratory using standard TTP containing PCR mixes. 
This system will only work if  no amplicon containing TTP have been produced 
and all measures to reduce contamination are rigorously applied.
The results of "lab2" also show high levels of contamination up to 64% in 
water samples but the sensitivity for this group was fair in saliva samples but 
low in sputum samples this would imply inhibition in sputum samples.
The sensitivity o f "lab3" was very poor with very low detection rates in 
samples spiked with 1(P,1(P or 10  ^ bacteria, this may have been due to 
inhibition or the fact that only 2% of the total sample was used in the PCR 
test. This laboratory found that extra bands produced when using primers 
INS 1/2 gave false positive results at 24% in sputum samples. This could be 
explained by the fact the dot blot format used will give posistive results for 
non-specific amplifications often produced by primers INS1/INS2.
"Lab4" is discussed in detail below.
"LabS" the results of this laboratory show high levels o f specificity but low 
levels o f sensitivity this may be partly due to the methodology used, biotin 
labelled PCR product was captured on an avidin coated microtitre plate and 
detected colorimetrically. Where colorimetric detection is used there must 
always be a "cu to ff level o f background colour and it may be that this was 
set at a high level to give good sensitivity but reduced sensitivity.
"Lab6" showed high levels o f both sensitivity and specificity with the 
exception of BCG in sputum where some false positive results were recorded.
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This group used the contamination control system involving the use o f dUTP 
instead of dTTP as outlined previously. The reuslts of this group indicate that 
the system can be very effective but not entirely so as there are 4 false positive 
results in all, these may have been due to well to well spillover during agarose 
gel loading.
"Lab?" had the best results in sample set A but did not attempt to examine set 
B as contamination was discovered. This result clearly demonstrates how easily 
a good diagnostic laboratory could become contaminated. One explanation for 
the contamination would be the use o f a nested PCR based test, this often 
produces so much product that the chances o f future amplicon contamination 
are raised. Sensitivity for this laboratory was low at the 1(P spiking level 
which is not very encouraging since the sample tested contained 20% o f 100 
bacteria (or 20 bacteria) and thus should have been well within the theoretical 
level of PCR sensitivity.
All groups show levels of sensitivity far lower than the generally accepted 
levels for PCR based test. Low sensitivity may be due in part to inhibition of 
PCR by factors in the sample, by loss of DNA during extraction process and 
in the fact that "lab3" only used 2% of the available DNA after extraction for 
PCR.
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3.3.2Results obtained by lab4
The results of our group indicate a high level o f false positivity up to 28% for 
BCG in water samples, o f 16% for BCG in sputum and of 17% BCG in saliva. 
The high level o f false positive results would be unacceptable in a diagnostic 
laboratory where diagnosis and treatment are made on PCR results such as 
these. The sensitivity o f our IS6110 based test was surprisingly poor showing 
only 22% positive PCR results where spiking was at the 1(P level in sputum. 
When only 10% of the extracted sample was used there should still have been 
10 cell equivalents o f DNA which is well within our expected detection limits. 
Possible explanations for lack of sensitivity include inefficient extraction of 
DNA from BCG cells and inhibition by factors in the sputum. It was surprising 
to find a negative in the samples spiked with 10  ^BCG cells.
The data summarised here ignores the "not done" samples as recorded by 
Noordhoek. Samples recorded as not done were three samples lost in the 
extraction proceedure and three samples for which bands were blurred and 
therefore had to be dicounted, given further time these would have been 
repeated. These samples were lost at the DNA extraction stage and as such 
were beyond my control.
Due to anomolies found the data o f "lab4" was re-examined, it was found that 
an autoradiograph had been misread by myself and Dr.Dale. This was due to 
the fact the gels were loaded in two equally sized rows and the autoradiograph 
had been inverted. The results shown in table 3 .6  demonstrate the corrected 
data recorded by our group once the autoradiograph had been read correctly. 
This amendment accounts for 2 of our false positive results and the false 
negative at the 10  ^ spiking level, thus inreaseing sensitivity at the 10^ cells 
spiking level to 100%.
The probable cause o f our total 21 false positives was as follows spillover (this 
occurred from well to well at the agarose gel loading stage in 4 cases), 
misreading o f the autoradiograph (where bands were recorded as positives that
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on re-examination were seen to be splodges on the autoradiograph) in 2 cases 
and; no obvious cause (in 15 cases some of which were probably contaminated 
during the DNA extraction).
The probable cause o f false negative results (not including those at 1(P level 
where sensitivity is low) include: result obscured by background on 
autoradiograph (in 4 cases out o f the total 13 false negatives), faint bands in 
2 cases, misreading o f gel where autoradiograph was read the wrong way 
round in 2 cases; no obvious cause in 5 cases. These false negative results may 
well be explained by the presence of inhibitory factors in some cases.
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3.4 DISCUSSION
In Noordhoek* s discussion (Noordhoek et a l  1994) the conclusions drawn from 
this study are very pessimistic about the routine use of PCR for tuberculous 
diagnostics, suggesting that problems of inhibition and contamination are so 
great that until there is more "innovation and automation" PCR could not be 
recommended as a routine diagnostic tool.
Several shortcomings in the trial however made a pessimistic outcome 
inevitable. Firstly M.bovis BCG which only contains one copy o f IS6110 was 
used to spike samples instead of M. tuberculosis which usually has 10-15 copies 
o f IS6110. Thus the use o f M. tuberculosis could have given up to 10 fold more 
sensitive results, making the use of PCR more favourable. Secondly the 
laboratories may have had research experience with PCR but they were not 
operating constantly under the conditions needed for diagnostic use o f PCR. 
Thirdly the time allowed for sample processing was short so that samples could 
not be repeated if  they were dubious. Fourthly there was no specific funding 
for the laboratories to carry out the PCR tests to that once again samples could 
not be re-tested due to high cost.
In conclusion the findings of Noordhoek et a l ,  1994 seem to be extremely 
pessimistic but do not account for the shortcomings in the logistical operations 
o f this trial. I f  a future study were to be designed it might be better evaluated 
in laboratories in countries where tuberculosis is endemic and laboratories are 
operating only as diagnostic centres.
The wide variation in the results found were inevitable when no standard 
protocol had been designated and different amounts o f samples from 2-100% 
were used in the PCR tests themselves. The most important consideration 
arising from this study is that from laboratory to laboratory high levels of 
variation will occur if  personnel are not given strict guidelines to follow. 
Automation may be the answere to some o f these problems since it would 
reduce the likelyhood of error and cross-contamination, automation may also 
makes tests cheaper as less personnel would be needed.
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CHAPTER 4 
IN-SITU POLYMERASE CHAIN REACTION 
4.1INTRODUCTION 
4.1.1 Advantages of in-situ detection
Species-specific diagnosis o f infection with slow growing mycobacteria is time 
consuming and prone to failure due to low numbers of organisms in specimens 
and inefficient handling o f samples can lead to loss o f viability and under 
diagnosis.
In-situ polymerase chain reaction (in-situ PCR) is a novel molecular technique 
that combines the extreme sensitivity of PCR with the anatomical localisation 
provided by in-situ hybridization. The need for extraction o f nucleic acid from 
tissue is surmounted reducing the risk o f contamination, indeed sample to 
sample or amplicon contamination is unlikely using in-situ PCR.
The limitations o f currently available methods for detecting low levels of 
mycobacterial infection include such considerations as time needed for culture 
o f organisms and sensitivity where cultures are less viable after storage or 
transportation. Methods that involve culture and Southern blotting are slow and 
require much equipment. Techniques that require tissue to be smashed prior 
to PCR analysis or Southern blotting are prone to contamination, and where 
low levels of infection are present the high background of uninfected tissue can 
mask results or give PCR inhibition. In-situ PCR can provide additional 
information not available by conventional methods since it can identify 
intracellular distribution of infection between cell types.
A further advantage of in-situ species-specific detection o f mycobacteria would 
be the opportunity to elucidate the causative agents of diseases thought by 
some to be of mycobacterial cause such as Crohn's disease, W hipple's disease, 
sarcoidosis and rheumatoid arthritis. Many believe that the failure o f workers 
to isolate (culture) these organisms from disease site is due to the fact that the 
mycobacteria are in unusual forms such as cell wall deficient spheroplasts or 
metabolically deficient forms that are not susceptible to conventional antibiotic 
therapy.
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4.1.2In-situ hybridisation
In-situ hybridization (ISH) is a powerful tool for the detection o f specific 
nucleic acid sequences in individual cells (Lawrence et a l ,  1984), tissue 
section (Shiota et a l , 1991), in whole body sections (Hafen et a l ,  1983) and 
in chromosomes (Hofler, 1991). ISH is often used for the examination o f gene 
expression. ISH depends on the hybridization o f a labelled nucleic acid probe 
(mRNA or DNA) to complementary sequence usually mRNA. Northern blots 
however represent the mRNA levels averaged from all the cells in the original 
sample. ISH is more sensitive and can detect the amount o f mRNA in a single 
cell. Furthermore since ISH is a histological technique cell relationships are 
maintained and it is possible to identify exact cell types expressing the gene of 
interest. Potentially interaction between cells that express different proteins can 
be uncovered. ISH also allows the maximum use o f tissue that is in shirt 
supply (i.e. clinical biopsies).
ISH has been used to detect M. leprae inside in vitro infected macrophages 
using a sulphonated oligonucleotide probe. (Amoldi et a l , 1992). Apart from 
this work very little ISH work has been published for the detection o f bacteria 
since it is considered that their cell walls may be a barrier to passing of 
hybridization reagents.
4.1.3Direct and indirect methods of in-situ PCR
Indirect in-situ PCR is essentially similar to PCR performed conventionally 
with standard nucleotides after PCR amplification the sample is subjected to 
ISH with a probe usually internal to the PCR product. The disadvantage o f this 
technique relative to direct in-situ PCR is that it is less sensitive slower and 
often requires use of multiple primer sets to gain require sensitivity, this means 
that the exact nature of the amplified product is unknown. Direct in-situ PCR 
involves the direct labelling o f amplification products during PCR the 
substitution o f some of the dTTP for digoxygenin, biotin fluorescein or 
labelled dUTP leads to its incorporation during PCR and it can be subsequently 
detected. The advantage of direct in-situ PCR is the speed with which it can 
be carried out (generally in one day) and it has high sensitivity. The
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disadvantage is said to be it lack o f specificity (Long et a l , 1993) and its high 
level of variation leading to lack o f reproducibility. However all studies 
published have used virally infected material usually with high levels of viral 
infection. Direct in-situ PCR can be a very sensitive and accurate technique 
when vigorous controls are used, such as tissue infected with other organisms, 
nonsense or non-specific primer controls and Taq minus controls. 
4.1.4Technical considerations of direct in-situ PC R  
The considerable technical difficulties o f in-situ PCR have leads to its limited 
use. The primary choice is that of type of section, generally frozen sections or 
cellular spreads are though to be the choice for amplification. However for use 
in mycobacterial diagnostics 5^M  formalin fixed paraffin embedded sections 
are most readily available. The fixative of choice for amplification of 
mycobacterial DNA by PCR is neutral buffered-formalin fixed material (Greer 
et a l , 1990; de W it et a l , 1991). This material is then paraffin embedded, cut 
into 5/iM sections and attached to Vectorbond (Vector laboratories) slides. 
Vectorbond slide coating is a proprietary modification o f amino-acryl silane 
procedure and gives excellent in situ hybridization with good tissue 
morphology after hybridization procedures.
Tissues sections are then deparaffinised by standard methanol and ethanol 
treatments. Probably the most important step for efficient amplification if  the 
permeablisation of tissue, several methods such as proteinase K (various 
concentrations) 30mins at 37°C. However the method that appears effective 
with sections is saponin treatment (Yamawaki et a l ,  1993). This highly 
surface active plant glycoside appears to allow penetration o f PCR reagents 
into the cell but maintains cell morphology such that amplified product is 
maintained within the cell. Standard saponin treatment is at 0.1 % for 30mins, 
the slides are then frozen at -20°C ready for use.
PCR target choice is also a practical consideration, it is thought to be 
necessary to keep product small since formalin fixation can reduce the size o f 
available DNA fragments.
In-situ PCR must be rigorously controlled at all times since false positivity can 
have several causes such as non specific incorporation of labelled nucleotides.
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Long et al. (1993) state that non specific incorporation of labelled nucleotides 
into cellular DNA occurs through internal priming and "DNA repair", possibly 
related in part to the exonuclease activity o f Taq polymerase. These workers 
also postulate that formalin fixed sections will have more DNA damage and 
are less efficient tissues for in-situ PCR when compared to cell suspensions.
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4.2METHODS 
4.2.1Fixation of biopsies
Biopsies were neutral formalin fixed using formalin which consisted o f 4% 
(vol/vol) formaldehyde in 0.35 % (wt/vol) NaHzPO^.ZHgO and 0.65 % (wt/vol) 
NazHPO^.lZHgO incubation was 2hr, they were then transferred to 70% 
(vol/vol) ethanol placed in tubes and stored.
4.2.2Section cutting and mounting
Sections were paraffin embedded (at UCL) and 5 ^m  section were cut and 
attached to Vectorbond (Dako,laboratories) coated slides. 
4.2.3D eparaffinisation
Sections were treated with 100% methanol (AnalaR grade, Fisons) for 35- 
40mins with periodic agitation, extended exposure to methanol may increase 
permeability of mycobacterial cells. Sections were then transferred to 100% 
ethanol (fresh and clean) for 10-15mins. Sections were then air dried. 
4.2.4Saponin treatm ent
This treatment permeablises the tissue in readiness for PCR. Slides were 
placed in racks that hold then vertical and treated in a large volume o f 0.1 % 
saponin (Sigma) in PBS (Oxoid, tablets) for a minimum of 30mins at RT, 
slides were then washed for lOmins in distilled water air dried and either used 
immediately or stored in a -20®C freezer.
4.2.5Preparation of PCR reagents
PCR reagents were prepared in clean conditions for PCR so that sections were 
treated in much the same way as PCR reagents for in tube PCR contamination 
was still a possible problem. Reagents for PCR were prepared as a mastermix 
where the concentration of nucleotides (Boehringer Mannheim) were 200/iM 
except for dTTP which was lOO/xM and the addition o f 0.5 nmoles 
digoxygenin-11-dUTP (Boehringer Mannheim)per 100^1 reaction mix with 2.5 
units of Taq polymerase (Boehringer Mannheim) /100/xl reaction mix. 
Magnesium concentration was 2.5mM which required the addition of 
concentrated magnesium (Promega) since standard Boehringer X I buffer is 
only 1.5mM. Water was PCR grade (United States Biochemicals). Primers 
were included at 200 ng each primer per 100/tl o f reaction mix. Each slide had
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300-400/xl o f reaction mix overlaid on the section. The plastic coverslip was 
then attached to the slide with gum. The gum was allowed to set in the fridge 
for 5mins then PCR was carried out on the Hybaid Omnigene thermal cycler.
(denaturing) X I
(annealing)
PCR cycling conditions were:
94®C 2mins
58-64°C 1.5mins
72®C 2.5mins
94°C Imins
With a final cycle of: 58-64 ®C
(extension)
(denaturing) 35 cycles
briefly held at 30°C. Slides were then placed at RT and their coverslips were 
removed, they were then immediately processed through detection steps.
4.2.6Detection of digoxygenin incorporation
After PCR amplification the coverslip and gum were removed and the slide 
was placed in a slide holder and washed in PBS (Oxoid tablets) for 5mins. 
Inactivation of alkaline phosphatase was then carried out by agitating slides in 
30% acetic acid AnalR, Fisons) vol/vol in distilled water. Slides were then 
briefly washed in distilled water and placed in a fresh dish o f PBS. After 
which conventional digoxygenin detection was carried out; slides were first 
equilibrated in buffer 1 (lOOmM maleic acid(Sigma), 150mM NaCl; pH7.5). 
Slides were blocked by agitating in buffer 2 (l% (w /v) blocking reagent 
(Boehringer Mannheim) dissolved in buffer 1.
Anti-digoxygenin alkaline phosphatase 1:500 (lOX higher concentration than 
usual, 1500mU/ml) was dissolved in buffer 2. Slides were drained o f buffer 
2 and 500/xl o f anti-digoxygenin (anti-DIG) solution was carefully placed in the 
section, slides were incubated for 30mins with anti-DIG solution in a square 
plastic petri dish with the lid on to prevent drying out.
Slides were replaced in racks and washed 2 X 15mins with sufficient volumes 
o f buffer 1 to cover the section, followed by 1 X 5mins in buffer 3 (lOOmM 
Tris-HCl, pH 9.5;100mM NaCl,50mM M g C y . The chromogen solution was 
then made up by adding 22.5/xl of NBT solution (Boehringer Mannheim) and
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11.5III o f X-phosphate in 5ml of buffer 3. Approximately 500fil o f colour 
substrate was placed on each section and they were incubated for Ihr in the 
dark. Reactions were stopped by draining the slide and placing 1ml TE buffer 
on the slide for 5mins. Slides were then air dried and immediately had a 
coverslip attached using glycergel (Dako). Slides were examined 
microscopically and photographed using a Leitz orthoplan photomicroscope 
using Kodak 64T (tungsten) film.
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4.3RESULTS
4.3.1Detectioii of Mycobacterium paratuherculosis in  bovine gut tissue 
Johne's disease in cattle is a chronic enteritis which causes diarrhoea and 
emaciation caused by M. paratuherculosis. No therapy is available, control of 
this disease relies on detection and culling o f infected animals as early as 
possible. A rapid and reliable test is needed to control the spread o f disease. 
Culturing methods are very slow taking at least 3 months to complete since M. 
paratuherculosis grows very slowly. We decides to look at Johne's infected 
material to establish the feasibility o f the use o f in-situ PCR for the detection 
o f mycobacterial disease in tissue sections. Tissue blocks from a post mortem 
cow known to have died o f Johne's disease were selected. The gut tissue 
examined rotted significantly before being paraffin embedded and cut into 5 pm 
sections. PCR amplifications were carried out using primers which amplify 
fragments from IS900 an insertion sequence specific to M.paratuherculosisX 
Vary et al., 1990; Fidler et a/. 1994) PCR was carried out in-situ as described 
with an annealing temperature of 58°C for 40 cycles.
After amplification and detection slides showed significant levels o f amplified 
product in the same cells in the section that showed the presence of 
mycobacteria by Ziehl-Neelsen staining (data not shown). Controls for this 
experiment were firstly, minus Taq slides which showed no signal, secondly 
IS6110 primers specific to M. tuberculosis (i.e. nonsense primers), some 
amplification was seen with these primers but it was reduced by raising the 
annealing temperature to 62°C. Thirdly some tuberculosis sections were tested 
in parallel but did not demonstrate amplification.
These results indicated that amplification o f M. paratuherculosis DNA had 
taken place but its specificity may have been questionable. They clearly 
indicated that signal came from the bacteria in the section. These results were 
particularly significant because the very high levels o f amplification in this 
fixed tissue demonstrated firstly that cells were permeable to the PCR reagents 
and secondly that the amplified product was not easily flushed out o f the cells.
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Supernatants taken from the PCR reagents left on the slide amplification were 
precipitated and electrophoresed through a 2% agarose gel; no product was 
observed. This indicated that contamination had not occurred and that product 
remained within the cells.
4.3.2Detection of Mycobacterium tuberculosis in human lung and lymph 
node
This blind study was devised by Dr. H. Fidler and executed by myself and Dr. 
Fidler.
This study was designed to study the effectiveness o f in-situ PCR for the 
detection of M. tuberculosis in paraffin embedded sections o f human lung and 
lymph node. Patients to be studied were selected from known tuberculosis 
patients who showed necrotising granulomas but some were negative for acid 
fast bacilli (AFB) by Ziehl-Neelsen staining. Controls were uninfected liver, 
pancreas and spine and lung carcinoma, healthy lung tissue was not available. 
Patients biopsy blocks were cut into 5 ^tm sections and coded at the Middlesex 
Hospital Histopathology Department. Sections were then deparafflnised as 
described and subjected to saponin treatment for 30mins.
PCR was carried out using primers INS 1/2 (Hermans et a l .  1990) which 
amplify a 259 bp product o f the tuberculosis complex {Mycobacterium bovis, 
M. tuberculosis and BCG) specific insertion element IS6110. The annealing 
temperature used was 58°C. After amplification standard detection was carried 
out with acetic acid treatment. Supernatents were recovered where possible 
from the slides and precipitated with ethanol, no PCR products were seen. 
Results were recorded separately by Dr.Fidler and myself and then decoded 
by a party not involved in this study, results as table 4.1.
The results of this study indicated that in non-carcinoma lung tissue it was 
possible to detect low levels of M. tuberculosis that were not detectable by
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TABLE 4.1
IN-SITU PCR/fflSTOLOGY OF SLIDES AND PATIENT CLINICAL
STATUS
Slide code In-situ result AFB found Clinical status
T4 (+ ) TB
T5 + - TB
T6 + 4- TB
T8 + - TB
TIO + 4- TB
T12 + 4- TB
T16 (+ ) 4- TB
T18 - - TB
T19 + - TB
T21 - - TB
T22 - - TB
T23 - - TB
T24 - - TB
T25 (+ ) - TB
T26 (+ ) - TB
T28 - - TB
T29 - liver
T31 - pancreas
T32 - spine
T33 4- C
T34 - C
T35 4- c
T36 4- c
T37 4- c
T38 4- c
T40 - c
T41 4- c
T42 4- c
T43 4- c
Key:
+  =  positive result
- =  negative result
(+ )  =  probable positive result
TB =  clinical diagnosis of tuberculosis
C =  carcinoma section
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Ziehl-Neelsen staining. However it also indicated that alkaline phosphatase 
based detection methods were unsuitable for the differential diagnosis of lung 
tuberculosis and carcinoma. Peroxidase detection was carried out but results 
were insensitive. Other techniques such as the use o f fluoresceinated anti- 
digoxygenin antibody were more effective but there were very high levels of 
non-specific fluorescein attachment.
Future studies would not use lung carcinoma tissue as a control, it is however 
very unusual for biopsies of healthy lung to be taken. It must also be stated 
that the differential diagnosis of lung tuberculosis and lung carcinoma is often 
required. It is unlikely however that a trained histopathologist would not be 
able to differentiate the advanced carcinomas used in this study from 
tuberculosis. Close examination o f the carcinoma section also reveals that 
signal is not discrete or nuclear, so further studies would discount any such 
signal. If  alkaline phosphatase tests had been carried out before PCR in-situ 
false positives due to endogenous alkaline phosphatase may have been avoided.
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4.3.3Detectioii of Mycobacterium leprae in  skin biopsies 
A primary problem of leprosy diagnosis is the spectrum of the disease: 
lepromatous patients may have high numbers o f organisms but tuberculous 
patients have a very low number of organisms often very had to detect by 
conventional Ziehl-Neelsen staining. Now that leprosy patient numbers are 
declining generally it is important to have early diagnosis of even tuberculous 
cases so that the disease may one day be eradicated. I  demonstrate the use of 
in-situ PCR for the diagnosis o f tuberculoid leprosy in formalin fixed tissues 
in a double-blinded study.
Skin biopsies were collected from skin lesions o f patients presenting at the 
Green Pastures Hospital,Pokhara,Nepal. Smears from the lesion were also 
taken by the histopathologist in Nepal and assigned a bacterial index (BI) 
according to the Ridley and Jopling scale (Ridley and Jopling, 1966) and a 
laboratory diagnosis was made. Eleven specimens from patients with a 
diagnosis of leprosy and one patient with no histological evidence for leprosy 
were examined in this study. Biopsies were incubated in neutral buffered 
formalin for 2 hours. They were then transferred to 70% ethanol this should 
maintain the sections in a suitable condition for PCR analysis to be effective 
(Faillo et a l ,  1992). After 18-24 months they were sent to the department of 
histopathology. University College, London, where they were paraffin 
embedded, 5pm  sections cut and placed on vectorbond coated slides. Sections 
were Ziehl-Neelsen stained and examined at UCL for any signs o f leprosy and 
assigned a BI score.
The sections were then recoded and returned to University of Surrey for in-situ 
analysis. One section examined at UCL had a BI of 5 and was used as a 
positive control to develop the technique. Other control sections included 1 
uninfected spleen section, 1 section positive for tuberculosis and one gut 
section from a heavily infected Johne's disease cow these section were not 
coded. Sections were deparaffmised, air dried, then permeabilised by 0.1% 
saponin treatment. For PCR, the primers L E P l/2  were used these primers
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anneal specifically to the 18kDa antigen of M. leprae (Booth et a l , 1988) and 
were shown to be Af. leprae specific (Woolford and Dale, 1992). The primer 
sequences were:
LE Pl = 5 ' AGA AAA CTT GTC TAT CAC A 
L E P 2= 5’ CGA TTA GGC ATT TAT GAT T 
These primers produce a 592 bp product.
The biopsy sections were also examined for the presence o f endogenous 
alkaline phosphatase activity, after saponin treatment and washing in distilled 
water they were equilibrated with buffer 3 and exposed to colour reagents 
(Boehringer Mannheim) for the detection o f alkaline phosphatase. No 
appreciable levels of alkaline phosphatase were shown in any o f the sections. 
In-situ PCR was then carried out on all the slides were then scored positive or 
negative depending on presence of intense purple signal. Peripheral, weak and 
non—focalir origin signal in samples was discounted and samples were
repeated, the section were given a score ( + ,  +  +  , +  +  + )  depending on the
amount of PCR positive signal obtained (PCR signal was indicated by purple 
precipiation). These results were decoded by a person not involved in the 
study. The in-situ PCR results clinical data and histological data obtained are 
summarised in table 4.2.
Tube controls for PCR efficiency using 25/xl o f PCR mastermix with 4 ng 
exogenous Af. leprae DNA were positive and where no exogenous DNA was 
added negative, carried with the slides using the same PCR parameters. 
Supernatants collected from the slides where ethanol precipitated and 
electrophoresed through a 2% agarose gel. PCR product was only seen in the 
positive tube control, indicating that the mix was not contaminated, that the 
mix effectively performed PCR and that amplification within the cells did not 
leak out significantly.
Histopathological examination of the sections indicated that the twelve 
specimens were from seven BT patients, one BB/BT patient, one TT patient, 
one LL patient, one indeterminate patient, and one patient with no histological
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evidence for leprosy. Seven o f the eleven sections from patients with a 
diagnosis o f leprosy were positive for M. leprae DNA by in-situ PCR. The 
single coded negative control section was negative for M. leprae DNA. All 
section with a BI of 1.5 or more were positive by in-situ PCR. This is 
consistent with the findings o f workers using standard tube PCR on frozen 
sections (Jamil et al, , 1993). Four in-situ specimens were negative for acid-fast 
bacilli (B I=0) when examined either in Nepal or at UCL. 2 sections with BI 
o f 1 (UCL) were not detected by in-situ PCR. However, both o f these sections 
had a B I= 0  when examined in Nepal. Examination for AFB at UCL was very 
thorough, 6  sections were examined and only 1-2 AFB were seen in these 
sections. We only examined 1 section by in-situ PCR. We may have seen more 
positives signal if  we had examined more sections of if  we had sections from 
a different part o f the biopsy.
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TABLE 4.2
IN SITU PCR AND HISTOLOGY OF SPECIMENS
UCL histology Nepal histology Clinical data PCR result
B I= 0 , BT B I= 0 , BT no treatment -
B I= 0 , TT B I= 0 , PB/BT no treatment +
B I= 0 , BT B I= 0 , PB/BT no treatment -
B I= 0 , BT B I= 0 , BT with 
neuritis
no treatment 4-4-4-
B I= 0 , BT B I= 0, MB in 
reversal
no treatment 4-4-4-
B I= 0 , BT B I= 1 , MB/BT 
reversai and 
neuritis
2 years MDT 4-
B I= 0 , no signs 
o f leprosy
B I= 0 , no signs 
of leprosy
no treatment -
B I= 1 , BT* B I= 0, MB/BT no treatment 4-
B I= 1 ,
indeterminate
B I= 0 , MB/BT in 
reaction
3 months MDT -
B I= 1 .5 , BT, 
G F=25%
B I= 0 , MB/BT no treatment 4-
B I= 3 , BB/BT^ B I= 2 , BL in 
reaction
1 dose MDT 4-
B I= 5 , LL B I= 4, BL in 
reaction
no treatment -f "4"
Key to figure 4.2:
BI=Bacillary Index 
T T = tuberculoid 
M B= multibacillary 
G F = granuloma fraction 
* = early stage 
#=probably in fraction
BT=borderline tuberculosis 
LL=lepromatous 
PB=paucibacillary 
M D T= multiple drug therapy
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Histological examination o f the samples positive by in-situ PCR shows the very 
strong and discrete (pruple) signal obtained from the positive sections, figure 
4.1 show the epidermal edge of section 13856 from an LL patient with a 
B I= 5 , the presence o f purple signal on the extreme epidermal edge may show 
the passage o f live or dead leprosy bacilli through the skin. Figure 4.2 is 
section 13862 from a BT patient in whose sections no acid fast bacilli were 
seen, that has been weakly counter-stained with 10% methylene blue, where 
purple precipitation indicates presence o f M.leprae DNA. This figure shows 
apparent presence of M.leprae DNA around the peripheral edge o f a 
granuloma in the dermis. Figure 4.3 shows apparent presence o f M.leprae 
DNA around a sweat duct, and figure 4.4 show the apparent presence of 
M.leprae DNA around sebaceous glands in the dermis o f a patient suffering 
from leprosy.
The staining pattern observed in figure 4.1 may be due to necrotic or apoptotic 
death o f cells. DNA liberated during cell death may have given rise to large 
amounts of free DNA in the cells which can act as a primer for PCR and give 
amplification of a non-specific PCR product.
Figure 4.5 shows the effect of adding exogenous M.leprae DNA to the in-situ 
slide. Here peripheral staining o f the section is demonstrated. This is probably 
due to absorbtion o f PCR product into the outer more exposed cells on the 
section. No other signal was observed on this section which was formerly 
positive, this suggests that the presence of contaminating DNA may produce 
false negative results.
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FIGURE 4.1
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This figure shows the apparen t presence of M.leprae DNA (indicated by 
purple staining) in the epiderm al layer of a leprosy pa tien t's  skin. 
Objective used X 400.
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FIGURE 4.2
This figure shows the apparen t presence of M.leprae DNA (indicated by 
purple staining) around a in  a granulom a in the derm is of a  leprosy 
patien t's  skin. This section has been weakly stained with m ethylene blue. 
Objective used is X 1000.
109
FIGURE 4.3
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This figure shows the apparen t presence of M.leprae DNA (indicated by 
purple staining) around the sweat duct of a leprosy patien t's  derm is. This 
section is counterstained with m ethylene blue. Objective is X 1000 .
no
Figure 4.4
0
This figure shows the apparen t presence of M.leprae DNA (indicated by 
purple staining) in sebaceous glands of the dermis of a leprosy patient. 
This section is counterstained with methylene blue. Objective used is X 
1000.
I l l
FIGURE 4.5
•4
This figure shows the effect of exogenous aniplicon contam ination of the 
PC R  mix used for in-situ am plification. Staining of peripheral areas of the 
tissue section can be observed, no endogenous am plification derived 
strain ing was observed
l l lB
4.4DISCUSSION
These results indicate only that a technique such as in-situ PCR may be 
specific and sensitive would be a valuable diagnostic tool especially in 
mycobacterial disease diagnosis where samples are scarce and often contain 
very low levels o f organisms.
Tuberculosis is a growing health threat in both developed and undeveloped 
countries accurate early diagnosis is very important to prevent the spread of 
the disease, these results indicate that in-situ PCR may be used to detect levels 
o f Af. tuberculosis below the levels detected by acid fast staining if  naked 
DNA is being detected and not just whole organisms. In-situ PCR might be 
used as a supplementary diagnostic technique where low levels o f infection are 
suspected but not for general use due to its high cost and complexity of 
processing.
Since the 1981 WHO recommendation o f multidrug therapy for leprosy case 
numbers have been reduced. Early and accurate diagnosis o f low levels of 
infection are now needed to eradicate the disease. Whilst BI gives a measure 
o f live and dead bacilli and MI an indirect measure o f viability; both are 
subjective and lack standardisation. Tuberculoid leprosy cases are the most 
difficult to diagnose accurately , both the presence of acid-fast bacilli and the 
histopathological characteristics are important for diagnosis o f the spectrum of 
leprosy. Studies have shown that M. leprae bacilli can be detected in leprosy 
tissue sections by conventional PCR (deWit et a l ,  1992; Jamil et a l ,  1993). 
These technique cause destruction of the tissue morphology and the complex 
extraction techniques used can lead to contamination o f the tissue and the 
release o f substances inhibitory to PCR, (Clarridge et a l , 1993).My findings 
indicate that in-situ PCR is not subject to contamination by previous PCR 
amplificants as are many PCR based diagnostic tests (Noordhoek et a l , 1994). 
This may even enable its use in field based tests. Further large scale studies 
would be necessary to examine the reliability o f in-situ PCR and to further
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confirm its specificity in fixed tissue sections.
In-situ PCR may also be o f value for other bacterial diseases, or 
mycobacterial diseases where culture is slow or impossible. This technique 
may also be useful in studying the role o f cell wall deficient organisms in 
persistence o f mycobacterial infection, and in investigating the role of 
mycobacteria in diseases o f unknown etiology such as Crohn's disease and 
sarcoidosis. Such analysis would only be valid if  the specificity o f the in-situ 
test was previously proven.
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CHAPTER 5 
DETECTIO N  O F MYCOBACTERIUM BOVIS AND 
MYCOBACTERIUM KANSASII INFECTIONS
5.1INTRODUCTION 
S,l,lMycobacterium bovis infections
Tuberculosis infection in cattie is important both as an economic and public 
health problem. Li the 1930s 40% of slaughtered cattle in England and Wales 
had obvious tuberculosis, in 1950 18% of herds had at least one infected cow 
but by 1961 this figure was only 3.5% and it had reduced to 0.15% by 1991 
(Hardie and Watson, 1991). Herd prevalence of bovine tuberculosis in 1991 
in the European Community ranged from 0% in Denmark to 10.8% in Spain, 
with a prevalence o f 8 .8 % in Ireland. These differences still indicate problems 
caused by lack of proper control measures or reservoirs o f infected wild 
animals.
Tubercle infection in humans caused by Af. bovis which once accounted for 
25% of all cases of human tuberculosis (Pritchard, 1988), has experienced an 
important downward trend in recent decades due to control o f diseased cattle, 
meat inspection and pasteurization of milk. However there are still a few cases 
reported mostly acquired from reactivation o f infection acquired in youth or 
by contact when working with diseased cattle as demonstrated by Sauret et a l , 
(1992).
Attempts to control bovine tuberculosis as discussed in chapter 1 are hampered 
by a reservoir o f tubercle bacilli in some wild animals. In the U .K . the 
prominent reservoirs are badgers and wild or farmed deer. In the U .K ., 
M.bovis infection in deer was initially diagnosed in 1985 in animals imported 
from Hungary (Stuart et û/,1988). Infection in farmed deer is now controlled 
much the same way as that in cattle.
Current diagnosis of bovine tuberculosis (as also described in chapter 1) is by
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the caudal fold skin test for delayed type sensitivity (DTH), a test analogous 
to the human mantoux test. In cattle, a DTH reaction to a subcutaneous 
injection o f Mycobacterium bovis tuberculin or purified protein derivative 
(PPD) is indicative o f an infection with Af. bovis. The PPD produces a 
swelling at the site o f injection, normally the caudal fold in infected animals. 
Monitoring of the swelling is carried out on a subjective basis by the 
examining veterinarian (Radford et a l ,  1990). The test is neither highly 
sensitive nor specific. Problems are caused by cattle which react to tuberculin 
or PPD but no tuberculous lesions can be located; these cattle are designated 
"no visible lesion" (nvl) cattle. The cause o f such response may be presence 
o f other mycobacterial pathogens such as M. paratuherculosis or transient 
sensitizing infection with other mycobacteria such as soil and water forms, 
recently there has been an increase in Mycobacterium avium isolation amongst 
cattle and deer (personal communication, P.Crosston) this may in part be due 
to more effective isolation of such organisms.
Serological tests would be considered more useful but serological diagnosis is 
hampered by the large degree of cross reactivity of many mycobacterial 
antigens, with both non-pathogenic mycobacteria and bacteria o f other genera 
(Bloom, 1986). The problem is compounded by the spectrum o f immune 
response to mycobacterial infection, where different species and individuals 
vary in immune response to mycobacterial challenge.
The use of both serological tests and antigen detection methods for diagnosis 
of bovine tuberculosis has been examined by Wood et al, 1992. These workers 
used the M.bovis pxo\&m MPB70 in an ELISA test against sera from cattle, 
this ELISA showed a specificity o f 96.4% and a sensitivity o f only 18.1%. 
These workers also carried out an enzyme immuno assay (EIA) based on 
cellular responses to gamma interferon in whole blood culture; this test had 
a sensitivity o f 81.8% and a specificity o f 99%. When these workers carried 
out the single intradermal tuberculin test they achieved a sensitivity o f 68.1  % 
and specificity of 96.7% , Wood et al. 1992 therefore workers suggest that the
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gamma interferon assay may be a practical diagnostic test for large groups of 
cattle.
5 .1 .2C ontrol and  trea tm en t of bovine tuberculosis
Control o f bovine tuberculosis consists o f identifying the animals harbouring 
tubercle bacilli, by the tuberculin test, and destroying them. Thus, preventing 
spread o f tubercle bacilli to other animals. Despite the expense o f such a 
solution it can be an effective control measure, producing a generation o f cattle 
which never become infected with tubercle bacilli, at least in areas with no 
natural reservoir of infection.
Many treatments have been employed to treat tuberculosis including special 
diets, injection of living or dead bacilli. X-ray, pneumoperitoneum and 
pneumothorax, (Myers and Steele, 1969). The advent of antituberculosis drugs 
including streptomycin and isoniazid allowed for consideration o f treatment of 
infected cattle. However such drugs were found unsuitable because they only 
suppress the tubercle bacilli, giving the farmer a false impression that the 
animal is cured and not subject to restrictions. After drug therapy such animals 
may still shed viable bacilli not only to animals but to people, moreover such 
bacilli may be resistant to drugs as a result o f prolonged exposure to them 
(Myers and Steele, 1969). Animals that have had antibiotic treatment are not 
suitable for human consumption.
Efforts to immunize cattle using vaccines such as BCG have been found to be 
useless, also the application o f such vaccines can lead to tuberculin sensitivity, 
when most diagnosis is based on tuberculin sensitivity this is not tenable.
5.1.3The gene encoding M. bovis secretory protein  M PB70
Mycobacteria have a complex antigenic structure, only a small proportion of 
which has been characterised (Young et a l ,  1992). The wide variety o f
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different immunogenic components have been demonstrated by immunologic 
techniques such as crossed immunoelectrophoresis (Harboe and Nagai, 1983). 
MPB70 is a  major antigen o f M. bovis, produced in small amounts by 
M. tuberculosis and occurring also in some BCG sub strains in varying amounts 
(Harboe et al., 1986). MPB70 accounts for about 10% of the total protein 
content o f the nutrient fluid after culture on Sauton medium. This antigen 
exhibits little cross reactivity with other bacteria with the exception of 
Nocardia asteroides, and no known cross reactivity with other mycobacterial 
species. The protein is an active component o f PPD (Harboe et al., 1990) and 
is known to elicit DTH response (Harboe et ah, 1986) and to stimulate 
lymphocyte proliferation (Fifis et ah, 1989).
The use o f isolated Af. bovis antigens, such as MPB70, in immunodiagnostic 
assays is hindered by difficulties in the growing o f the organism and the 
purification of antigens according to Hewinson and Russell, 1993.
Wood et al. (1988) produced a set of monoclonal antibodies recognising 
MPB70 and showed that these were specific for M.bovis and M.bovis BCG, 
with limited reactivity to M. tuberculosis using either culture filtrates or 
sonicated extracts. Other mycobacterial species (including a strain of 
M.kansasii did not show cross-reactivity with these MAbs. Radford et al. 
(1990) mapped the binding sites for two of these MAbs (SB9 and SBIO) and 
determined the relative importance of each amino acid at each position in the 
putative epitopes, using substitution analysis in synthetic peptides. Radford et 
al. (1990) also located a dominant epitope recognised by serum from an 
infected cow. These sites are referred to subsequently in this chapter as the 
SB9, SBIO and polyclonal antibody binding sites.
A different diagnostic approach is to use the sequence o f the gene encoding 
MPB70 in a PCR based test. A PCR test was designed based on the DNA 
sequence o f the MPB70 gene from M. bovis AN5 (Radford et ah, 1988). The 
primers used produced a 259 bp product that spanned the monoclonal binding
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sites SB9/SB10 and polyclonal binding sites for this antigen gene.
5,l,4Mycobacterium kansasU infections
Mycobacterium kansasii is an opportunistic pathogen that has been identified 
as an agent of disease in many parts o f the world. It characteristically produces 
a chronic lung infection that closely resembles pulmonary tuberculosis, but 
with milder symptoms. Infections with M, kansasii are more frequent in 
individuals with an underlying condition such as chronic obstructive pulmonary 
disease and occur with more frequency in certain high risk groups such as 
workers with pneumoconioses (Bailey et a l , 1974). Disseminated disease has 
also been observed in association with AIDS (Levine and Chaisson, 1991). 
Until the advent of gene probe based tests identification o f Af. kansasii was on 
the basis of biochemical tests, such as catalase production and urease activity, 
and the photochromogenic nature of the organism. Huang et a l ,  (1991) have 
demonstrated a specific probe for the identification of M. kansasii 
Until recently it was believed that there was little heterogeneity between Af. 
kansasii strains. Indeed Huang et a l,  (1991) stated that their probe showed no 
heterogeneity between strains. However recent work has demonstrated at least 
two genetic subtypes (Ross et a l ,  1992). The workers found that the 
commercially available probe (Gen Probe, California) for Af. kansasii did not 
hybridize to certain Swiss and Belgian strains tested, Ross et a l  1992, 
sequenced the 16S rRNA gene o f isolates that did not hybridize to this probe 
and found that there were five bp changes. This defines a variant found 
predominantly in Europe. This evidence is the first to imply there may be 
more genetic diversity amongst M. kansasii strains than previously indicated. 
The PCR test we designed for the detection o f Af. bovis based on the gene 
encoding MPB70 was observed to cross react with certain human and animal 
isolates of M. kansasii. This implied there was an MPB70 gene analogue in 
Af. kansasii and that there may be variation in this gene analogue between Af.
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kansasii strains. A protein homologue has not yet been identified. MPB70 
was not found in one M. kansasii strain when examined by Harboe et a l ,  
(1986) and by other workers using monoclonal antibodies SB9, SBIO and 
polyclonal antisera, (G. Hewinson, personal communication).
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5.2M ETHODS
5.2.1Chrom osom al DNA extraction from  slow growing m ycobacteria 
Cultures were grown in 10ml Middlebrook medium (Oxoid) with OADC 
supplement (Oxoid) for 4-6 weeks. At 48hr before harvesting each 10ml 
culture had 1ml o f 10% glycine added or 100/xl o f lOOmg/ml cycloserine 
added. Cultures were harvested by centrifugation at 4  OOOrpm for 10 min. 
The pellet was resuspended in 200/zl of lysozyme (2mg/ml), 0.3M  sucrose, 
RNase(50/ig/ml) solution made up in TE pH8.0, and incubated at 37®C for 
3hr. After which 100^1 o f 5% SDS in TE (pH 8.0) and 5fig proteinase K 
was added and the preparation was incubated at 37°C for a further 30mins. 
The resulting solution was extracted twice with an equal volume o f phenol, 
then once with phenol/chloroform and once with chloroform. It was 
precipitated overnight with 3 volumes of 100% ethanol and 0.1 volume of 
5M sodium acetate. The preparation was spun at 12 OOOrpm for 30 min in 
an MSE microcentaur microfuge, the supernatant was discarded and the 
pellet dried in a warm oven and the pellet was resuspended in 30-100/xl of 
water or T.E.
5.2.2Q uantificatioii of DNA by gel electrophoresis 
Chromosomal DNA from mycobacteria was quantified by electrophoresis of 
1/xl of DNA through a 0.8% agarose gel on which a DNA size marker 
which consisted of 1/xg of Lambda H indlll digested DNA (Gibco BRL) was 
also electrophoresed. The quantity o f sample was then estimated relative to 
the marker bands.
5 .2 .3C rude preparation  of bacterial colonies fo r PC R
Colonies were prepared according to the method o f Gussow and Clackson
(1989).
Colonies were picked from plates or slopes and resuspended in 500/xl of 
sterile water, this was boiled for 5 min in a boiling waterbath. Tubes were 
cooled to room temperature and then centrifuged for 5 min at 12,(XK) rpm.
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1-2/tl of the supernatant was used in PCR.
5.2.4Digestion of genomic DNA
1-2/xg o f purified genomic DNA was digested using chosen enzyme in a 
200/xl reaction for 4hr at 37®C. A further 5 units o f enzyme were then 
added and the reaction was allowed to proceed for a further 2hr at 37°C. 
The reaction was then precipitated using 20/xl o f 3M sodium acetate and 
600/il o f cold 100% ethanol overnight at -20°C. The digested DNA was 
then centrifuged at 14,000 rpm for 30mins, the supernatant was discarded, 
the pellet washed briefly with 70% ethanol and dried in a vacuum 
centrifuge (Uniscience) for 7 min at 45°C. Pellets were then resuspended in 
20 /xl of sterile water.
5.2.5 Single Stranded Conformational Polymorphism Analysis
The technique of single stranded conformational polymorphism (SSCP) 
analysis as described by Orita et a l  (1989), is based on the fact that short 
double stranded DNA molecules if  denatured to form single strands then 
electrophoresed through non-denaturing polyacrylamide gels (often 
containing glycerol) will demonstrate different banding patterns depending 
on their exact sequence. The secondary structure assumed by single­
stranded nucleic acids varies according to their sequence. Many mutations 
have been demonstrated with this technique including rifampin resistance 
mutations in M. tuberculosis stains (Telenti et a l  1993) and studies o f the 
rpoB gene in M. avium and M.intracellulare (Guerrero et a l  1994).
The initial step in the SSCP is the amplification of labelled PCR products o f 
the required sequence. Amplification conditions were altered in that Taq 
antibody (Clontech) was included in the reaction according to 
manufacturer's instructions. Taq antibody binds to Taq polymerase at 
temperatures below 70°C but once heated to this temperature it becomes
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permanently dissociated. The use o f this antibody prevents the formation of 
primer-dimers and other spurious PCR products formed due to misspriming 
in PCR reaction tube prior to the first dénaturation step. Nucleotide 
concentrations used were 200/iM except for dCTP which was 20/xM and the 
addition o f 1/xCi o f ^^P labelled dCTP (NEN) per 50/tl reaction. 
Amplifications were carried out on a Perkin-Elmer 9600 thermal cycler 
where initial dénaturation was carried out at 95°C for 5 min, there followed 
30 cycles o f 94°C 20 sec, 56°C 20 sec and 72°C 50 sec with a final holding 
temperature o f 4°C.
After amplification PCR products were electrophoresed through a 2% 
agarose gel to assess the efficiency of reaction. SSCP analysis was carried 
out by electrophoresis o f a suitable amount of ^^P labelled PCR product 
though a 6 % polyacrylamide (Gibco BRL) gel containing 5% glycerol 
(Fisons). The polyacrylamide gel was suitable for an S2 sequencing kit 
(Gibco BRL) electrophoresis was carried out at 30 watts for 5 hr. The 
polyacrylamide gel was then dried and exposed to X-ray film (Kodak) for 
1-3 days before development.
5.2,6E,coU plasm id DNA Preparation
Two methods were used for plasmid preparation, the first when screening 
large numbers of clone and the second a commercially available method, 
for preparing plasmid DNA suitable for manual and automated sequencing. 
Small scale plasmid preparations, minipreps, were made using a technique 
based on a modified Birnboim and Doly (1979) procedure according to Ish 
Horowitz (Manniatis et a /., 1982). A 5ml sample o f medium containing an 
appropriate antibiotic was inoculated with a single bacterial colony and 
incubated overnight at 37°C with vigorous shaking. A 1.5ml portion o f the 
culture was poured into an Eppendorf microfuge tube and centrifuged at 12 
(XX) rpm for 1 min. The medium was removed by aspiration leaving the 
bacterial pellet as dry as possible. The pellet was then resuspended in l(X)/xl 
of a solution of 50mM glucose/lOmM EDTA. This was vortexed and stored
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at room temperature for 5 min. Then 200/xl of a solution containing 0.2M 
NaOH and 1 % SDS which was freshly prepared was added, the tube was 
mixed by inversion and placed on ice for 5 min. Ice cold 3M-potassium 
acetate, pH 4.8 (150/xl) was added to each tube and the contents were 
vortexed then placed on ice for 5 min. They were then centrifuged at 12 
OOOrpm for 5 min. 400/xl o f the supernatant was transferred to a new tube, 
1ml o f ethanol was added and the tube allowed to stand for 2  min and then 
centrifuged for 3 min. The supernatant was removed and the pellet 
resuspended in 200/xl of 0.05M  Tris base/0. IM  NaAC pH 8.0, (solution 4) 
and 200/xl o f ethanol. Tubes were allowed to stand for 2 min and were then 
centrifuged for 3 min. Supernatant was removed and the pellet was 
resuspended in 50/xl of solution 4. Samples o f the same clone were pooled 
and RNase added at 100/xg/ml. Tubes were then placed at 37®C for Ihr. 
Samples were then extracted once with phenol/CHClg and once with CHCI3, 
and reprecipitated with 3 vol ethanol and no extra salt.
Promega Wizard preparative columns were used for the preparation o f 
plasmid DNA suitable for cloning, method used was that described in the 
manufacturer's instructions except that 5.5 ml o f appropriate culture was 
used and Wizard resin was heated to 37°C prior to use. Once the 
preparation was removed the from column it was made up to 200 /xl and 
extracted once with phenol/CHClg and once with CHCI3, and then 
precipitated with 3 vol ethanol overnight at -20®C. The following day the 
preparations were centrifuged at 14 000 rpm for 30 min, the supernatant 
removed and the pellet resuspended in 20 /xl o f water.
5.2.7 Cloning using EMBL3
EMBL3 is a replacement vector capable o f accepting BamHl compatible 
fragments (Sau 3A,Mbo I, Bgl II or Bam H I). The arms are prepared by 
double digestion with Bam HI and Eco RI followed by selective 
precipitation, this separates the arms from the stuffer fragment. The
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EMBL3 system takes advantage of spi (sensitive to P2 inhibition) selection. 
Lambda phage which contain active red and gam genes are unable to grow 
on host strains which contain P2 phage lysogens. Lambda phage without 
these genes are able to grow on strains lysogenic for P2, such as P2392, a 
P2 lysogen o f LE392, and SRB(P2), a P2 lysogen o f SRB. The red and 
gam genes in EMBL3 are located on the stuffer fragment; therefore, wild 
type EMBL3 cannot grow on P2392. When the stuffer fragment is replaced 
by an insert, the recombinant EMBL3 becomes red- and gam- and is able to 
grow on P2392 and SRB(P2). By plating the library on P2392 or SRB(P2) 
you allow only recombinant phage to grow.
Ligation of Sau 3A partially digested M. kansasii DNA into EMBL3 vector 
digested with BamHl/Eco R1 was carried out as per manufacturer's 
instructions (Stratagene, California) at 4°C for 48hr.
Packaging was carried out using Stratagene, Gigapack II Gold packaging 
extracts according to packaging instructions. Phage packaged DNA was 
stored at 4°C until it was titred.
5.2.8Preparing host bacteria
Strain from glycerol stock was streaked out on an Luria agar (LA) plate 
overnight at 37°C. A single colony from this plate was grown in 10ml of 
LB supplemented with lOmM MgSO4/0 .2 % maltose, this was incubated 
overnight at 37°C. The bacteria were pelleted at 200 rpm for 10 min, and 
resuspended in half the original volume o f lOmM MgSO^. These cells were 
used for plating within 48hr.
5.2.9Titering the library
For a l(X)mm plate 200/xl o f plating bacteria had neat and consecutive 
dilutions o f phage stock added, the cells were adsorbed with diluted phage 
for 15-20 min at 37®C. 3ml o f melted top agar (cooled to 48°C) was added 
and it was poured onto prewarmed LA plates and placed at 37°C overnight.
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5.2.10Library amplification
On the first day 50ml o f broth supplemented with maltose and MgSO^ was 
inoculated with a single colony of the appropriate bacterial host. It was 
grown overnight in an Ehlenmeyer flask. On the second day the bacteria 
were pelleted at 2 000 rpm for lOmins. The pellet was gently resuspended 
in 15ml of lOmM MgSO^. 600/xl o f plating cells were needed for each 
150mm plate, aliquots of the packaged library suspension containing about 
50,000 recombinant bacteriophage was mixed with 600/xl of plating cells, 
cells and phage were incubated for 15 min at 37°C. 6.5ml o f melted top 
agar and spread evenly onto a pre warmed 150mm plate of bottom agar, 
plates were then incubated at 37°C for 6 -8hr. Plates were then overlaid 
with 10ml o f SM buffer. Plates were stored at 4°C overnight. The next day 
the bacteriophage suspension from each plate was pooled onto sterile glass 
universals, the plates were rinsed with a further 2ml of SM buffer and 
pooled. Chloroform was added to 5% of the total volume, this was then 
incubated at RT for 15 min. Cell debris was removed by centrifugation for 
5 min at 2 000 rpm, the supernatant was recovered and placed in a glass 
bijou with addition of chloroform to 0.3% of volume, aliquots were stored 
at 4°C.
5.2.11Plaque and colony lifts for screening
Positively charged membrane (Boehringer Mannheim) was cut to the size o f 
the agar plate with well separated small plaques or small colonies growing 
in it, the membrane was then gently laid on the plaques or colonies and 
marked so that it could be reoriented on the plate. After 1 min the 
membrane was removed and placed on 2 sheets o f 3MM (Millipore) paper 
soaked in denaturing solution for 7 min. The membranes were then placed 
on 2 sheets of 3MM paper soaked in neutralising solution. Membranes were
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then transferred to 2 sheets of 3MM paper soaked in 2 X SSC, membranes 
were then air dried and baked at 120°C for 30 min, they were then placed 
in hybaid bottles with meshes between each membrane ready for 
hybridisation with appropriate probe.
5.2.12Subcloniiig into plasm id vector pUC18 
The EMBL3 clone once isolated was separately Sail and Bam H I 
(Boehringer Mannheim) digested and the fragments produced were shotgun 
cloned into pU ClS cut with the appropriate enzyme and treated with calf 
intestinal phosphatase (Boehringer Mannheim).
5.2.13 Sequencing Protocols
Chain termination sequencing using sequenase version 2 .0 .(USB)
The chain termination sequencing method involves the synthesis o f a DNA 
strand by a DNA polymerase in vitro using a single-stranded DNA 
template. Synthesis is initiated at only one site where the oligonucleotide 
primer anneals to the template. The synthesis reaction is terminated by the 
incorporation o f a nucleotide analog that will not support continued DNA 
elongation. The chain terminating nucleotide analogs are the 2 ',3 '-  
dideoxynucleoside 5 '- triphosphates (ddNTPs). These lack the 3 '-OH group 
necessary for DNA chain elongation. When proper mixtures o f dNTPs and 
one of the four ddNTPs are used, enzyme catalyzed polymerization will be 
terminated in a fraction o f the population o f chains at each site where the 
ddNTP can be incorporated. Four separate reactions, each with a different 
ddNTP give the complete sequence in formation. A radioactive nucleotide is 
also included in the synthesis, so the labelled chains o f various lengths can 
be visualised by autoradiography after separation by high resolution 
electrophoresis.
Sequenase 7-deaza-dGTP sequencing kit HJSB)
Some DNA sequences, especially those with dyad symmetries containing
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dG and dC residues, are not fully denatured during electrophoresis. When 
this occurs, the regular patten o f migration o f DNA fragments is 
interrupted; bands are spaced closer than normal (compressed together) or 
sometimes further apart than usual. When this occurs sequence data is lost. 
The substitution o f a nucleotide analog for dGTP (7-deaza-dGTP), which 
forms weaker secondary structure, can eliminate these gel artifacts and most 
compressions are eliminated. Mycobacterial DNA often has a high 
proportion o f guanidine and cytosine residues (is G/C rich) and sequencing 
compressions can be eliminated by the substitution o f 7-deaza-dGTP into the 
sequencing reaction.
5.2.14Single Stranded Sequencing of PCR products
Single strand templates of PCR products were prepared by the separation of 
the PCR product strands using streptavidin coated magnetic beads (M-280) 
from Dynal UK. PCR was carried out using standard conditions except that 
one primer used was biotinylated at the 5 ' end. After PCR amplification 
PCR products were purified using a Pharmacia micro-spin column S-3CX) 
HR. PCR product was then attached to 30/xl of washed streptavidin coated 
beads. The non-biotinylated strand was removed by treatment with lOOfil of 
0.15M  NaOH, the beads bearing the biotinylated strand were washed and 
resuspended in 5/d o f water. The non-biotinylated strand was precipitated 
using ethanol.
Removal of the biotinylated strand from the magnetic beads was carried out 
by heating them to 65°C for 5 min then using the M PC-E magnetic rack 
(Dynal) the supernatant containing the single stranded PCR product was 
removed and used in the standard Sequenase 2.0 sequencing protocol 
(USB).
5.2.15Automated sequencing
Automated sequencing was carried out using the Applied Biosystem (ABi)
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373A. This technique is based in the laser detection o f fragment labelled 
using fluorescent dye terminators.
5.2.16Sequence analysis packages
Initial consensus of DNA sequence was generated using Amersham Staden 
Plus computer analysis package, Staden and McLachan 1982. Multiple 
DNA sequence and amino acid alignments were then carried out using 
Clustal V (Higgins and Sharp, 1988).
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5.3RESULTS
5.3 .1PC R  test fo r Mycobacterium bovis
Primers for the specific amplification of M. bovis DNA were designed by 
Glyn Hewinson using the sequence of the gene encoding the antigen MPB70 
(Radford et ah, 1988). The sequence o f these primers designate A2/B2 is as 
follows:
A 2=  5 -GG CCG GCC TCG GTG CAG GGA ATG TCG CAG GAG 
B 2=  5 '-CA  CTA CGT GGT AGG TCA GGA TGC TGG TGA CAC 
These primers produce a 259 bp fragment from tuberculosis complex 
mycobacteria.
These primers were tested for specificity for the tuberculosis complex using 
a panel o f mycobacterial species including Mycobacterium smegmatis, 
Mycobacterium avium, Mycobacterium phlei, Mycobacterium kansasii, and 
other bacteria such as Escherichia coli and Nocardia asteroides, (results not 
shown). There was no cross reaction of primers except when certain 
M.kansasii strains were amplified. Two further primers designated A3/B3 
(sequence no shown) were synthesized that produced a PCR product internal 
to the PCR product of primers A2/B2. When the product o f primers A3/B3 
using M.bovis as a template was used as a probe for Southern blots o f PCR 
products o f primers A2/B2 derived from M. tuberculosis complex organism 
and other mycobacterial species the probe was M. tuberculosis complex 
specific, i.e. not hybridising to the M.kansasii PCR product. This detection 
system was used by CVL, Weybridge to differentiate M.bovis infections 
from other mycobacterial infections in suspected M.bovis infected herds of 
cattle and deer.
An examination of a larger number o f M.kansasii strains was instigated to 
look for the possible analog of the M. bovis MPB70 gene.
A panel of M.kansasii isolates from animals; were grown and DNA was 
extracted using the crude boiling method (Gussow and Clackson, 1989). 1- 
2/xl was used in a 50/xl PCR reaction using primers A2/B2, the PCR
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products generated were electrophoresed through a 2 % agarose gel and 
Southern blotted. They were probed with a digoxygenin probe produced 
from the 259 bp product o f M. bovis using primers A2/B2. These results 
are shown in figure 5.1. These results demonstrate the production o f a 259 
bp product by most of the strains tested, two strains M18 and 2007 gave no 
detectable product and strain 129 produced a product smaller then 259 bp. 
To further indicate that there was genuine homology between the product 
produced by primers A2/B2 in M.bovis and M.kansasii a probe was also 
made using the PCR product o f primers A2/B2 from Af. kansasii strain 129. 
The same membrane shown in figure 5.1 was stripped o f probe and the 129 
probe was hybridized to it as shown in figure 5 .2 .
These results indicated the presence of a specific PCR product from 
M,kansasii strains when using primers based on the sequence o f the M.bovis 
MPB70 encoding gene. These results suggested that there may be an 
MPB70 gene analog in M kansasii which was not expected, since it had not 
been observed previously at DNA or protein level.
5.3.2D ifferential H ybridization of M, bovis and  M. kansasii probes 
To further investigate the apparent MPB70 analog in Af. kansasii the PCR 
tests for several strains of M.kansasii dsid M.bovis was repeated using 50/xl 
reactions, 20/xl of the PCR mix after amplification was loaded on one gel 
and 20/xl on a duplicate gel. Following gel electrophoresis both gels were 
Southern blotted. One gel was probed with a digoxygenin labelled probe 
consisting o f the 259 bp product of primers A2/B2 derived from Af. bovis 
strain AN5 and the other with the similar fragment derived from the 
amplification of the same fragment from M. kansasii field strain 684. After 
probing overnight both blots were washed stringently; 2 X 15 min at RT 
with 2 X SSC,0.1% SDS and 2 X 30 min at 65°C with 0.1 X SSC, 0.1% 
SDS. Detection was carried out simultaneously according to manufacturer's 
instructions (Boehringer Mannheim).
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FIGU RE 5.1 Southern blot showing PCR products of A2/B2 prim ers for 
field strains of M.kansasii probed with M.bovis 259 bp  probe
1 2 3 4 5 6 7 8 9  10 1112 
8
8
131415161718192021 22
Legend - lanes are: l:PhiX174 H aelll cut markers markers;2:Af.kû/way/i 
strain 8 ; 3:129, 4:286, 5: 684; 6:M18; 7:M19; 8:M20; 9:M21 10:M309; 
ILblank; 12:M.bovis AN5; 13:PhiX174 markers; 14:1190; 15:2007; 
16:2021; 17:2436; 18:2444; 19:2486; 19:5141; 20:negative contol; 21:blank 
22: M.bovis.
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FIGU RE 5.2 Southern blot as 5.1 b u t probed with the PCR product of 
prim ers A2/B2 when M  kansasii s tra in  129 is am plified.
1 2 3 4 5 6 7 8 9  10 1112
f
t
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Legend - Since the same blot as shown in figure 5.1 is used here lanes are 
exactly as figure 5.1 (previous page).
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When the strains on this blots were compared blot to blot a demonstrable 
difference in hybridisation of probe can be seen figure 5.3 . The M.bovis 
probe hybridises most to the M.bovis and M.tuberculosis strains and not at 
all to the PCR product of strain 129, probably because there was 
insufficient DNA from strain 129 for the weak hybridisation to be detected. 
The M. kansasii probe hybridised most strongly to M.kansasii strains M21 
and 684 and comparatively weakly to other M.kansasii strains and to 
M.bovis and M.tuberculosis strains. These results imply there is an MPB70 
analog in M. kansasii strains and the differential hybridisation also implies 
heterogeneity in the sequence of the analog among the M.kansasii strains, 
some strains o f M.kansasii having an analog more homologous to M.bovis 
than others.
5.3.3M PB70 analog in hum an M. kansasii strains 
To investigate the distribution of this MPB70 analog in M. kansasii strains 
we examined 5 strains of human origin. The strains tested were isolated 
from different parts of the UK and collected at the PHLS Cardiff. PCR 
was carried out on these 5 strains with a positive control M. bovis and one 
negative control (no DNA). The products o f the PCR reaction were 
electrophoresed through a 2% agarose gel and then Southern blotted and 
probed using the 259 bp probe derived from the amplification o f Af. bovis 
DNA using A2/B2 primer pair. Figure 5.4 shows that a PCR product was 
amplified form the M.kansasii strains, and that the signal arising from the 
hybridisation of the M.bovis probe was weaker than the M.bovis
As demonstrated in figures 5.1 and 5.2 strain 268 is a mixed culture, probably 
a co-culture of M.bovis and M.kansasii, this is indicated by the fact that the 
bands hybridizing to the different probes are of different sizes.
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FIGU RE 5.3 D ifferential hybridization . P robe A is gnerated from  
A2/B2 PCR product of M.bovis s tra in  AN5. Probe B is generated from  
the PC R  product of M.kansasii s tra in  684 using the same prim ers.
B
1 2 3 4 5 6 7
I
Legend - Lanes are: l:phiX174 H aelll cut markers; 2: strain M21 3:684; 
4:286; 5:129; 6 :M.bovis; 7: M.tuberculosis.
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FIGU RE 5.4 Southern blot of M.kansasii strains isolated from  hum ans, 
p robed with 259bp probe dervived form  M.bovis
1 2  3 4 5 6 7 8
Legend -lanes are l:PhiX174 H aelll markers, 2:M.bovis; 3:8376; 4:8388; 
5:8888; 6:8632; 7:9224; 8 :negative control.
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control. This indicates that these is a human M.kansasii isolates also 
contain an MPB70 analog, and that it is not identical to that in M.bovis.
5.3.4Restriction Fragment Length Polymorphism (RFLP) analysis of M. 
bovis and M. kansasii strains
The presence of a gene analogue in M. kansasii strains was indicated by the 
PCR data shown above. To prove that the analog was derived from the 
genomic DNA of each strain and not from contamination o f PCR, genomic 
blots o f these strains were necessary. Genomic DNA extraction were 
performed on various M. kansasii strains using the method described by 
Zamuddin and Dale (1989). DNA yield was estimated by comparison of 
DNA on 0.8% agarose gels compared with a known amount of lambda 
Hind III restricted DNA marker (BRL). Approximately 1/xg of 
chromosomal DNA from each strain was restricted in a 100/xl reaction 
using 10 units o f the restriction enzyme Pvu II (Boehringer Mannheim) for 
4hr at 37°C. Following digestion the DNA was electrophoresed through a 
0.8% agarose gel and Southern blotted. After baking the membrane was 
hybridized to the PCR generated 259 bp product o f Af. bovis amplification 
with primers A2/B2. This probe had been digoxygenin labelled. 
Hybridisation was carried out overnight at 65°C, washes were 2 X 15 min 
in 2 X SSC, 0.1% SDS at room temperature, and 2 X 30 min in 0.1% SSC, 
0.1% SDS at 65°C. These results are shown in figure 5.5. They indicated 
the presence o f an analog which may contain a Pvu II restriction site 
causing 2  bands to be found in the size range 1.8-2 .3  kb instead o f the one 
band o f approximately 4 kb. The faint bands shown by some strains may 
indicate the lower homology o f the M. kansasii analog to the M. bovis 
probe. Some strains also show a band at 4kb this may represent the MPB70 
analog in some M.kansasii strains that does not have the PvuII restriction 
site. It was also difficult to obtain enough DNA from some o f these strains 
to carry out RFLP analysis.
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FIGU RE 5.5 R FL P analysis (PvuII digest) of selected M.kansasii 
strains, where probe is the 259bp PC R  product of prim ers A2/B2 using 
M.bovis AN5 as tem plate
1 2 3 4 5 6 7 8 9  10111213
Legend - Lanes:Llambda Hindlllcut markers; I'.M.bovis AN5, 3:M.bovis 
AN5; 4:M.kansasii ; 5: strain 129; 6:M19; 7:M21; 8:M309; 9:8376; 
10:8672; 11:8388; 12:8888; 13:9224.
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in  oroer to conrirm me presence or an m f b  /u gene analog in a commonly 
available M.kansasii sitain a library was constructed using M.kansasii KTCC 
strain 10268.
5.3.5Coiistruction of an EMBL3 genomic library of M.Kansasu siram 
NTCC 10268
LigatiQn
0.4/ig o f M.kansasii strain NTCC 10268 partially Sau3A digested into 
fragments o f 9-24kb was ligated to 1/xg o f lambda EMBL3 Bam Hl/EcoRl 
predigested arms in a 10/xl reaction that was incubated at 9®C for 48hr. 
Simultaneously 0.3/xg of pME test insert was ligated into 1/xg o f EMBL3 
predigested arms to function as a ligation and packaging control.
Packaging
Ligation mixtures were packaged using Stratagene Gigapack II Gold 
packaging extracts according to manufacturer's instructions. 500/xl of 
packaged phage mixture was produced which was then suitable for titering 
and amplification.
5.3.6Library screening
The EMBL3 library yielded approximately 1.4 x 10  ^plaque forming units, 
plating the phage on the recombinant restrictive host E.coli P2392, revealed 
that the library was approximately 60% recombinant phage. The library was 
amplified according to manufacturer's instructions and dispensed into 2 ml 
aliquots. The amplified library was titered and 10 000 phage were plated 
out on large assay plates, they were then screened using the 259 bp PCR 
derived fragment o f M. bovis AN5. Two positive clones were detected 
these were characterised by restriction fragment analysis with enzymes Bam 
H I, Eco R1 and Sal 1. When digested with Sal 1 there were 2 hybridising 
fragments. The hybridizing fragments were shotgun cloned into the plasmid 
vector pUC 18 and selected by hybridization of the clone with the 259 bp 
fragment of M. bovis AN5. A Sal 1 clone was selected with a 4kb insert 
that hybridised strongly with the M. bovis probe. The other Sal 1 fragment 
was not isolated, all further sequencing was carried out on this clone.
This clone sequenced manually (initially) using Sequenase version 2.0. and
138
To calculate whether this library represents the genome of M.kansasii the 
following information was taken into account; the average insert size was 
approximately 12 kbp, and the library was 1.4 X 10  ^plaque forming units of 
which 60% was recombinant phage. Thus the number o f base pairs represented 
was:
8.4 X 10  ^ X 1.2 X 10  ^= 10’ base pairs
The genome size of M.kansasii is 4.5 X 10*^  bp, thus the library in total 
represents the genome 222  times.
The exact probability of having any given sequence in the library can be 
calculated from the equation:
N  =  In(l-P)
In(l-f)
where P is the desired probability, f  is the fractional proportion o f the genome 
in a single recombinant, and N  is the necessary number of recombinants.
To achieve a 99% probability of finding a given sequence in a clone in this 
M.kansasii library the number of clones that must be screened is:
N =  In(l-0.99)
=  1.7 X 10^In 1- 1.2 X 10^
4.5 X 10^
using the Applied Biosystems automated sequencer.
5.3.7Sequence data analysis
The data obtained was analyzed and a contig o f 505 bp was established 
including the 5 ' end o f the predicted coding sequence. This showed high 
homology to the MPB70 gene o f M.bovis BCG gene (Terasaka et û/.1989) 
the Clustal V alignment of the two DNA sequences is shown in figure 5.6. 
The ribosomal binding site of MPB70 is identical to that o f M.bovis BCG 
Japan (Terasaka et al. 1989). The rest of the DNA sequence examined 
shows a high level o f homology.
When the predicted amino acid sequence o f M.kansasii MPB70 analog is 
compared to that of Terasaka et al. 1989, there are some important 
differences between the amino acid sequences. The homology o f the two 
predicted proteins as shown in figure 5.7 is lower in the area that forms the 
signal peptide. However this region conforms to the general structure for 
signal peptides in that it has a basic amino acid adjacent to the N-terminus 
followed by a hydrophobic region. Apart from one conservative 
substitution at the cleavage site of the mature MPB70 protein there is high 
homology at this cleavage site. This indicates that the protein is likely to be 
secreted by M.kansasii.
Some interesting variations in predicted amino acid sequence are shown at 
the monoclonal and polyclonal antibody binding sites. The sequence form 
the first proline of the monoclonal antibody site SB9 to the end o f this site 
differs in only one position from that characterised by Radford et al. (1990) 
as recognised by the SB9 MAb on the M.bovis MPB70 antigen. The 
replacement o f a threonine by a serine at this position is not expected to 
affect the binding of SB9, as Radford et al. (1990) showed that SB9 binds 
to the synthetic peptide PSGPASV almost as effectively as to the original 
sequence PTPASV. The reported absence of reaction o f SB9 with 
M.kansasii (Wood et al. 1988) may be due to the low level o f production
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FIGURE 5.6
CLUSTAL V multiple DNA sequence alignment of M.bovis BCG gene encoding 
MPB70 and M.kansasii 10268 MPB70 gene analog (inconplete)
10268
Terasaka
AAAAGGGCTGCGGGTGTACTCCTTCACCTACGGCTGATTTCGATCATCGG
CAAGGGGCTACAGGTTTTTTCCTTCACCTACGGATGAAT----------- ATC—
*  *  * * * * *  *  *  *  *  *  * * * * * * * * * * * * * *  *  *  *  *  * * *
10268
Terasaka
10268
Terasaka
10268
Terasaka
10268
Terasaka
CCATCCAAGACCGCCACAGTTCCGAATTACCAATGTCAGGCATGAACAGA 
-CATCCAAGACCCGGACGGCTCCGAAGAAATCATGTCGGGGGTAGCGAGA 
* * * * * * * * * * *  **  * * * * * * *  * * * * * *  **  * * * *
TGGCATA— CCGCCATCGACAATCCCCG ?VAGGAG :  C G A m -A G C C gf
CGGCACAAGCCGCCGTCTeCGG-CAGCG AAGGAG rGAACGGClATGfU^GGT 
* * * * *  * * * * * * *  *  *  * * ! * * * * *  *1 * *  *   *  *
^UVIAGTTCAATGGCAGCAACAGGTTTGGTAGCAGCGGCTGTTGTGGGTC 
AAAGAACACAATTGCGGCAACCAGTTTCGCGGCGGCCGGCCTGGCGGCTC 
**  * * * * *  * * * * * * *  * * * * * * * **  * * * **  * *
t g g c g g t t g c c a c c t c g c c g a c t g c g g c g g c Æ c c g a t c t g g t g g g g c c g
TGGCGGTGGCTGTCTCACCGCCGGCGGCCGCAGGCGATCTGGTGGGCCCG 
* * * * * * *  **  * * *  * * *  * * * * * *  ***** * * * * * * * * * * * *  * * *
10268
Terasaka
GGGTGTGCGGATTATGCGGCCGCCAACCGCAGTGGCCCGGCGTCGGTGGA 
GGCTGCGCGGAATACGCGGCAGCCAATCCCACTGGGCCGGCCTCGGTGCA 
**  **  * * * * *  **  * * * * *  * * * * *  * * * *  * * *  * * * * *  * * * * * *  *
10268
Terasaka
GGGAATGTCGCAGGTTCCGGTGGCGGTGGCGGCCTCCAACAACCCGATGC 
GGGAATGTCGCAGGACCCGGTCGCGGTGGCGGCCTCGAACAATCCGGAGT 
* * * * * * * * * * * * * *  * * * * *  * * * * * * * * * * * * * *  * * * * *  * * *  *
10268
Terasaka
TCACGACGTTGACCTCGGCGGTATCCGGCCGGCTCAACCCTCAGGTGAAG 
TGAGAAGGGTGAGGGGTGGAGTGTGGGGGGAGGTGAATGGGGAAGTAAAG * **  * * *  * * * *  * **  * **  * * * *  * * * * * *  **  *■* **  * * *
10268
Terasaka
TTGGTCGACACGCTCAACAATGGCCAGTACACCGTGTTCGCGCCGACCGA 
CTGGTGGACACCCTCAACAGCGGTCAGTACACGGTGTTCGCACCGACCAA * * * *  * * * * *  * * * * * * *  **  * * * * * * * *  * * * * * * * *  * * * * * *  *
10268
Terasaka
TGGGGGGTTGGAGAAGGTGGGGGGGTGGAGGATGGTGGAGGTGAAGAGGG 
GGGGGGATTTAGGAAGGTGGGGGGATGGAGGATGGAGGAGGTGAAGAGGA 
* **  **  * * * * * * * * * * * *  * * * * * * * * *  * * * * * * * * * * * *
10268
Terasaka
ATTG----------------------------------------------- AA
ATTGGTGAGTGGTGAGGAGGATGGTGAGGTAGGAGGTAGTGGGGGGGGAA
* ** * * *
10268
Terasaka
AGGTG------------------- -----------------------------
AGGAGGGGGGGGAAGGTGGTGGGGAGGGGTGAGAGGGTGGAGGGGGGGAG * * *  *
Legend - RBS:ribosomal binding site 
START:start codon 
> :mature MPB70
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FIGURE 5 .7
CLUSTAL V multiple sequence alignment of M.kansasii MPB70 
and M.bovis BCG MPB70 amino acid sequences
1 0 2 6 8
MPB70
1 0 2 6 8
MPB70
1 0 2 6 8
MPB70
1 0 2 6 8
MPB70
MK—  S SMAATGLVAAAWGLAVATS PTAAAADLVGPGCADYAAAK 
MKVKNT lAATS FAAAGLAALAVAVS PPAAAGDLVGPGCAE YAAAI  ^
* *  * * . .  , * * * *  **  * * *  ^* * * * * * * *  * * * * *
PSGPA
PTGPA 
* ***
SV EGM 3QVPVAY \A  SNNPML
SV\
* *
^  L, t t l t s a v s g r l n p q v n l v d t l n n g q y t v f a
QGMpQDPVAVtU^NNPELrTLTAALSGQLNPQVNLVDTLNSGOYTVFA
*  *  * * * * *  * k ± j L * _ ^ ± i *  * * * . * , * * / * * * * * * * * * * * *  * * * * * * *
PTDPAFDKLPASTIVQLKTDSNL---------------------------------- ------------------------
PTNAAFSKLP^TIDELKTNSSLLTSILTYPîWAGQTSPANWGTRQTLQ
GAS VTVTGQGNS LKVGNADWCGGVS TANATVYMIDS VLMPPAS SAEA
L e g e n d  -  A : S B 9  
B i S B l O
C : p o l y c l o n a l  b i n d i n g  s i t e  
> : m a t u r e  p r o t e i n  s t a r t s
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o f MPB70 analog in M.kansasii, or may indicate that other regions of the 
intact protein moderate the binding o f SB9 to this sequence.
In contrast, the substitution o f a valine for an aspartic acid in the region 
aligning with the SBIO MAb binding site was shown by Radford, using 
substitution analysis with synthetic peptides to virtually abolish SBIO 
binding.
Within the region mapped by Radford as being the dominant epitope 
recognised by sera from infected cattle, Radford's data shows that 
substitution of a methionine for a glutamate is expected to result in a 
considerable reduction in antibody binding, an acidic amino acid being 
preferred at this position.
It should be noted that the C-terminal of the M.kansasii MPB70 gene analog 
was never cloned.
5.3.8Single Strand Conformational Polymorphism (SSCP) analysis of 
selected M.kansasii strains
SSCP analysis was carried out as described using primers A2/B2 on 
M.kansasii strains. These included 7 animal isolates, 2 human isolates and 
the NTCC strain 10268. Analysis was also carried out on M.tuberculosis 
(lab strain), M.bovis strain AN5 and M.bovis BCG Pasteur strain. The 
SSCP profiles produced are shown in figure 5.8. The data shown indicates 
that all TB complex stains examined had the same profile. There were 
however three different profiles shown for the M.kansasii strains. Strains 
8376 and 8388 are human clinical isolates and showed the same profile as 
each other and the same profile as M.kansasii animal isolates 60626, 684 
and M21 and also the same profile as strain NTCC 10268. A second profile 
was shown by isolates 447 and 516, a third very different profile was 
shown by M.kansasii strains 1063 and 129. These two strains also showed 
smaller PCR products when amplified using primers A2/B2 this is further 
demonstrated in their SSCP profile figure 5.8. The SSCP profile groupings 
do not seem to correlate to the little bacteriological data known about these 
strains, these strains are all isolated cases and therefore we
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FIGU RE 5.8 SSCP profiles of M.tuberculosis complex and M.kansasii 
strains using PCR product from  prim er A2/B2
1 2 3 4 5 6 7 8 9  101112131415
& ¥
Legend - Lanes: 1: M.tuberculosis not denatured. 2\M.tuberculosis; 
3:M.bovis BCG (Pasteur); 4:M.bovis AN5; 5:M.kansasii 10268; 6:129; 
7:M21; 8:447; 9:516; 10:684; 11:1063; 12:60626; 13:8376; 14:8388; 
15:8388 not denatured.
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cannot say that an SSCP type forms an outbreak. Studies o f the 
epidemiology o f M.kansasii outbreaks might be carried out using this SSCP 
test.
5.3.9Sequence analysis of the di^erent SSCP profile producing strains 
of M.kansasii
PCR amplification o f M.kansasii strains using one biotinylated prim er 
enables single stranded sequencing o f the PCR products. A selection o f the 
results is shown in figure 3.9a. Strains 516 and 10268 differed in 10 
positions, while 129 showed an additional number o f base changes, an 
apparent deletion at the 5 ' end of the sequence determined would account 
for the smaller size o f the PCR product with this strain as well as its 
markedly different SSCP pattern. This also correlates with the Southern blot 
data which shows the loss o f the Pvu II in strain 129 (Figure 5.5). As 
expected from the SSCP analysis, the sequence o f 1063 was identical to that 
o f 129. Similarly, 684 (data not shown) was identical to 10268, as 
predicted from the similarity of the SSCP analysis. Hybridisation data in 
figure 5.3. also confirms the stronger homology o f 684 to Mycobacterium 
bovis compared to that o f strain 129. The sequence data therefore confirms 
the conclusions of the SSCP analysis and differential hybridization, in that 
the M.kansasii strains examined contain 3 variants of the MPB70 analog. 
The predicted amino acid sequence comparison figure 5.9 o f this region of 
M.kansasii analog shows extensive homology between
representatives of the types, apart from a deletion in strain 129. 
Polymorphisms among M.kansasii strains may enable strain differentiation 
to be carried out using the SSCP technique, it may therefore be useful for 
epidemiology of M.kansasii transmission between cow or deer herds.
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FIGURE 5.9A
CLUSTAL V multiple DNA sequence alignment of incomplete MPB70 
analogs of specified M.kansasii strains
1 0 2 6 8  a t g c t c a c g a c g t t g a c c t c g g c g g t a t c c g c c c g g c t c a a c c c t c a g g t
6 ATGCTCACTACACTGACGTCGGCGGTATCCGGCAAGCTCAACCCTCAGGT
129 GTG—  ----GCA-------— GGCGATCTCGGGTCAGCTCAACCCGAACGT
1063 GTG------ GCA---------GGCGATCTCGGGTCAGCTCAACCCGAACGT
* *  *  * * * *  *  * *  *  * * * * * * * * *  *  * *
1 0 2 6 8  GAACTTGGTCGACACGCTCAACAATGGCCAGTACACCGTGTTCGCGCCGA
5 1 6  GAACTTGGTCGACACGCTCAACAATGGGCAGTACACCGTGTTCGCGCCGA
1 2 9  CAATCTCGTCGACACGCTCAACGGCGGCCAGTTCACCGTGTTCGCGCCGA
1 0 6 3  CAATCTCGTCGACACGCTCAACGGCGGCCAGTTCACCGTGTTCGCGCCGA
* *  *  * * * * * * * * * * * * * * *  * *  * * * *  * * * * * * * * * * * * * * * * *
1 0 2 6 8  CCGATCCCGCGTTCGACAAGCTGCCGGCGTCGACGATCGTCCAGCTCAAG
5 1 6  CCGATGCCGCGTTCGGCAAGCTGCCGGCGGTGACGATCGACCAGCTCAAG
1 2 9  CCAATGACGCCTTCGCCAAGATCGATCCGGCCACATTGGAGACCCTCAAG
1 0 6 3  CCAATGACGCCTTCGCCAAGATCGATCCGGCCACATTGGAGACCCTCAAG
* *  * *  * * *  * * * *  * * * *  *  * *  * *  *  *  * * * * * *
10268 ACCGATTCAAACCTG
516 ACCGATTCAAACCTG
129 ACCGACTCCGACCTG
1063 ACCGACTCCGACCTG
* * * * *  *  *  * * * * *
FIGURE 5.9B
CLUSTAL V multiple sequence alignment of predicted amino acid 
sequence (incomplete) of selected M.kansasii strains
10268 MLTTLTSAVSARLNPQVNLVDTLNNGQYTVFAPTDPAFDKLPASTIVQLK
516 MLTTLTSAVSGKLNPQVNLVDTLNNGQYTVFAPTDAAFGKLPAVTIDQLK
129 W QAISGQLNPNVNLVDTLNGGQFTVFAPTNDAFAKIDPATLETLK
* . * «  * * * * * * * * * * *  * *  * * * * * *   ^  ^  ^  ^ *  *
10268 TDSNL
516 TDSNL
129 TDSDL
* * *  *
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5.4DISCUSSION
The presence of an MPB70 gene analog in M.kansasii has not been 
previously demonstrated. Data from Cousins et a/, 1991 indicates that no 
analog was found using the primers tested in that study. This seems to be 
due to the fact much of the homology seen between M.bovis and M.kansasii 
stains is variable among strains and will not be apparent in all strains. 
Although figure 5.6 shows extensive homology between M.bovis (BCG) and 
M.kansasii sequences, the differences are sufficient to allow specific PCR 
primers to be designed.
Our data also indicates a heterogeneity between M. kansasii strains. This 
has also been suggested by authors including Huang et ah, 1991 when 
examining variation in rRNA sequences which are usually highly conserved 
within a species. It may be that M.kansasii strains are continually adapting 
to the intracellular environment, or that the MPB70 gene was simply 
mutated at some point in the evolution of M.kansasii as an animal pathogen. 
Heterogeneity within a gene such as the MPB70 analog may be best 
examined by single strand conformational polymorphism (SSCP) analysis. 
Our SSCP analysis of a limited number of M.kansasii strains shows three 
profiles o f PCR product produced using primers for the MPB70 gene. 
Sequencing data confirms the existence of a variable MPB70 gene analog in 
these strains.
Sequence analysis o f M.kansasii strain NTCC 10268 indicates that if  the 
protein is produced from this MPB70 gene analog there will be amino acid 
differences that may prevent the binding of monoclonal antibodies SBIO and 
polyclonal antisera raised to M.bovis AN5 minor changes as described in 
the specific binding sites would significantly reduce the antibody binding 
capacity according to Radford et al, 1990. However the changes in the SB9 
binding site are insufficient (according to Radford) to prevent the binding of 
this monoclonal antibody, this may be explained by the possibility o f SB9 
binding being moderated by other parts o f the protein not examined in 
Radford's study. The absence of protein production is supported by the fact 
SB9 binding to M.kansasii proteins was not observed by Wood et al, 1988
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or by G.Hewinson (personal communication). Alternatively apparent 
absence o f protein this may be due to lack o f sensitivity o f their assay or 
the fact the protein may not be produced under the conditions used. Another 
explanation for the apparent absence of the protein may be strain to strain 
variation in M.kansasii MPB70 analog production similar to that seen in 
M. tuberculosis strains secreting MPB70.
These results begin to elucidate the strain variation between M.kansasii 
strains. A more detailed study with clearer bacteriological data may help to 
distinguish different types of M.kansasii strains in animal and human 
isolates, and to examine the relative pathogenicity of M.kansasii infections.
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CHAPTER 6
OVERALL DISCUSSION 
When PCR was first recognised has a powerful tool for the amplification of 
DNA many hailed it as the new method that would supersede many other 
diagnostic procedures due to its specificity to chosen disease and its extreme 
sensitivity. Many early studies were based on DNA extracted from cultures 
and purified. These studies gave very optimistic and often unrealistic claims 
that PCR would detect one bacterium in a given sample and in some cases 
even a fraction o f a genome where multiple copies of a target sequence 
where found within the genome. These claims were correct with regard to 
purified DNA tested but bear little relation to the sensitivity levels generally 
found in studies o f clinical samples. The study o f Noordhoek et al. 1994 
demonstrated that when samples were studied blind lower levels of 
sensitivity were achieved when it was not known whether the sample should 
give a positive result or not.
Other studies have demonstrated that PCR is a more sensitive method of 
detection than culturing and can be applied to many types o f clinical sample 
Kox et al. 1994. This study also demonstrates the use o f an anti­
contamination procedure involving uracil-N-glycosylase. It would seem that 
ifPCR is to be used in routine diagnostic laboratories this kind o f precaution 
would be essential.
The main disadvantages of PCR its vulnerability to contamination usually by 
amplicons from previous amplifications. Contamination o f clinical samples 
during processing prior to amplification may be a common method of 
amplification. The results of Noordhoek et al. 1994 demonstrate the 
consequences of gross laboratory contamination indeed one group out o f the 
seven showed positive results for all samples tested in one sample set, 
indicating they had no controls whatsoever. It may be that it is the lack of 
caution shown by some workers when using PCR that has caused many 
gross contamination problems, but a more ominous problem is low level 
contamination which might cause problems in routine diagnostic 
laboratories.
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A further major obstacle to the use o f PCR for diagnostics is inhibition of 
Taq polymerase by constituents o f the sample. False negative results can be 
clinically as dangerous as false positives and may lead to greater disease 
spread. The problem of inhibition is not insurmountable, but purification of 
sample is often necessary, this greatly increases the time taken to carry out 
the PCR based test and can increase sample to sample contamination.
Speed o f sample analysis is one o f the great advantages o f PCR based tests, 
a simple PCR test can be carried out and examined by electrophoresis 
within one day. Southern blotting analysis o f a PCR sample if  necessary can 
take up to three days, when compared to culture techniques (taking 3-6 
weeks) PCR is an extremely rapid test. Commercially the speed o f PCR 
tests makes them very attractive. Companies have begun to look at 
automation of the PCR process from sample extraction to product detection. 
If  a fully sealed automated system could be perfected the problems o f 
contamination might be much reduced. Systems based on capture probe 
methods lend themselves to automation since the probe for the PCR product 
can be attached to such supports as microtitre plates. I f  large scale 
automation could be achieved the costs of PCR based technology might be 
reduced due to reduction of labour costs.
Diseases that might greatly benefit from PCR diagnostics are those where 
low numbers of organisms are present, such as tuberculous meningitis or 
where very rapid diagnosis is essential such as in HIV infected patients or 
acute infections. In specific cases such as these PCR may be an invaluable 
rapid test due to its sensitivity. But where disease is chronic or bacterial 
numbers are high cheaper tests may be such more appropriate such as 
Ziehl-Neelsen staining of smears or culturing o f sample. Compared to such 
tests PCR is an extremely expensive test and a complex one.
The possibility of field based diagnosis with PCR was mooted at an early 
stage in its use for mycobacterial diagnostics. It may yet be that laboratories 
could use PCR but probably only for small numbers o f samples.
The cost o f performing PCR based tests is high partly due to the fact it can
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only be carried out commercially under licence to the pharmaceutical 
company Roche, and related products such as Taq polymerase can only be 
marketed under license. Other companies interested in diagnostic techniques 
based on nucleic acid amplification have sought ways o f circumventing 
these obstacle. The most studied alternative amplification technique: strand 
displacement amplification (SDA) was developed by Becton Dickinson, this 
process is isothermal and therefore does not require specific equipment. 
Another amplification method has been described by Gen-Probe 
incorporated, transcription mediated amplification (TMA) is also an 
isothermal test, both techniques are described in chapter 1. Many more 
amplification techniques are likely to be developed to circumvent the 
problems of patenting, one such technique is the cycling probe reaction 
which is based on the hybridization of a DNA target with a probe consiting 
of DNA-RNA-DNA sequences.
PCR has been applied to many laboratory problems such as isolation of 
genes for which no specific probe is available in many cased degenerate 
primers have been used to isolate genes from chromosomal DNA.
A further possible use o f PCR is to elucidate the causative agents o f 
diseases of unknown aetiology such as sarcoidosis and Crohn’s disease. 
However studies of archival tissue from which DNA has been extracted 
have proven inconclusive and hard to repeat, Fidler et al. 1994 
demonstrated the presence of mycobacterial DNA in a proportion o f 
samples tested. The questions raised by such work is whether the presence 
o f bacterial DNA necessarily implies they are the causative agents o f 
disease or whether they are persisters from previous disease or even 
secondary colonisers o f disease site. The use o f in-situ PCR might help to 
clarify the point but it would still only indicate the presence of bacterial 
DNA and even if  found inside granulomas it may not be related to the 
primary cause of the disease.
The existence of gene analogs is a unexpected problem in the use o f PCR, 
assuming that a particular gene or insertion element is specific to a 
particular bacterium might be problematic, as described in the thesis under
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less stringent PCR conditions than those originally designed for a PCR test 
gene analogs may be detected that lead to inaccurate diagnosis. The constant 
adaptation of mycobacteria to intracellular pathogenicity may lead to the 
loss or acquisition of insertion elements used for diagnosis, it may always 
be prudent to confirm PCR diagnosis with other techniques if  possible or 
use multiple confirmatory tests.
Despite much evidence against the use of PCR for routine diagnostics I feel 
that cautious optimism should be shown for its effective use for the 
diagnosis of specific diseases such as tuberculous meningitis where sample 
group is small, and perhaps o f larger sample groups where tests are fully 
automated from sample DNA extraction to PCR product analysis so that any 
chance o f contamination can be eliminated.
In 1892 Bang stated that " the tuberculin-test is no more perfect than are
other things in this world. Sometimes it fails", I believe the same to be true 
o f polymerase chain reaction, judiciously used it is a infinitely powerful to 
but inappropriately applied it can be a very dangerous technology indeed. 
The principle question addressed in this thesis is whether PCR is a suitable 
test for large scale routine mycobacterial diagnostics. The simple conclusion 
I have drawn is that PCR is not at this point in time a robust enough test to 
be used in routine mycobacterial diagnostics.
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1. SUMMARY
Conventional methods of detecting polymerase 
chain reaction (PGR) products require equipment 
and expertise which may not be available in diag­
nostic bacteriology laboratories, especially in de­
veloping countries. To this end we have examined 
other methods of product detection, including 
fluorescein-12-dUTP incorporation during PGR 
amplification, and reverse probing, where the 
PGR product is used as the probe in a scaled 
down hybridization with a fixed capture probe 
consisting of a fragment entirely internal to the 
sequence of the PGR product. These techniques 
have shown sensitivities of 20 fg of purified my­
cobacterial DNA, which corresponds to approxi­
mately five cells.
Correspondence to: A.J. Woolford, Molecular Microbiology 
Group, School of Biological Sciences, University of Surrey, 
Guildford, Surrey GU2 5XH, UK.
2. INTRODUGTION
Gombatting infectious diseases such as tuber­
culosis and leprosy in tropical countries requires 
the development of diagnostic tests that are not 
only sensitive and specific but are also capable of 
being carried out under field conditions with a 
minimum of equipment. Recent developments in 
gene probe technology, especially the introduc­
tion of the polymerase chain reaction (PGR), 
have opened up the possibility of rapid tests that 
are theoretically capable of detecting a single 
organism in a clinical specimen, and in practice 
are capable of sensitivities approaching that level 
[1-5].
The achievement of this objective requires not 
only simple and robust methods for carrying out 
the PGR reaction itself, but also simplified tech­
niques for detecting the amplified product. The 
conventional method uses agarose gel elec­
trophoresis, combined with Southern blotting and 
hybridisation with a specific labelled nucleic acid 
probe to confirm the identity of the band and 
enhance the sensitivity. These are not yet routine
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procedures in diagnostic microbiology laborato­
ries in this country, and would certainly present 
considerable problems for routine use in a devel­
oping country, especially by mobile teams under 
field conditions. Gel electrophoresis requires a 
stable electricity supply; detection of labelled 
probes commonly uses either radiolabelled nu­
cleotides which have a short half-life or non-iso- 
topic procedures involving enzyme labelling which 
requires refrigeration to maintain stability and 
complex multi-stage detection processes. Further­
more, the procedure takes too long to be really 
suitable for a mobile clinic. The principal aim of 
this work was therefore to investigate alternative 
technologies involving fewer steps and less equip­
ment which would therefore prove more amenable 
for this purpose.
3. MATERIALS AND METHODS
3.1. Preparation o f DNA
M. bouts DNA was extracted from a culture 
grown in 7H9 media using a previously described 
method [6]. M. leprae DNA was a gift from J.J. 
McFadden.
3.2. PCR primers
The following PCR primers were used:
BCG1 GAA GGT CGT CAT CGA CGG TAA GGA
BCG2 CGC CGT TGA CGT TAC CGA GCC CAA
BGG3 TCC GTG GTC TGC ACA A
BC G 4 GGT TGC CGT CGG TGA A
L E P 1  AGA AAA CTT GTC TAT CAC A
L E P 2  CGA TTA GGC ATC TAT GAT T
Primers BCGl and BCG2 amplify a 173-bp 
fragment from a 19-kDa protein antigen gene 
present in the Mycobacterium tuberculosis com­
plex (M  tuberculosis, Mycobacterium bovis and 
BCG) [7,8]. Primers BCG3 and BCG4 result in 
amplification of a 100-bp fragment internal to the 
173-bp fragment of this antigen and were used to 
make a probe for detection of the amplified prod­
uct from BCGl and BCG2. Primers LEPl and 
LEP2 amplify a 592-bp fragment of an 18-kDa 
protein antigen gene of Mycobacterium leprae [9].
These primers were synthesized on an Applied 
Biosystems 381A DNA synthesizer. For the pro­
duction of rhodamine-labelled or biotin-labelled 
primers, the Aminolink 2 reagent (Applied 
Biosystems) was used: this attaches a highly reac­
tive primary amine to the 5' end of the oligonu­
cleotide [10].
3.3. Fluorescein incorporation during PCR
Known amounts of M. leprae DNA were am­
plified using standard PCR conditions [11] with 
200 jCiM of each dNTP except dTTP which was 33 
pM; .each reaction contained 2 nmol fluorescein- 
12-dUTP (Boehringer-Mannheim). Reaction vol­
umes were 90 pi. PCR conditions were: 94°C for 
1 min; 30 cycles of 55°C/1 min, 72°C/2 min, 
94°C/1 min; and finally 1 cycle of 55°C/5 min, 
72°C/7 min.
In order to separate the product from unincor­
porated fluorescein, 70 /a 1 of the reactions were 
applied to a 1-ml Sephadex G-50 (Sigma) column 
and spun at 2500 rpm for 3 min. A 40-/xl aliquot 
of each eluent was spotted onto clingfilm and 
exposed to UV transillumination.
3.4. Reverse probing PCR
Biotinylation of primers was achieved using 
the NHS-ester of Biotin (Clontech) in an 
overnight reaction according to the manufactur­
ers instructions.
PCR was carried out using a Hybaid Omni­
gene PCR machine. For the amplification of the 
173-bp fragment of M. bovis temperatures were: 
94°C for 1 min; 30 cycles of 37°C/1 min, 72°C/2 
min, 94°C/1 min; and finally 1 cycle of 37°C/5 
min, 72°C/7 min. PCR mixes consisted of stan­
dard conditions for 100 p i reaction with 200 ng of 
each primer per reaction.
The capture probe consisted of 20-40 ng of 
the 100-bp fragment generated by PCR using 
primers BCG3 and BCG4 which was attached to 
individual pieces of a positively charged mem­
brane (Pall) by dot blotting after dénaturation. It 
was fixed by placing the membrane on several 
sheets of 3MM paper (Whatman) soaked in 0.4 M 
NaOH for 20 min. Prehybridization was carried 
out with 500 p i  of prehybridization solution con­
sisting of skimmed milk (0.05 g), 6 ml of 20 X SSC, 
1 ml of 10% SDS and 13 ml of water. Hybridiza­
tion with 85 p i of biotin-labelled PCR product
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was carried out overnight at 65°C in a total vol­
ume of 585 p\. Biotin was detected using 
enzyme-linked streptavidin [12].
4. RESULTS AND DISCUSSION
4.1. PCR-incorporation o f fluorescent label
One of the simplest procedures for detection 
of the PCR product would be by dye incorpora­
tion. Initial experiments using rhodamine-labelled 
primers lacked sensitivity, but the availability of 
fluorescein-substituted dUTP enabled us to at­
tempt an alternative approach, namely the incor­
poration of fluorescent label into the amplified 
product, during the amplification reaction. This 
reaction was carried out with M. leprae DNA, 
using primers LEPl and LEP2. For analysis, a 
20-pl sample of each separate PCR reaction was 
electrophoresed through a 1.5% agarose gel. Fig-
1 2 3 4  5 6  7 8
Fig. 1. Detection of PCR products by agarose gel elec­
trophoresis. 1, no DNA; 2, 20 fg M. leprae DNA; 3, 200 fg; 4, 
2 pg; 5, 20 pg; 6, 200 pg; 7, 2 ng; 8, markers (phiX174 HaelU  
digest), (a) direct visualisation; (b) after ethidium bromide 
staining.
Fig. 2. Direct detection of fluorescent PCR products. 1, no 
DNA; 2, 20 fg M. leprae DNA; 3, 200 fg; 4, 2 pg; 5, 20 pg; 6, 
200 pg; 7, 2 ng.
ure la  shows the gel before ethidium bromide 
staining, viewed on a UV transilluminator; the 
amplified product from 2 pg of DNA was clearly 
visible. This degree of sensitivity was at least 
comparable to that obtained by ethidium bromide 
staining, as subsequent ethidium bromide stain­
ing did not significantly improve the detection 
level (Fig. lb). The fluorescence observed in Fig. 
lb is due to both the fluorescent label and the 
ethidium bromide staining.
Other workers have demonstrated the use of 
fluorescently labelled PCR primers for colour 
complementation assays; however to optimize 
such techniques a gene scanner (ABi) is needed 
[13,14]. A further advantage of the incorporation 
of fluorescent label during the PCR amplifica­
tion, as described here, is that it can be adapted 
to allow detection of the product without agarose 
gel electrophoresis. This merely requires separa­
tion of the product from the unincorporated la­
bel, which is readily achieved by Sephadex gel 
filtration. The results (Fig. 2) show that fluores­
cence was observed in PCR samples where only 
20 fg of M. leprae DNA was amplified. This 
represents approximately 5 M. leprae organisms. 
No fluorescence was detected in the negative 
control, in the absence of added DNA. A high 
degree of sensitivity can therefore be obtained 
using standard equipment; the intensity of the 
fluorescence could be enhanced by optimising the 
excitation frequency.
However, this system still does not fully meet 
the requirements of a simple field test, as it 
requires the separation of the PCR products from 
the unincorporated label by a Sephadex column. 
A simpler procedure would be to apply the PCR 
reaction to a filter and wash it with TCA. How­
ever, we found that the filters we used resulted in 
quenching of the fluorescence with associated 
loss of sensitivity (results not shown). Further-
314
REVERSE-PROBING TECHNIQUE
bio t in - la b e l l ed
primer
probe
PCR
o
b io t in - la b e l l ed  
PCR p ro du c ts
nylon m e m b r a n e
^ 1 1  I  I  1 1  I  N i l  1 1 1 1 1 1 1 1 ^
O
c a p tu r e  p r o b e  fixed 
to  nylon m e m b r a n e
PCR p ro d u c t s  hybrid ize to fixed p robe; 
biotin label is d e t e c t e d  by enz y m e-su b s t i tu ted  
streptavidin
Fig. 3. Diagrammatic representation of the strategy for reverse probing.
more, although these primers and PCR condi­
tions have been shown to be specific for M leprae 
(results not shown), for application as a practical
diagnostic test it would be preferable to confirm 
the specific nature of the product for each sam­
ple.
3 4 5 6  7 8 9  1011
B
2
■ *
5
mm 
10
Fig. 4. (a) Sensitivity of biotinylated primers for PCR. The amounts of M  bovis DNA used as template were: 1, 4 fg; 2, 20 fg; 3, 40 
fg; 4, 400 fg; 5, 4 pg; 6, 40 pg; 7, 400 pg; 8, 4 ng; 9, 4 ng; 10, negative (no DNA) control; 11, hX174 H aelll markers, (b) Reverse 
probe technique to detect biotin-labelled PCR products. 1, non-specific control (M. smegmatis DNA as capture probe with 
amplified product as in track 9 in (a); 2, 4 fg; 3, 20 fg; 4, 40 fg; 5, 400 fg; 6, 4 pg; 7, 40 pg; 8, 400 pg; 9, 4 ng; 10, negative control (no
DNA in PCR; track 10 in (a)).
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4.2. Detection o f products by ‘reverse probing’
In order to avoid the need for Sephadex gel 
filtration of the products, and to ensure the speci­
ficity of the test, we used a reverse probe tech­
nique (Fig. 3). This involves the use of single­
strand nucleic acid fragments, complementary to 
one strand of the target sequence (but not includ­
ing the PCR primer sequences) as a ‘capture 
probe’. These DNA fragments are bound to indi­
vidual pieces of nylon membrane, to detect the 
presence of suitably labelled PCR-amplified 
product. Thus after PCR-amplification, the con­
tents of each tube were applied to a separate 
piece of membrane carrying the complementary 
sequence; after washing to remove non-specifi- 
cally bound material, the labelled specific ampli­
fied product can be detected.
For this experiment we used primers BCGl 
and BCG2 to amplify a 173-bp target fragment 
from the 19-kDa antigen gene of the M. tubercu­
losis complex. The capture probe was a 100-bp 
fragment entirely internal to this fragment (i.e., it 
does not include the original primer sequences), 
generated with primers BCG3 and BCG4, and 
was bound to the filters as described in m a t e r i ­
a l s  A N D  m e t h o d s .
Due to the quenching effect of the filters, we 
were unable to use fluorescent label, and there­
fore we employed primers that were 5'-end- 
labelled with biotin. Aliquots of M. bovis DNA 
containing a wide range of amounts of DNA (4 fg 
to 4 ng) were subjected to PCR amplification, 
using the biotin-labelled 19-kDa-specific primers 
BCGl and BCG2. The success of the PCR proce­
dure, and the sensitivity of the amplification step, 
was confirmed by subjecting a 10- / a 1 aliquot to 
agarose gel electrophoresis (Fig. 4a); an amplified 
product was just visible with 20 fg of template 
DNA.
The remainder of each PCR mix (90 p\) was 
hybridized to an individual filter bearing the cap­
ture probe. Following overnight hybridization, the 
presence of M. bovis DNA was demonstrated. 
Using this procedure, a strong reaction was seen 
when as little as 20 fg of M  bovis DNA was used 
as a template (Fig. 4b, spot 3). This corresponds 
to approximately five cells. In this experiment, a 
weaker positive signal was also seen with 4 fg of
starting DNA, but this level of sensitivity was not 
achieved routinely. In order to test the specificity 
of this procedure we used a similar amount (40 
ng) of M. smegmatis DNA as a non-specific cap­
ture probe and 4 ng of M  bovis DNA as the PCR 
template (this corresponds to the highest DNA 
level used in the test reactions). Although, as 
expected, there was a strong band of amplified 
product (Fig. 4a, track 9), there was no hybridisa­
tion to the non-specific capture probe (Fig. 4b, 
spot 1).
The reverse probing technique described here 
is therefore capable of detecting purified DNA 
corresponding to less than 10 cells. Although it is 
likely to be at least an order of magnitude less 
sensitive with tissue samples, this procedure has 
considerable potential due to its sensitivity and 
simplicity. However, it requires further work to 
establish the optimum size of the immobilized 
capture probe and improved methods for attach­
ing it to the filter, since it appears that a consid­
erable proportion of the capture probe is unavail­
able for hybridization to the PCR product. In 
addition, alternative non-quenching supports 
need to be investigated to enable the method to 
be applied to fluorescent labelled products, which 
would be simpler to detect. Fiss et al. [15] have 
recently described a reverse probing technique 
using biotin end-labelled primers as the reverse 
probe, while other workers have demonstrated 
that the incorporation of digoxygenin during PCR 
is an effective way of making probes for in situ 
hybridization [16].
The results we have obtained establish that the 
incorporation of fluorescent molecules into PCR 
products does not significantly decrease the sensi­
tivity of the test, and that the combination of 
fluorescent labelling and reverse probing has con­
siderable potential for the development of a sim­
ple and robust diagnostic screening procedure 
that would be applicable under field conditions.
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